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Summary of thesis
In mammals, there are subsets of genes that are only expressed from one 
parental allele. This phenomenon, known as genomic imprinting, relies on epigenetic 
marks to distinguish between the two parental alleles. These epigenetic marks are 
erased and re-established in the germ line of every generation.
Cdknlc is an imprinted gene in humans and mice. Maternal specific 
expression of Cdknlc depends on a germ line DNA methylation mark at a distant cis 
element (KvDMRl), also known as the imprint control region. When DNA 
methylation is lost at KvDMRl, Cdknlc expression is suppressed. On the paternal 
allele, silencing of Cdknlc is associated with the expression of a distantly located 
non-coding RNA (Kcnq lo t i  /Lit 1) overlapping the KvDMRl, which is presumed to 
mediate silencing through the formation o f heterochromatin. In somatic cells, long 
term full silencing of paternal Cdknlc is maintained by DNA methylation at a CpG 
island within Cdknlc.
We have shown that embryonic germ (EG) cells, derived from 12.5 dpc 
primordial germ cells, are a good model for studying the early epigenetic events that 
lead to heritable silencing of imprinted genes. Cdknlc expression was suppressed in 
differentiated EG cells compared to embryonic stem (ES) cells indicating that this 
domain is silent in EG cells. The Cdknlc CpG island was hypomethylated in both 
undifferentiated and differentiated EG cells and was also hypomethylated in ES and 
androgenetic (AG) stem cells indicating that DNA methylation was not required for 
silencing Cdknlc. Suppression of Cdknlc was likely due to the acquirement of 
repressive histone marks. H3K27me3 was found enriched at the Cdknlc promoter in 
differentiated EG cells and in undifferentiated and differentiated AG cells but was 
absent in undifferentiated EG cells indicating that this mark was specifically recruited 
during EG cell differentiation.
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Abstract
Abstract
Genomic imprinting is the process of allele-specific gene regulation. Heritable 
epigenetic modifications such as DNA methylation and chromatin modifications 
establish and maintain differences between the parental genomes that result in the 
expression o f only one allele. Imprints (including methylation marks) are reset in the 
germ line during gametogenesis. Mouse distal chromosome 7 contains a 1 Mb 
imprinted domain that is homologous to human 11 p i5 chromosome region and 
contains approximately 16 imprinted genes. Dysregulation of imprinting within this 
cluster can cause Beckwith-Wiedemann syndrome (BWS) in humans, a 
developmental disorder characterised by foetal overgrowth, embryonic tumours and 
developmental abnormalities. The majority o f familial cases of BWS, which represent 
less than 5 % of the total reported, are caused by mutations in the cyclin-dependent 
kinase inhibitor gene CDKN1C. Imprinting of mouse Cdknlc is controlled by the 
imprinting control region KvDMRl, a differentially methylated CpG island within 
intron 10 of the imprinted Kcnql gene. Maternal methylation of the KvDMRl 
correlates with suppression o f the antisense non-coding RNA transcript K cnqlotl/L itl 
and expression of the surrounding genes. On the paternal chromosome, KvDMRl is 
unmethylated and K cnqlotl/L itl is expressed. The surrounding genes are silent. It has 
been proposed that K cnqlotl/L itl acts in a similar way as Xist in X-chromosome 
inactivation by recruiting histone modifying enzymes such as the polycomb repressor 
complexes (PRC) and DNA methyltransferases.
Primordial germ cells (PGC) derived from 12.5 dpc embryos can be cultured 
‘in vivo ’ as embryonic germ (EG) cells. They lack DNA methylation at ICRs and are 
thought to represent an ‘imprint erased’ cell type. In the absence of an imprint the
7
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maternally expressed genes within the IC2 domain are silent (Lee et al. 2002; Tada et 
al. 1998). There appears to be a default sequence of silencing that occurs in the 
absence of an imprint. Tada et al. showed that Cdknlc was not expressed in in vivo 
differentiated EG cells. Moreover, the locus acquired de novo methylation when 
differentiated in vivo (Tada et al. 1998).
The aim of this study was to determine the default sequence of epigenetic 
events that lead to the silencing of Cdknlc in EG cells, as reported by Tada et al., by 
establishing an in vitro model for differentiation. Expression of the imprinted genes 
within the IC2 domain was examined by real time quantitative RT-PCR in order to 
determine if the genes were silenced during differentiation of the EG cells. Various 
DNA methylation techniques were used to determine if  Cdknlc methylation, which 
was reported to occur de novo in vivo, was established in these differentiated cells. 
Also the histone modifications associated with ‘non-imprinted’ and ‘imprinted’ 
chromatin were examined in EG and androgenetic (AG) cells in order to determine if  
there were changes to histone modifications during differentiation that might be 
involved in the silencing of the IC2 domain genes.
Our data confirmed the absence of DNA methylation at both the germ line and 
somatic DMRs within the IC2 domain in undifferentiated EG cells. We showed that 
the maternally expressed genes were not expressed in these cells after differentiation, 
reflecting the in vivo data. In contrast Kcnqlotl/L itl expression was detected in 
undifferentiated and differentiated EG cells at levels that appeared biallelic. Our 
analysis also confirmed the observations of others which suggest the existence of at 
least two types of imprinted gene, those that require an imprint to be silenced (the 
normal accepted view of imprinting) and those that require an imprint to be expressed. 
This is supported by data from cloned embryos made from day 11.5 XX and XY
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PGCs where, in the absence of an imprint on KvDMRl, Cdknlc is not expressed (Lee 
et a l 2002).
We showed that methylation at the Cdknlc DMR was not acquired in 
differentiated EG cells. Surprisingly, we also found that ES cells were 
hypomethylated at the Cdknlc locus in both undifferentiated and differentiated cells 
indicating that silencing of paternal expression of Cdknlc occurs independently of 
DNA methylatioa Chromatin immunoprecipitation (ChIP) analysis showed that the 
repressive H3K27me3 modification was present in both undifferentiated and 
differentiated AG cells. In contrast, this mark was only present in the differentiated 
EG cells. This suggested that H3K27me3 was actively recruited to the Cdknlc locus 
as EG cells differentiated. This supports the hypothesis that EG cells are not 
equivalent to the silenced paternal allele o f the mouse distal chromosome 7 domain 
but represent an earlier chromatin state. Therefore, we can use these cells to identify 
the sequence of events that lead to silencing of Cdknlc.
9
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Chapter 1: General Introduction
1. General Introduction
1.1 Epigenetic regulation of gene expression
1.1.1 Genetic and epigenetic information
All the information required for an organism to grow, develop and reproduce
is encoded within its DNA. The number of protein coding genes found within the 
human and mouse genome is approximately 20,000 -  25,000 (Abdellah et a l 2004; 
Lander et al. 2001; Waterston et a l  2002). Development of an organism is a very 
orderly process that involves the silencing and expressing of genes at specific time 
points to give the array of differentiated cell types within the adult organism. This 
switching on or off of genes is known as ‘epigenetics’ and was first described by 
Waddington in the 1940s as a way o f modifying the actions of genes during 
development (Waddington 1942). It is now accepted that, in most cases, chemical 
modifications to DNA and chromatin are responsible for these complex changes in 
gene expression and not alterations or deletions to the DNA sequences. This includes 
the methylation of DNA and the packaging of DNA into chromatin (Hebbes et a l 
1988; Holliday and Pugh 1975; Monk et a l 1987; Razin and Cedar 1977). Epigenetic 
information is naturally robust and reliable, can be stably inherited through numerous 
cell divisions and is involved in diverse processes from controlling tissue-specific 
gene expression, genomic imprinting and X-inactivation (Hebbes et a l 1988; 
Jeppesen and Turner 1993; Monk et a l 1987; Roemer et a l 1997).
1.1.2 Mono-parental embryos
The non-equivalence of the parental genomes in mammals was first identified
in the early 1980s in experiments using pronuclear transplantation to generate 
‘gynogenetic’ (2 maternal genomes) and ‘androgenetic’ (2 paternal genomes) mouse
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embryos (Barton et al. 1984; McGrath and Solter 1984; Surani and Barton 1983; 
Surani et al. 1984) (figure 1.1). These embryos died at around 10 days of gestation 
and, when the foetuses were compared, morphological and developmental differences 
were observed (McGrath and Solter 1984; Surani et al. 1984). The gynogenetic 
embryos developed to the 25-somite stage but were growth retarded and showed poor 
development of the extraembryonic tissues (Barton et al. 1984; Surani and Barton 
1983). Androgenetic embryos developed poorly with almost exclusive development 
of the extraembryonic tissues (Barton et al. 1984; Surani et al. 1984).
Both gynogenetic and parthenogenetic embryos contain two maternal 
genomes. However, gynogenetic embryos are created by pro-nuclear injection 
whereas parthenogenetic embryos are created by artificially activating an oocyte. 
Parthenogenetic foetuses demonstrate the same developmental abnormalities as 
gynogenetic foetuses suggesting that the presence of two female pronuclei is not 
developmentally viable (Surani and Barton 1983; Surani et al. 1984). The pro-nuclear 
transplantation experiments demonstrated that, in mammals, both parental genomes 
are required for normal embryonic development (McGrath and Solter 1984; Surani et 
al. 1984).
12
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Normal embryo
ParthenogeneticAndrogenetic
Figure 1.1: Parthenogenetic and androgenetic embryos.
Pro-nuclear transplantation was used to create parthenogenetic (2 maternal genomes) 
or androgenetic (2 paternal genomes) embryos. Parthenogenetic embryos show 
relatively normal embryonic development (Emb = Embryo) until 10.5 dpc but poor 
development of the extraembryonic tissue (YS = yolk sac, TB -  trophoblast). 
Androgenetic embryos have a well defined trophoblast at this time point but poor 
development of the embryo. Adapted from (Barton et al. 1984; Surani et al. 1984). 
Copyright Macmillan Publishers Limited.
1.1.3 Genomic imprinting
Within vertebrate groups, genomic imprinting is a type of gene regulation that
is specific to mammals and results in differential expression of some autosomal genes 
[Reviewed in (Delaval and Feil 2004; Reik and Walter 2001)]. Most autosomal genes 
are biallelically expressed but there are a subset of genes that are only expressed from 
either the paternal or the maternal allele (Beechey et al. 2008; Cattanach and Kirk 
1985). Imprinted genes are expressed (and imprinted) predominantly in the 
developing embryo, placenta and the perinatal and postnatal brain. They are
13
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commonly involved in embryonic growth, foetal development and behaviour after 
birth; many also seem to be important for placental development (Beechey et a l 
2008; Keveme et a l 1996; Mann et a l 2004; Plagge et a l 2005; Salas et a l 2004). 
Thus far, approximately 90 imprinted genes have been identified (Beechey et a l 
2008). Those that are involved in growth promotion, such as the insulin-like growth 
factor 2 (Jgf2\ tend to be expressed from the paternal derived chromosome whereas 
those that are growth suppressing, like the cyclin-dependent kinase inhibitor Cdknlc, 
tend to be expressed from the maternally derived chromosome (Caspary et a l 1999; 
Morison and Reeve 1998). Figure 1.2 shows a number of imprinted genes found 
within the mouse genome.
Imbalanced expression of imprinted genes is probably responsible for the 
death o f gynogenetic and androgenetic mouse embryos. The paternally expressed 
genes Pegl/Mest, Ig/2, Peg3 and Snrpn are not expressed in gynogenetic or 
parthenogenetic embryos whereas maternally expressed genes HI9 and Igf2r are 
biallelic. Conversely, in the androgenetic embryos HI9 and lgf2r are repressed but 
Igf2 and Snrpn are biallelically expressed (Horii et a l 2008; Obata et a l 1998; Szabo 
and Mann 1994).
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Figure 1.2: Location of imprinted genes in the mouse genome.
The majority of imprinted genes within the mouse genome are found and co-ordinately regulated in clusters and contain both maternally 
and paternally expressed genes. Around 90 imprinted genes have, so far, been identified. The majority of the imprinted genes have roles 
in embryonic growth, development and behaviour. From (Beechey et al. 2008).
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1.1.4 The evolution of imprinting
The evolution of imprinting is a hotly debated topic with many theories
surrounding the question of why we have imprinted genes. The majority of the genes 
in the mammalian genome are diploid (the exceptions are present on the sex 
chromosomes) which is presumed to reduce the effects of deleterious mutations that 
can result in a missing, altered or non-functioning protein. Genomic imprinting 
effectively negates the effect of diploidy so essentially all imprinted genes are 
functionally haploid. This means that a mutation in the expressed copy of the gene can 
not be compensated for as the second copy is silent.
The parental conflict theory, developed by David Haig, predicted that 
paternally expressed genes would be growth promoting whereas maternally expressed 
genes would be growth inhibiting (Haig 1997; Haig and Westoby 1989) [Reviewed in 
(Moore and Reik 1996; Wilkins and Haig 2003)]. This applies to mammalian species 
where there is an unequal provision o f resources after conception (Haig 1997; Moore 
and Haig 1991). In the parental conflict model it is theorised that the paternal genome 
derived imprinted genes are driven to promote growth by extracting maximal 
resources for the offspring, while the maternal derived genes aim to limit this demand 
so as to not affect the mother’s own fitness and productivity (Haig and Graham 1991; 
Moore and Haig 1991). This theory, however, can only be applied to imprinted genes 
that regulate growth.
Other theories have been proposed to explain why we have imprinted genes 
[Reviewed in (Wilkins and Haig 2003)]. One theory is that genomic imprinting arose 
as a mechanism to protect females from ovarian trophoblastic disease (Varmuza and 
Mann 1994). Another suggests that imprinting may have also developed as a way to 
protect a subset of alleles from natural selection and so allow mammals to adapt
16
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quickly to environmental changes (Beaudet and Jiang 2002). The fact that many o f the 
imprinted genes are involved in growth and nutrition does seem to suggest that the 
parental conflict theory is a good explanation for the evolution of imprinting. 
However, it may be that imprinting evolved as a result of multiple evolutionary 
pressures.
Among vertebrates, autosomal imprinting has only been found in eutherian 
mammals and marsupials but not in egg-laying species such as fish, amphibians, 
reptiles or birds (Killian et a l 2001; Nolan et al. 2001; Suzuki et a l 2005) and not in 
the oviparous monotremes such as the platypus and the echidna (Killian et a l 2000; 
Killian et a l  2001). This suggests that imprinting may have evolved along side the 
emergence of viviparity and particularly for the development of the extraembryonic 
tissues including the trophoblast. Many imprinted genes, such as achaete-scute 
complex homolog-like 2 (Ascl2) and tumour-suppressing subchromosomal 
transferable fragment 4 (Tssc4\ are expressed solely in the placenta (Cerrato et a l 
2005; Umlauf et a l 2004). However, this would also comply with the parental 
conflict model as controlling placental development can affect the growth of the 
developing offspring.
Although imprinting of a considerable number of genes is highly conserved 
between the mouse and human, there are also several genes where the imprinting 
status differs between the two species (Kalscheuer et a l  1993; Monk et a l 2006). The 
insulin-like growth factor receptor 2 (IGF2R) gene is imprinted only during early 
development then lost in later developmental stages in some humans whereas the 
imprinting status of the mouse Igf2r gene is stable at all developmental stages 
(Lerchner and Barlow 1997; Monk et a l 2006; Riesewijk et a l 1998). The IGF2R 
gene is polymorphically imprinted in humans with the majority showing biallelic
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expression of this gene (Riesewijk et a l  1998; Xu et a l 1993). This may be because 
mice are multiparous while humans are generally uniparous resulting in relaxation of 
imprinting in humans due to reduced selective pressure on IGF2R.
1.1.5 Imprinting disorders and Beckwith-Wiedemann syndrome 
(BWS)
Genomic imprinting is essential for normal embryonic growth. There are 
several disorders that result from a disruption in imprinting, often leading to severe 
growth anomalies or inviability for the developing embryo (Lee 2003). An example is 
Beckwith-Wiedemann Syndrome (BWS), a congenital disorder characterised by pre- 
and post-natal macrosomnia, macroglossia, organomegaly, exomphalos and 
embryonic tumours (Beckwith 1969; Gicquel and Le Bouc 2001) [BWS reviewed in 
(Maher and Reik 2000)]. The disease was mapped to a 1 Mb imprinting domain on 
human chromosome 1 lp l5 (Koufos et a l 1989; Ping et a l 1989) that contains both 
growth promoting and growth inhibiting genes and is homologous to an imprinting 
domain on mouse distal chromosome 7 (Onyango et a l 2000). BWS can arise as a 
result of uniparental disomy (UPD), specific mutations or translocations of human 
chromosome 1 lp l5 (Hatada et a l 1996; Henry et a l 1991; Hoovers et a l  1995; Lam 
et a l 1999). There are also some epigenetic abnormalities that can also lead to 
disruptions in imprinting such as loss of imprinting of KCNQlOTl/LITl which is the 
most common genetic alteration in BWS (Lee et a l  1999; Weksberg et a l 2001).
Interestingly, the only mutation that results in familial cases of BWS is located 
within the growth inhibitor gene CDKN1C that is normally silent on the paternal 
chromosome. Maternally inherited mutations have been identified in ~ 40 % of BWS 
families and ~5 % o f sporadic cases (Hatada et a l 1996; Lam et a l 1999; Lee et a l 
1997). CDKN1C encodes a cyclin dependent kinase inhibitor belonging to the CIP
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family of regulators and is involved in regulation of the cell cycle during the transition 
between the G1 and S phases (Lee et a l 1995; Matsuoka et al. 1995). From 
experiments in mice where Cdknlc was deleted, it was identified that loss of Cdknlc 
expression results in multiple developmental abnormalities, such as exomphalos and 
renal medullary dysplasia, that are associated with BWS, as well as contributing to the 
overgrowth phenotype (Zhang et a l 1997). This concurs with the observation that 
exomphalos is more common in patients with mutations in CDKN1C but not IGF2 
(Cooper et a l 2005; Lam et a l  1999). Over-expression of the IGF2 gene, within the 
same cluster, contributes not only to the overgrowth phenotype but is involved in 
Wilm’s tumour development (Bliek et a l  2001; Cooper et a l 2005; Sparago et a l 
2007). BWS patients with a loss of imprinting of IGF2 are phenotypically 
indistinguishable from those with mutations in CDKN1C although those with a 
mutation in CDKN1C are unlikely to develop embryonic tumours (Caspary et a l 
1999; Weksberg et a l  2001). The effects of increased 1GF2 in BWS may be mediated 
through a decrease in CDKN1C expression as it has been shown that Cdknlc 
expression is reduced in mice with high serum levels of Igf2 (Caspary et a l 1999; 
Grandjean et a l 2000).
1.2 Mechanisms of imprinting
1.2.1 ICRs and models of gene silencing
Epigenetic mechanisms such as DNA methylation and chromatin
modifications regulate gene expression in several areas of the mammalian genome 
including X chromosome inactivation, heterochromatin formation, silencing of 
parasitic elements and genomic imprinting (Hebbes et a l 1988; Kohlmaier et a l 
2004; Lehnertz et a l 2003; Li et a l 1993; Sado et a l 2000).
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Imprinted genes generally occur in clusters that extend for distances as large 
as 4 Mb (Buiting et a l 1995; Koufos et a l 1989; Lopes et a l 2003). They are co- 
ordinately regulated within these clusters suggesting the presence of shared regulatory 
elements acting to control imprinting of multiple genes. These regulatory elements are 
termed imprinting control regions (ICRs) and several have been identified by their 
differential methylation patterns in imprinted clusters and loss of imprinting when 
these regions are deleted (Ainscough et a l 2000; Buiting et a l 1995; Lee et a l 1999; 
Leighton et a l  1995; Smilinich et a l  1999; Thorvaldsen et a l 1998). Heritable 
modifications of DNA and chromatin may work together to confer imprinting as 
methylation of an ICR can affect expression of imprinted genes that are several Kb 
away (Lopes et a l  2003; Zwart et a l 2001). Not all genes within a domain are 
imprinted. Therefore, either ICRs have the ability to control which genes within a 
cluster become imprinted or there are differences in the target sequences between 
imprinted and non-imprinted genes. Imprinted genes and ICRs are often associated 
with CpG islands (Smilinich et a l 1999; Sutcliffe et a l 1994; Wutz et a l 1997). 
These CpG islands often show allele-specific differences in 5-methylcytosine (5meC) 
patterns and are called differentially methylated regions (DMRs) (Li et a l 1993; 
Sutcliffe et a l  1994; Thorvaldsen et a l 1998; Tremblay et a l 1997). The DMRs lie 
within the imprinting centre and differential DNA methylation is usually, but not 
exclusively, established in the germ line and so point to a role in controlling 
imprinting (Davis et a l  2000; Smilinich et a l 1999; Tucker et a l 1996).
It is not yet fully understood how imprinting occurs over such large domains. 
Many of the imprinted domains that have been studied so far appear to employ 
different mechanisms for imprinting ranging from an insulator model, to block access 
of imprinted genes to enhancers, and to the non-coding RNA model that recruits
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chromatin remodelling enzymes. The insulator model has been proposed for the Ig/2- 
H19 imprinting domain (figure 1.3 A) where the ICR functions as a methylation- 
sensitive binding domain for the zinc-fmger transcription factor CTCF (CCCTC- 
binding factor) which is located between the reciprocally imprinted Igf2 and HI 9 
genes (Leighton et a l  1995; Schoenherr et a l 2003; Thorvaldsen et a l 1998; Yang et 
a l 2003). The CTCF protein has been described previously as an activator, repressor 
and chromatin insulator element and forms a transcriptional switch between HI 9 and 
Igf2 expression (Bell and Felsenfeld 2000; Ishihara et a l 2006; Schoenherr et al. 
2003; Yang et a l 2003). The ICR is unmethylated on the maternal chromosome and 
can bind CTCF. This insulates Igf2 from the downstream shared enhancers resulting 
in expression of HI 9, a non-coding RNA transcript. On the methylated paternal 
chromosome, CTCF cannot bind the ICR so the enhancers can drive expression of 
Ig/2 (Schoenherr et a l  2003; Thorvaldsen et a l 1998; Yang et a l 2003). A functional 
role for the HI 9 transcript has not yet been determined but it may serve to recruit 
repressive histone modifications to the Igf2 gene to further prevent transcription 
(Gabory et a l  2006; Jones et a l  1998a).
The non-coding RNA model was proposed for the Igf2r domain where the 
ICR is found within the Igf2r gene (figure 1.3 B). The ICR is a differentially 
methylated CpG island located at the promoter region of an antisense non-coding 
RNA transcript called Air which is expressed on the unmethylated paternal 
chromosome whereas the surrounding genes are silent (Lyle et a l 2000; Sleutels et a l 
2002; Wutz et a l  1997). On the methylated maternal chromosome the antisense 
transcript is not expressed. Imprinting of the Igf2r gene has been shown to occur in 
opossum and canines but in the absence of both methylation of the DMR and 
expression of the antisense transcript (O'Sullivan et a l 2007; Weidman et a l 2006),
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suggesting that these mechanisms may have evolved later to regulate silencing within 
the Igf2r imprinting domain.
The non-coding RNA model has also been proposed for the mouse distal 
chromosome 7 IC2 imprinting domain (figure 1.3 C). In this domain maternal 
methylation of the ICR (known as KvDMRl) results in the expression of the 
surrounding maternally expressed genes (Fitzpatrick et a l 2002; Kanduri et a l 2002). 
On the paternal chromosome, DNA methylation is absent from KvDMRl, the 
surrounding maternally expressed genes are silent but there is expression of the 
paternally expressed non-coding RNA, Kcnq lo ti/L it 1, from a promoter within 
KvDMRl (Diaz-Meyer et a l 2003; Fitzpatrick et a l 2002; Shin et a l 2008).
Non-coding RNAs are found within most imprinting domains and an attractive 
hypothesis is that they are involved in targeting repressive histone modifications to 
the flanking genes as has been shown for Xist and X chromosome inactivation 
(Clemson et a l 1996). It is also possible that expression of the non-coding RNA in 
imprint domains simply reflects the activity of other regulatory elements such as 
boundary and silencer elements. However, recent data for the Igf2r cluster (Sleutels et 
a l 2002) and the IC2 domain (Mancini-DiNardo et a l 2006) suggests that it is 
transcription of the non-coding transcript itself that is required to establish silencing 
of neighbouring genes.
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Figure 1.3: Coordinated regulation of imprinted genes within clusters.
A ICI domain from mouse distal chromosome 7. When unmethylated the H I9 DMR 
binds CTCF preventing access of Ig/2 to its downstream enhancers (Cerrato et al. 
2005). B lgf2r imprinted domain showing the non-coding RNA model of regulation. 
The DMR is located on the promoter region of Air. When methylated expression of 
Air is prevented resulting in expression of the surrounding imprinted genes (Sleutels 
et al. 2001). C IC2 domain from mouse distal chromosome 7. Maternal methylation 
of the KvDMRl results in expression of the surrounding maternally expressed genes. 
On the paternal allele, lack of methylation at the KvDMRl results in expression of a 
non-coding RNA Kcnq lo ti  /Lit 1 and silencing of the surrounding maternally 
expressed genes (Cerrato et al. 2005).
Blue boxes indicate paternally expressed genes, orange boxes indicate maternally 
expressed genes, and white boxes are biallelically expressed genes. Red lolly pops are 
germ line methylation marks, blue lolly pops are somatic methylation marks. Pink 
boxes are differentially methylated regions (DMRs). Arrows indicate direction of 
transcription.
1.2.2 DNA methylation and gene silencing
DNA methylation is part of a multi-level control mechanism which regulates
the expression of eukaryotic genes. DNA methylation normally has a repressive 
function when found at the promoters of genes. Genomic methylation can be inhibited
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by treating cells with 5-azacytidine resulting in the reactivation of the transcriptionally 
inactive X-chromosome and abnormal gene expression (Jones et a l 1983; Mohandas 
et a l 1981; Vasques et a l  2005).
DNA is methylated by the addition of a methyl group at the 5 position of 
cytosine to form 5-methylcytosine (5meC) (Razin and Cedar 1977). The majority of 
DNA methylation within the mammalian genome occurs at symmetrical CpG 
dinucleotides and is mediated by DNA methyltransferases (Bestor et a l 1988; Bird 
1986; Li et a l 1992) [reviewed in (Bird 2002)] (figure 1.4). The proportion of 5meC 
in the vertebrate genome is just 1 - 2 %, potentially as a consequence of the mutagenic 
nature of 5meC which can undergo deamination (Chan et a l 2001; Cooper and 
Krawczak 1989; Ehrlich et a l 1982; Razin and Cedar 1977). CpG dinucleotides are 
under-represented in the mammalian genome except for discrete regions called CpG 
islands. CpG islands are defined as regions of DNA that are more than 200 bp in 
length with a normal CpG (cytosine-guanine) dinucleotide density i.e. CpG 
dinucleotides are not under represented (Bird et a l 1985; Gardiner-Garden and 
Frommer 1987). Many CpG islands are associated with the promoter regions of genes 
and the majority are unmethylated (Gardiner-Garden and Frommer 1987; Yamashita 
et a l 2005). During development, some CpG islands become methylated and the 
associated genes become stably silent (Monk et a l 1987). CpG islands can also be 
found in many parasitic elements such as retrotransposons, LINEs and SINEs and 
these are usually methylated (Walsh et a l 1998; Yoder et a l 1997).
Methylation o f CpG islands is normally linked with gene silencing. 
Methylation of cytosine is associated with alterations to the chromatin structure, 
affecting the interaction of transcription factor complexes with DNA [reviewed in 
(Bird and Wolffe 1999; Jones and Takai 2001; Santos et a l 2005)]. Specificity protein
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1 (SP1) is a transcription factor found in eukaryotes that binds to a conserved ‘GC 
box’ motif containing a potentially methylated CpG site. Methylation of this site, 
however, does not prevent SP1 from binding (Harrington et a l 1988). SP1 binding 
can form a physical barrier that prevents nearby CpG islands from becoming 
methylated and may be required to keep frequently active genes switched on 
(Brandeis et a l  1994; Siegfried et a l 1999). There is evidence to suggest that removal 
of the SP1 binding sites flanking a CpG island can lead to its de novo methylation 
during development (Brandeis et a l 1994; Macleod et a l 1994; Siegfried et a l  1999). 
There are a large number o f parasitic DNAs within the mammalian genome and these 
elements must be constantly silenced suggesting that it may be necessary for the 
genome to stay in a default silent, and so methylated state (Walsh et a l 1998; Yoder 
etal. 1997).
DNA methylation can recruit non-histone proteins, such as the methylated 
CpG-binding domain (MBD) proteins. These are transcriptional repressors that 
interact with, and establish complexes with, histone deacetylating complexes 
(HDACs) and nucleosome remodelling proteins (Jones et a l 1998b; Nan et a l 1998; 
Reese et a l 2007). MECP2 is a MBD protein involved in gene silencing and 
mutations in MECP2 have been found in Rett syndrome patients (Amir et a l 1999; 
Makedonski et a l  2005). This protein is thought to promote silencing by binding to 
methylated DNA and recruiting HDACs to the surrounding chromatin, blocking 
transcription in mammals (Jones et a l 1998b; Nan e ta l  1998).
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Figure 1.4: Methylation of cytosine at CpG dinucleotides.
Cytosines are methylated at the 5 position of cytosine at the symmetrical CpG 
dinucleotide by the action of DNA methyltransferases (Dnmts). From 
http://www.sci.osaka-u.ac.ip/introduction/eng/biology.html
1.2.3 DNA methyltransferases (Dnmts)
DNA methyltransferases (Dnmts) are enzymes that are responsible for
establishing and maintaining methylation at CpG dinucleotides. In mammals there are 
three distinct families of DNA methyltransferases: Dnmtl, Dnmt2 and Dnmt3. Dnmt3 
enzymes are thought to control de novo methylation in the germ line and in the pre­
implantation embryo (Hsieh 1999; Okano et al. 1998a; Xie et al. 1999) (Figure 1.5).
Dnmtl is a maintenance methylation enzyme as it has a high affinity for hemi- 
methylated DNA in vivo. Targeted deletion of the Dnmtl gene in mice results in 
global de-methylation causing mid-gestational lethality, growth retardation and 
dysregulation of some, but not all, imprinted genes (Caspary et al. 1998; Lei et al. 
1996; Li et al. 1993; Li et al. 1992). Xist repression in visceral endoderm is unaffected 
in Dnmtl-/- embryos, suggesting that Dnmtl is not required for imprinted X
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chromosome inactivation. Random X inactivation, however, is unstable suggesting 
that Dnmtl expression may be necessary to maintain random X inactivation in the 
embryo (Sado et al. 2000; Vasques et al. 2005). Dnmtl null ES cells are viable 
although they contain low levels of DNA methylation probably because there are 
other Dnmts in ES cells that are responsible for de novo methylation (Lei et a l 1996; 
Li e ta l  1992).
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Figure 1.5: Function of DNA methyltransferases (Dnmts) in establishing
methylation marks at DMRs in germ cells.
Dnmtl contains both the catalytic domain, responsible for enzymatic activity of the 
enzyme, and a cysteine rich domain of no known function. Dnmt2, Dnmt3a and 
Dnmt3b all share the catalytic domain however, Dnmt2 lacks the cysteine rich 
domain. Dnmt3L has no catalytic activity and is thought to direct methylation of other 
Dnmts to specific targets. Dnmts are expressed during gametogenesis at stages where 
imprints are established and have different functions depending on whether they are 
expressed in males or females. Vertical bars inside the catalytic domain correspond to 
highly conserved motifs found in most DNA methyltransferases.
Dnmtl is known to interact with histone modifying enzymes and methyl CpG 
binding proteins (Fuks et a l 2000; Kimura and Shiota 2003; Robertson et a l 2000). It 
also interacts with the de novo DNA methyltransferases Dnmt3a and Dnmt3b 
suggesting that Dnmtl may play a role in establishing as well as maintaining 
methylation (Margot et a l 2003). DnmtSb and Dnmtl double knockout cells have an 
approximately 95 % reduction in the 5meC content compared with only 20 % 
reduction seen in the single Dnmtl knockout and less than 3 % seen in the Dnmt3b
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knockout (Rhee et a l 2002). This leads to reactivation of normally silent genes such 
as p l6 INK4a, T1MP-3 and TWIST suggesting that Dnmt3b and Dnmtl co-operate to 
maintain global patterns of DNA methylation (Leu et a l 2003; Rhee et a l 2002).
An oocyte-specific isoform of Dnmtl (Dnmtlo) has been shown to 
accumulate in the nucleus at the beginning of oocyte growth (Howell et a l  2001; 
Mertineit et a l 1998). In the pre-implantation embryo, Dnmtlo enters the nucleus 
transiently at the eight-cell stage and maintains the maternal methylation pattern 
(Mertineit et a l 1998; Ratnam et a l 2002). Deletion of the oocyte-specific isoform of 
Dnmtl does not affect global methylation patterns yet results in reactivation of some 
of the normally silent imprinted genes probably due to the loss of maternal 
methylation marks (Bourc'his et a l 2001; Howell et a l 2001; Li et a l 1992). This 
indicates that the oocyte specific isoform of Dnmtl is a maintenance 
methyltransferase required to specifically maintain imprinted loci in oocytes and early 
embryonic development (Cirio et a l 2008; Howell et a l 2001).
Dnmt2 is a conserved gene found in eukaryotes (Jeltsch et a l 2006). For a 
long time the biological function of Dnmt2 was unknown. It has DNA 
methyltransferase activity but ES cells null for Dnmt2 are viable and show normal 
patterns of methylation (Goll et a l 2006; Okano et a l 1998b). Recent evidence now 
suggests that Dnmt2 has a role as a novel tRNA methyltransferase. Dnmt2 methylates 
tRNA3815 with high affinity, however the biological function of this is still unclear 
(Goll et a l 2006). It is possible that Dnmt2 plays a role in RNA interference and 
remodelling of chromatin as Dnmt2 activity has been associated with these two 
processes in Dictyostelium (Jeltsch et a l 2006).
There are two *de novo ’ DNA methyltransferases, Dnmt3a and 3 b, that are 
expressed in the germ line and are just two of the factors known to establish
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methylation patterns in germ cells (Kaneda et al. 2004; Kato et a l 2007; Okano et al. 
1999). Dnmt3a and Dnmt3b are de novo methyltransferases as they are responsible for 
the addition of methyl groups on unmethylated DNA. They are essential for de novo 
DNA methyltransferase activity in murine ES cells and in early embryos (Chen et al. 
2003; Okano et al. 1999).
Mice with a targeted deletion of Dnmt3a appear normal at birth but become 
growth restricted and die at about 4 weeks o f age (Hiura et al. 2006; Kaneda et al. 
2004). Conditional knockouts of Dnmt3a in germ cells show that it plays a role in 
DNA methylation during gametogenesis (Kaneda et al. 2004). Offspring of female 
conditional mutants die in utero with an absence of DNA methylation and show loss 
of maternal allele-specific expression of Cdknlc and Igf2r and biallelic expression of 
paternally expressed genes Pegl, Peg3 and Snrpn (Hiura et al. 2006; Kaneda et al. 
2004). Dnmt3a conditional mutant males show impaired spermatogenesis and loss of 
methylation at the Igf2-H19 DMR, IG-DMR of the Dlkl-Gtl2 locus and at a short 
interspersed repeat SINE B1 suggesting that Dnmt3a is required for methylation of 
these loci (Kaneda et al. 2004). The results of these conditional knockouts are similar 
to the phenotype seen in the Dnmt3L knockout mice suggesting that both Dnmt3L and 
Dnmt3a are essential for spermatogenesis (Bourc'his et al. 2001; Kaneda et al. 2004; 
Nimura et al. 2006; Webster et al. 2005).
Dnmt3b knockout mice are embryonic lethal. However, the offspring of mice 
with a conditional knockout of Dnmt3b in their germ cells showed no apparent 
phenotype (Kaneda et al. 2004) except for a reduction in methylation at satellite 
repeats (Kato et al. 2007). Dnmt3a and Dnmt3b are structurally very similar and may 
show some redundancy in their function indicated by the double knockout ES cells 
which show a more severe global demethylation phenotype (Bourc'his et al. 2001;
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Okano et a l 1999). ICF is a rare recessive human disorder resulting from a mutation 
in DNMT3B and causes immunodeficiency, centromeric instability and facial 
abnormalities (Ehrlich et a l 2006; Hansen et a l 1999; Vasques et a l 2005). The 
disorder is characterised by hypomethylation of satellite regions and subsequent 
chromosome instability (Ehrlich et a l 2006; Hansen et a l 1999; Xu et a l  1999). 
Mutation in the orthologous gene in mice is lethal but not in humans which is 
probably due to a reduced effectiveness o f the protein in humans as a result of mis- 
sense or in-frame mutations rather than from a complete loss of the functional protein 
(Hansen et a l 1999). Patients with ICF have normal expression of DNMT3A 
suggesting that some functions are unique to DNMT3B. These two proteins also exist 
as multiple isoforms in humans and mice so may have a greater diversity of function 
(Chen et a l 2005; Xie et a l  2006).
Dnmt3L is another member of the Dnmt3 family but lacks the catalytic 
domain found in Dnmt3a and Dnmt3b. The catalytic domain is required for activation 
of the target cytosine, binding o f the methyl donor s-adenosyl L-methionine and for 
sequence recognition (Aapola et a l  2000; Bourc'his et a l 2001). Dnmt3L shows 
sequence homology in the cysteine rich region of the protein and is thought to 
function as a co-adaptor protein to recruit other Dnmts to locally induce DNA 
methylation (Aapola et a l 2000; Bourc'his et a l  2001) (figure 1.5). In the mouse, 
Dnmt3L is expressed at high levels in both the testis and ovary and correlates with 
stages of gametogenesis where methylation at DMRs of imprinted genes are 
established, indicating that Dnmt3L is involved in establishing DNA methylation 
during gametogenesis (Aapola et a l 2004; Aapola et a l 2000; Bourc'his et a l 2001).
Recent studies have shown that Dnmt3L is essential for the establishment of 
correct DNA methylation at maternal DMRs in oocytes (Bourc'his et a l 2001;
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Bourc’his and Bestor 2004; Hata et al. 2002; Lucifero et al. 2007). Dnmt3L is only 
expressed in females in growing oocytes arrested at the diplotene stage of meiosis I 
(Bourc'his et al. 2001; Bourc’his and Bestor 2004). In female mice with a targeted 
deletion of Dnmt3L (Dnmt3L-/-), oogenesis proceeds as normal, however, the 
maternal methylation patterns are not correctly established in the oocytes and, as a 
result, the heterozygous progeny of these mice die at mid-gestation (-9.5 dpc) (Arima 
et al. 2006; Bourc'his et al. 2001; Bourc’his and Bestor 2004). It was suggested that 
death was a result of having a non-functional placenta caused by an imprinting defect 
(Arima et al. 2006). Dnmt3L binds and co-localises with Dnmt3a and Dnmt3b in the 
nuclei of mammalian cells (Hata et al. 2002; Margot et al. 2003). It is possible that 
Dnmt3L could direct methylation to ICRs by interacting with Dnmt3a which is known 
to put methyl groups on ICRs in germ cells (Margot et al. 2003). Snrpn and Igf2r 
ICRs are both maternally methylated DMRs that require Dnmt3a activity (Chedin et 
al. 2002). The Snrpn ICR is a good target for de novo methylation by a Dnmt3a and 
Dnmt3L complex as there is no evidence of methylation in the absence of Dnmt3a 
and very little methylation in the presence of Dnmt3a alone. When Dnmt3a is co­
expressed with Dnmt3L there is an increase in de novo methylation at the ICRs 
indicating that Dnmt3L has a role in stimulating de novo methylation by Dnmt3a 
(Chedin et al. 2002; Chen et al. 2005; Hata et al. 2002). However, it has also been 
shown that, in the absence of Dnmt3L, Dnmt3a can also act alone to mark other 
DMRs (Amaud et al. 2006). It has been shown that Dnmt3L physically interacts with 
a variant of Dnmt3a (Dnmt3a2) in ES cells and embryonic testes, localising Dnmt3L 
to the nucleus (Jia et al. 2007; Nimura et al. 2006). ES cells derived from Dnmt3L-/- 
mutant embryos show loss of maternal germ line methylation patterns which leads to 
biallelic expression of some maternally silenced genes, such as Kcnqlotl/L itl and
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Snrpn, and repression of several maternally expressed genes including Cdknlc, 
Mash2 and Igf2r (Arima et a l 2006; Bourc'his et a l 2001; Hata et a l 2002). Those 
genes regulated by paternal methylation, such as Igf2 and HI P, show normal 
monoallelic expression (Arima et a l 2006; Bourc'his et a l 2001).
During spermatogenesis, Dnmt3L is required for the acquisition of 
methylation at transposable elements, some paternally methylated DMRs, unique non- 
pericentric heterchromatic sequences and interspersed repeats (Bourc’his and Bestor 
2004; Kato et a l 2007; Webster et a l 2005). Dnmt3L is expressed in non-dividing 
pro-spermatogonia between 12.5 dpc and birth and declines when prospermatogonia 
have differentiated into dividing prospermatogonial stem cells (Bourc’his and Bestor 
2004). Male mice that lack Dnmt3L are sterile because of a complete absence of germ 
cells in the adults although there is a normal germ cell complement at birth. This 
suggests that there is progressive loss of prospermatogonia during development into 
adulthood (Bourc’his and Bestor 2004; Webster et a l 2005). The DNA from mutant 
germ cells is less methylated than that from wild type germ cells. Methylation is lost 
specifically from the LINE-1 and IAP retrotransposons whereas the major and minor 
satellite repeats remain unaffected. This indicates that in male germ cells, Dnmt3L is 
responsible for methylation o f dispersed repeats within euchromatin, possibly by 
recruiting Dnmt3a, whereas pericentric tandem repeats are methylated by a different 
DNA methyltransferase (Bourc’his and Bestor 2004; Kato et a l 2007). This probably 
accounts for the genomic instability seen in mutant male germ cells that results in 
sterility (Webster et a l 2005). The DMR of the Dlkl-Gtl2 imprinting cluster did not 
show loss of methylation in male mutant germ cells and only partial demethylation 
was seen at the HI9 DMR indicating that, in males, Dnmt3L is not involved in 
establishing these paternal germ line DMRs but is probably involved in establishing
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life-long silencing of retrotransposons in pro-spermatogonia (Bourc’his and Bestor 
2004; Kato et a l 2007). In female germ cells, meiosis and the methylation of repeat 
sequences is normal indicating that Dnmt3L plays different roles in male and female 
germ cell development (Bourc'his et a l 2001).
It is interesting to note that Dnmt3L is not found in chickens and fish but is 
found in species in which imprinting occurs suggesting that this gene may have 
evolved alongside genomic imprinting (Yokomine et al. 2006). As well as having a 
role in de novo methylation of DMRs, Dnmt3L may be an important factor for 
recruiting histone and non-histone proteins as studies have shown that Dnmt3L can 
repress transcription by binding directly to HDAC1 through its ATRX domain 
(Aapola et a l 2002; Aapola et a l 2000; Deplus et a l 2002).
1.2.4 Chromatin modifications
DNA exists in a highorder structure within each cell, tightly packaged around
nucleoproteins (Komberg 1974; Olins and Olins 1974). This sophisticated structure 
allows for storage, usage and replication of DNA. To allow transcription of DNA, 
chromatin must be dynamic to allow access for the transcriptional machinery. The 
basic repeating unit is the nucleosome consisting of an octamer of histone proteins -  a 
central tetramer o f H3 and H4 and two dimers of H2A and H2B (Arents et a l 1991; 
Finch et a l  1977; Stein et a l 1977) (figure 1.6). Approximately 147 bp of super 
helical DNA wrap around each nucleosome twice and each nucleosome is separated 
from the next by a 10-60 bp Tinker’ region of DNA to form the 11 nm bead like 
structure (Luger et a l 1997; McGhee et a l 1983). The DNA is packaged further by 
the addition of linker histone HI (Misteli et a l 2000; Pennings et a l 1994).
The bulk chromatin structure can be altered by the covalent modification of 
the N-terminal tails of core histones. Modification of the histone tails is important for
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regulating a variety of processes including transcription, mitosis and the formation of 
heterochromatin (Hebbes et al. 1988; Jeppesen and Turner 1993; Lehnertz et a l 2003; 
Soejima et al. 2004; Wei et al. 1999). Modifications include acetylation, methylation, 
phosphorylation and ubiquitination; a combination of which makes up the histone 
code (Chen et al. 1998; Hebbes et al. 1988; Strahl et al. 1999; Wei et al. 1999) 
[reviewed in (Jenuwein and Allis 2001; Kouzarides 2007)].
Acetylation o f specific lysine residues on the N-terminal tails of core histones 
can activate gene expression by promoting a more open chromatin conformation 
(Hebbes et al. 1988; Soejima et al. 2004), yet the methylation of specific lysine 
residues can promote either active or inactive regions of chromatin. For example, 
methylation of lysine 4 (K4) on H3 has been associated with gene activation, while 
methylation of lysine 9 (K9) on H3 is associated with heterochromatin (Lehnertz et al. 
2003; Strahl et al. 1999). In imprinted regions, the active parental allele has an open 
chromatin structure while the inactive allele has a more heterochromatin-like 
conformation that is transcriptionally repressive and corresponds to a difference in 
histone acetylation status (Fournier et al. 2002; Fulmer-Smentek and Uta 2001; 
Gregory et al. 2001; Jeppesen and Turner 1993). It is likely that modifications to the 
chromatin surrounding imprinted genes are responsible for maintaining the imprints 
and also maybe involved in establishing them. Tri-methylation at Lysine-27 of histone 
H3 (H3K27Me3) and di-methyl Lys-9 of histone H3 (H3K9Me2) are markers of 
repressed chromatin whereas acetylation Lys-9 of histone H3 (H3K9Ac) and di­
methyl Lys-4 of histone H3 (H3K4Me2) are markers of active chromatin (Cao et al. 
2002; Fournier et al. 2002; Higashimoto et al. 2003; Strahl et al. 1999; Umlauf et al.
2004). These histone modifications have been identified around several imprinted 
genes including the paternally repressed Kcnql and Cdknlc (Fournier et al. 2002;
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Higashimoto et a l 2003; Soejima et al. 2004; Umlauf et a l 2004). It may be that 
repressive histone modifications propagate along the imprinted cluster from the 
primary imprinting mark to silence the surrounding genes.
DNA methylation and methyl binding domain (MBD) proteins can recruit 
histone modifying enzymes and is evidence for a link between histone modifications 
and DNA methylation (Esteve et al 2006; Jones et al 1998b; Nan et a l 1998). 
Chromatin is remodelled by a variety of remodelling enzymes such as histone 
methyltransferases (HMTs), histone acetylases (HAT) and deacetylases (HDACs) 
(Deplus et al 2002; Fuks et a l 2000; Jones et a l 1998b; Wagschal et a l 2008; Zhang 
et a l 1999). Dnmts and MBD proteins may also play a role in RNA-directed silencing 
as these proteins have been shown to form complexes with RNA (Jeffery and 
Nakielny 2004).
Figure 1.6: Structure of the nucleosome.
DNA is packaged around an octamer of histone proteins. The N-terminal tails of the 
histones can be modified to allow or prevent access to the DNA by transcriptional 
machinery. From (Turner 2005). Copyright Macmillan Publishers Limited.
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1.2.5 Chromatin remodelling factors
Establishing the differential chromatin states on imprinted genes probably
involves the recruitment of non-histone proteins. Polycomb group protein (PcG) 
complexes are thought to be required for maintaining long-term gene silencing during 
development by altering the local chromatin environment (Cao et a l 2002; Mager et 
a l 2003). PcG proteins play specialised roles in silencing genes in ES cells (Boyer et 
a l 2006; Mager et a l 2003) and are thought to modify histones by forming a more 
condensed chromatin structure, which is not easily accessible to the transcriptional 
machinery and so maintains long-term gene silencing during development (Boyer et 
a l 2006).
There are two distinct complexes of PcGs (PRC1 and PRC2) that are 
conserved from fruit flies to humans and occupy a different set of target genes (Boyer 
et a l 2006; Mager et a l 2003). Polycomb repressor complex 1 (PRC1) contains a 
minimal core complex of polycomb (Pc), polyhomeotic (Ph), posterior sex combs 
(Psc) and Ringl that has the ability to block SWI/SNF remodelling and transcription 
in vitro (Breiling et a l 2004). Polycomb repressor complex 2 (PRC2) contains the 
H3K27/K9 methyltransferase Enhancer of Zeste Homologue 2 (Ezh2 or Enxl in the 
mouse) (Breiling et a l 2004; Cao et a l 2002), the histone-lysine methyltransferase 
zinc finger protein Suzl2 (Pasini et a l 2004) and the Embryonic ectoderm 
development (Eed) protein (Mager et a l 2003). These proteins were identified in a 
complex that co-localised with histone methyltransferase activity in humans and is 
specific for H3K27Me3 (Cao et a l 2002). PcG targets include a number of 
transcription factors that have important roles in development and lineage 
commitment (Boyer et a l 2006; Lan et a l 2007). During ES cell differentiation, the 
majority of the PcG targets are upregulated indicating that the PcG complexes are
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required to repress genes that are poised for activation on differentiation (Boyer et a l 
2006).
Eed has been shown to be required for the H3K27 di- and tri-methylation 
directed by the PRC2 complex (Boyer et al. 2006; Cao et al. 2002; Montgomery et a l
2005). The PRC2 complex also has the ability to interact with histone deacetylases 
and to co-localise with Xist on the imprinted X chromosome (Kalantry and Magnuson 
2006; Kalantry et a l  2006). It has been proposed that antisense non-coding RNA 
molecules, such as Air and Kcnqloti/Lit 1, have the same ability to recruit histone 
modifying enzymes and PRCs to silence imprinted genes. For example, the paternally 
expressed non-coding RNA Kcnqlotl/L itl may have the ability to recruit H3-K9 and 
K27 methylation along the adjacent repressed paternal allele of mouse distal 
chromosome 7. There is also evidence that the PRC2 complex can interact with and 
recruit the PRC1 complex. PRC1 binding can lead to the formation of a repressive 
chromatin state by preventing access o f the nucleosome remodelling factors SWI/SNF 
(Cao et a l 2002).
Montgomery et a l  (Montgomery et a l 2005) showed that Eed expression is 
also responsible for establishing global H3-K27 mono-methylation independently of 
the PRC2 complex suggesting that Eed may play other roles in gene silencing. During 
stem cell differentiation, Ezh2 and Eed levels decrease whereas Suzl2 levels remain 
constant. Suzl2 is also enriched on the imprinted X chromosome in the early stages of 
chromosome inactivation independent of Xist expression suggesting that Suzl2, like 
Eed, may play other roles in gene silencing independent of the PRC2 complex (de la 
Cruz et a l  2005).
It is likely that differential DNA methylation and histone modifications work 
together to establish imprinting across large domains. The link between DNA
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methylation and histone modifications has been shown in a number of studies (Fuks et 
al. 2000; Kimura and Shiota 2003; Robertson et al. 2000). Heterochromatin protein 1 
(HP1) family members have been shown to mediate communication between histone 
modifications and DNA methyltransferases. H3K9me3 creates a binding platform for 
HP1 which then interacts with Dnmtl to locally increase DNA methylation 
(Smallwood et al. 2007).
1.2.6 Mouse distal chromosome 7 IC2 domain
The mouse distal chromosome 7 imprinting cluster consists of two
independently regulated imprinting domains (figure 1.7) known as ICI and IC2 
(Cerrato et al. 2005). The centromeric cluster (IC2) of mouse distal chromosome 7 
contains a number of genes imprinted in both the embryo and placenta (Caspary et al. 
1998), including Kcnql (Kvlqtl), a primary channel-forming a-subunit of voltage 
gated potassium channels (Gould and Pfeifer 1998); Slc22al8 (Imptl) a poly-specific 
organic cation transporter (Dao et al. 1998); Phlda2 (.Impl), a growth gene involved in
If IP?placental development (Frank et al. 2002); and Cdknlc (p57 ), a cyclin dependent
kinase inhibitor (Hatada and Mukai 1995). There is also an unspliced and untranslated 
RNA, known as the Kcnql overlapping transcript 1 (Kcnqlotl) or the long intronic 
transcript 1 (Litl) that originates from a DMR within intron 10 of the Kcnql gene 
(Smilinich et al. 1999). The DMR (KvDMRl) acts as the ICR for the cluster which 
was shown by the deletion of this region resulting in loss of imprinting of at least six 
imprinted genes within the IC2 domain, including Kcnql and Cdknlc, in both mice 
and humans (Fitzpatrick et al. 2002; Niemitz et al. 2004).
On the maternal allele, the KvDMRl is methylated which is presumed to 
prevent transcription of Kcnq lo t i  /Lit 1. The surrounding genes are expressed. On the 
paternal allele the KvDMRl is not methylated, Kcnq lo ti/L itl is expressed and the
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surrounding genes are silent. How the KvDMRl affects silencing o f the surrounding 
genes is unknown but may be similar to the non-coding RNA model seen for Igf2r 
(Wutz et al. 1997). The Kcnq lo ti  /Litl RNA transcript may localise histone modifying 
enzymes to the surrounding genes as seen with Xist and imprinted X-chromosome 
inactivation. The results of truncating the Kcnq lo ti/L itl transcript indicates that it is 
not the germ line methylation mark at KvDMRl but the RNA transcript that is the key 
to silencing within this cluster (Shin et a l  2008).
The Cdknlc gene contains a large CpG island that is differentially methylated 
in the mouse but not in the human (Onyango et al. 2000). This may account for the 
low levels of expression (~10 %) from the imprinted paternal allele observed in 
humans but not in mice (Chung et al. 1996; Matsuoka et al. 1996). Cdknlc promoter 
methylation is a somatic methylation mark acquired in embryos during post­
implantation development and is not present in the germ line (Bhogal et al. 2004; 
Tada et al. 1998). It may be that the methylation mark on the mouse Cdknlc CpG 
island serves to lock down silencing in mice whereas imprinting of CDKN1C in 
humans is more reliant on other epigenetic marks.
Mouse distal chromosome 7 is homologous to the human l ip  15 imprinting 
domain (Engemann et al. 2000; Onyango et al. 2000). This imprinting domain shows 
a high degree of conservation between the two species including sequence, gene 
order, gene orientation and imprinting (Engemann et al. 2000; Paulsen et al. 2000). 
However, around and between the two domains lie genes, that are also regulated by 
KvDMRl, but where imprinting is less conserved and show differences between mice 
and humans (Engemann et al. 2000; Paulsen et al. 2000). Osbpl5 (Opbhl), NaplL4 
(Nap2), Cd81, Tssc4 and Ascl2 (Mash2) are imprinted in mice but expressed 
biallelically in human foetal tissues and placenta (Beatty et al. 2006; Monk et al.
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2006). Trpm5, a gene encoding for a taste receptor, is imprinted in humans but 
biallelically expressed in the mouse (Beatty et a l 2006). Conserved imprinted 
expression is seen for Phlda2, Slc22al8 and Cdknlc and these genes remain 
imprinted throughout development (Monk et a l 2006). Imprinting of Kcnql and 
Kcnqlot/Litl is also conserved and are imprinted in early foetal tissues and first 
trimester placenta but imprinting is relaxed in term placenta and late juvenile and 
adult stages (Caspary et a l 1998; Gould and Pfeifer 1998; Monk et a l 2006).
Imprinting in the IC2 domain is unaffected by loss of imprinting in the ICI 
domain. Mice lacking HI 9 show normal imprinting within the IC2 domain indicating 
that these two imprinting domains act independently.
Cdknlc is maternally expressed in mice and Cdknlc null mice show a variety 
of phenotypes similar to BWS including renal dysplasia, lens and gastrointestinal 
defects and skeletal abnormalities (Caspary et a l 1999; Zhang et a l 1997). Contrary 
to what is seen in humans, loss o f Cdknlc is embryonic lethal with approximately 10 
% of offspring dying in utero and the remainder dying within the first two days of 
birth (Takahashi et a l 2000; Yan et a l 1997; Zhang et a l 1997). This phenotype can 
be rescued by deleting the KvDMRl ICR from the paternal chromosome resulting in 
expression of paternal Cdknlc (Horike et a l 2000; Mancini-DiNardo et a l  2006). 
Loss of imprinting of IGF2 in humans is also associated with Beckwith Wiedemann 
syndrome. Mice with loss of imprinting of Igf2 are bom approximately 30 % bigger 
than their wild type litter mates whereas the Cdknlc mutants do not show any 
overgrowth at birth (Caspary et a l 1999; Leighton et a l 1995; Zhang et a l 1997). 
However, we have recently shown that loss of Cdknlc is associated with overgrowth 
at an earlier time point, 13.5 dpc, so this growth advantage may be lost during 
embryonic development (Andrews et a l 2007). Igf2 is paternally expressed and it
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may be that Cdknlc and Igf2 interact and have an antagonistic effect in the tissues in 
which they are co-expressed (Caspary et al. 1999).
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Figure 1.7: Mouse distal chromosome 7 imprinting domain.
Map of the imprinted genes within mouse distal chromosome 7 showing their relative 
position and allelic origin of expression. This imprinting domain contains two 
imprinted clusters ICI and IC2. Within these clusters the imprinted genes are co- 
ordinately regulated by differentially methylated regions (DMRs). Germ line 
methylation marks are acquired during gametogenesis (red lolly pop). Within the IC2 
domain there is a somatic differentially methylated mark (blue lolly pop) and is 
located in the promoter region of Cdknlc. Orange boxes represent maternally 
expressed genes, turquoise boxes represent paternally expressed genes, white boxes 
are non-imprinted genes. CpG are shown in pink. Arrows indicate gene expression.
1.2 Epigenetic reprogramming in the germ line
1.3.1 Gametogenesis and imprinting
Mouse primordial germ cells (PGCs) develop from the pluripotent epiblast and
can be detected as alkaline phosphatase positive staining cells at around 7.5 dpc 
(Ginsburg et al. 1990; Matsui et al. 1992; Yamazaki et al. 2005). These cells rapidly 
proliferate and migrate via the hindgut and dorsal mesentery at around 8.5-9.5 dpc. 
They reach the genital ridge at around 10.5-11.5 dpc where they continue to 
proliferate until 13.5 dpc (Durcova-Hills et al. 2001; Matsui et al. 1992; Tam and 
Snow 1981) (figure 1.8). The parental imprints are erased in early PGCs during 
migration and colonisation into the early embryonic gonad [reviewed in (Reik et al. 
2001)] where there is also reactivation of the silent X-chromosome (Kato et al. 1999;
M a t e r n a l
Paternal
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Monk et a l 1987). Loss of methylation at the DMRs of the imprinted genes correlates 
with the loss of monoallelic gene expression in these cells (Szabo and Mann 1995).
On colonizing the genital ridge, female PGCs enter meiotic prophase and 
meiotic arrest at around 13.5 dpc, whereas the male PGCs remain mitotic until 
approximately 15.5 dpc when they enter a state of mitotic arrest (Hajkova et a l 2002; 
Hiura et a l 2006). The new imprints on the ICRs are then established in a sex-specific 
manner. In oocytes, methylation occurs postnatally during the growth phase of the 
oocytes during follicular development (Hiura et a l 2006), whereas in sperm, re- 
methylation takes place earlier before meiosis in late foetal stages (Keijean et a l 
2000; Ueda et a l 2000).
It is not yet understood how the germ line specific imprints are established and 
what the signals are that determine which parental imprint is to be set. Igf2, HI 9, 
Rasgrfl, Dlkl and Gtl2 have been identified as genes which are epigenetically 
modified during spermatogenesis to give allele-specific gene expression in the 
embryo (Hiura et a l 2006; Kerjean et a l 2000). However, the majority of the germ 
line methylation is maternal and is established during oocyte growth (Obata et a l 
1998). This corresponds with the observation that de novo Dnmts are expressed 
throughout the oocyte growth phase (Lucifero et a l 2007; Lucifero et a l 2004). In the 
early embryo there is genome wide de-methylation and re-methylation (Monk et a l 
1987; Oswald et a l  2000; Santos et a l 2002), yet the germ line methylation marks of 
the imprinted genes are maintained (Kato et a l 1999; Lei et a l 1996). Imprinted 
genes may be protected from de-methylation by the nucleosomal structure in these 
regions (Kafri et a l 1993; Oswald et a l 2000). For example, the female pronucleus 
becomes de-methylated more slowly which may protect the oocyte imprints (Bouniol 
et a l 1995; Ram and Schultz 1993; Santos et a l 2002). Undifferentiated ES cells have
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a relatively high de novo DNA methylation activity but this activity is low in the post- 
gastrulation embryo and adult somatic tissues (Monk et al. 1987).
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Figure 1.8: Gametogenesis in the mouse and establishing parental specific
methylation patterns in the germ line.
Imprints are established in the germ line during gametogenesis. As the PGCs migrate 
to the genital ridge they undergo genome wide de-methylation. At 10.5 -  11.5 dpc 
imprints are erased as PGCs colonise the genital ridge, they then proceed down either 
the male or female germ line to acquire parental-specific methylation patterns. 
Primordial germ cells can be cultured as embryonic germ line stem cells (EG) in the 
same way as Embryonic stem cells (ES).
Adapted from (In Stem cell information [world wide web site]. Bethesda, MD: 
National Institutes of Health, U.S. Department of Health and Human Services, 2006 
[cited 24/07/2008] Available at http://stemcells.nih.gov/info/scireport/appendixa).
1.3.2 Culturing EG cells
Cells isolated from the inner cell mass (ICM) of blastocyst stage embryos can
be cultured in vitro as embryonic stem (ES) cells (Evans and Kaufman 1981; Martin 
1981). ES cells are similar to ICM cells, but do not undergo the rapid differentiation 
they would in vivo, and contain the imprints of both parental genomes (Dean et al. 
1998; Evans and Kaufman 1981; Rugg-Gunn et al. 2005). PGCs can be isolated from
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the developing gonadal ridges of 11.5 dpc and 12.5 dpc embryos and cultured in vitro 
as embryonic germ (EG) cells (Lee et a l 2002; Tada et al. 1998). These EG cells are 
capable of self-renewal in the same way as embryonic stem cells and can differentiate 
into a variety of tissues and contribute to the germ line in chimeras (Matsui et a l 
1992; Stewart et a l 1994). In culture, they form distinct colonies that resemble 
undifferentiated, pluripotent embryonic stem (ES) cells and can be cultured for many 
generations (Durcova-Hills et a l 2001; Kato et a l 1999; Matsui et a l 1992). EG cells 
are capable of reprogramming a somatic nucleus, a property inherited from the PGCs. 
EG-somatic cell hybrids show extensive erasure of the somatic nucleus methylation 
marks so that they resemble the EG cell nucleus (Kato et a l 1999; Tada et a l 1997).
Both EG and ES cells can be maintained in an undifferentiated state with 
potentially infinite self-renewal by the addition of exogenous factors, such as 
leukaemia inhibitory factor (LIF), to the culture media (Labosky et a l 1994; Matsui et 
a l 1992; Resnick et a l 1992) and express stem cell markers such as Oct-4, SSEA-1 
and endogenous alkaline phosphatase (Durcova-Hills et a l 2001; Rohwedel et a l 
1996). XY EG cell lines can be established much more frequently than XX cell lines. 
XX cell lines are unstable, probably due to the loss of imprinting of one of the X 
chromosomes (Durcova-Hills et a l 2001; Zvetkova et a l 2005). The inactive X 
chromosome is reactivated in PGCs at around 12 .5-13.5  dpc and both chromosomes 
continue to be active throughout oogenesis. In the male germ line the single X 
chromosome is transcriptionally inactivated and remains silent until after fertilisation 
in female pre-implantation embryos (Salido et a l 1992). EG and ES cells can be 
differentiated, as embryoid bodies, into diverse cell types and can be used to 
investigate how, when and where the early imprints in the two parental genomes and 
other epigenetic modifications are established (Doetschman et a l 1985; Labosky et a l
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1994; Rohwedel et a l 1996). Studies have shown that germ line imprints are 
epigenetically stable in ES cells even after prolonged culture (Rugg-Gunn et a l 2005; 
Szabo and Mann 1994).
1.4 Aims of the project
The precise sequence of epigenetic events that result in allele-specific gene 
expression is unclear. Several studies have looked at the establishment of the germ 
line epigenetic marks in oocytes and spermatocytes as well as the final imprints in 
stem cells and somatic cells. Much is also known about these epigenetic marks in 
migrating primordial germ cells at specific time points such as prior to imprint erasure 
(9.5 dpc) (Durcova-Hills et a l 2001; Szabo et a l 2002; Yamazaki et a l 2005) and 
post-erasure (11.5 -  12.5 dpc) (Hajkova et a l  2002; Lee et a l  2002; Tada et a l 1998; 
Ueda et a l 2000). Very little is known about the sequence of events that lead to 
silencing of imprinted genes within the germ line at particular imprinted domains. The 
mouse distal chromosome 7 domain relies on several key elements to establish 
differential gene expression including DNA methylation, histone modifications and 
the transcription of the non-coding RNA, Kcnq lo ti  /Litl, all of which are required for 
imprinting of this domain. One particular gene within this domain is of particular 
interest. Cdknlc requires a germ line DNA methylation mark at the imprint control 
region, KvDMRl, to be expressed and a somatic DNA methylation mark within the 
Cdknlc locus for its silencing.
The aim of this study was to investigate the epigenetic mechanisms that lead to 
heritable silencing of Cdknlc using an in vitro system. The work in this study was 
based on the observation that Cdknlc was not expressed in EG cells derived from 
imprint-erased PGCs (Tada et a l 1998). These cells lack DNA methylation at all the 
germ line and somatic DMRs. In the study by Tada et a l, the authors derived EG cell
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lines from 11.5 -  12.5 dpc PGCs (Tada et al. 1998). The DMRs of several imprinted 
genes within these cells were shown by the authors to be unmethylated. The EG cells 
were then aggregated with wild type embryos to create chimeras in order to determine 
how these cells contribute to the germ layers and to determine whether germ line 
transmission was possible. Primary embryonic fibroblasts (PEFs) were derived from 
13.5 dpc chimeric embryos. Fibroblasts derived from the EG cells were selected for 
by G418 resistance. The authors examined the germ line DMRs of several genes 
including Igf2r and Nnat and determined that these regions are unmethylated even 
after differentiation in vitro. The exceptions were HI9, which showed partial 
methylation, and Cdknlc, which showed de novo methylation of its somatic DMR. 
The expression levels of the genes were also examined. No expression of Igf2r, HI 9 
and Cdknlc was observed in both the EG cells and the differentiated PEFs. The 
results of this study appeared to indicate that Cdknlc acquires de novo DNA 
methylation in the absence of germ line methylation of KvDMRl suggesting that 
perhaps certain imprinted genes undergo dynamic and active silencing steps in the 
absence of a germ line imprint so providing an in vitro system in which these events 
could be studied.
The aims of this project were:
• to examine the expression status of Cdknlc and other genes within the distal 7 
imprinting domain and to determine if these genes were actively silenced in 
EG cell lines after in vitro differentiation.
• to determine whether Cdknlc underwent de novo DNA methylation after 
differentiation, similar to the in vivo situation.
• to accurately map the spread of methylation across the Cdknlc DMR over 
time.
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• to examine histone modifications in undifferentiated and differentiated EG 
cells and compare these to androgenetic ES cells (containing two silent 
paternal alleles) in order to determine if alterations to the chromatin structure 
were associated with silencing.
• to identify other domains that establish silencing in a similar way to the genes 
on mouse distal chromosome 7.
To achieve these goals, real time quantitative RT-PCR assays were designed to 
amplify the mouse distal chromosome 7 genes including Cdknlc. These assays were 
applied to cDNA prepared from somatic tissues and undifferentiated and 
differentiated ES and EG cells. DNA methylation assays were also developed for both 
the KvDMRl region and the Cdknlc DMR and were applied to genomic DNA 
isolated from somatic tissues and undifferentiated and differentiated ES and EG cells. 
This was to confirm that these regions were unmethylated in the undifferentiated EG 
cells and then to determine whether any changes occurred at different time points 
during the differentiation of these cells. Chromatin immunoprecipitation (ChIP) 
assays were designed to amplify the promoter regions of Phlda2, Cdknlc, Kcnql and 
Kcnqlotl/L itl in order to examine the epigenetic status of these regions in 
undifferentiated and differentiated EG and AG cells. Published ChIP primers were 
available, however these were designed to span polymorphisms between M. Spretus 
and 129/Sv, in order to apply allele-specific ChIP on M. Spretus x 129/Sv crosses, so 
were not necessarily within the promoter regions of imprinted genes. Designing 
primers to amplify the promoter regions of imprinted genes allowed us to specifically 
map the changes to the chromatin structure that possibly affect expression of the 
imprinted genes. The real-time quantitative RT-PCR assays were also used to identify
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other imprinted genes that might be predicted to behave as Cdknlc and these primers 
were applied to undifferentiated and differentiated stem cell material.
Through these assays, the project aimed to determine whether Cdknlc is actively 
silenced by a series of epigenetic events that occur by default, in the absence of DNA 
methylation at KvDMRl, or whether the gene was already silent i.e. germ line DNA 
methylation and other active steps are required to switch the gene on. The project 
would also identify other genes that behave in a similar fashion.
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2.1 Cell Culture
ES cell lines:
• CES3, XY diploid biparental ES cell lines derived from 129/sv ICM 
(gift from M A Surani).
• SF1-1, XY diploid biparental ES cell line derived from hybrid embryo 
[CBA/C57BL/6 FI x M. spretus] ICM (gift from R Feil) (Allen et al. 
1994; Feil et a l 1997).
• AKR1, XY diploid monoparental ES cell line derived from ICM of  
androgenetic embryo (gift from N Allen & M A Surani) (Allen et al. 
1994).
EG cell lines:
• TMAS21G, XY diploid EG cell line derived from mixed background 
Rosa26 E12.5 genital ridge (Tada et al. 1998).
• Sv6.1, XY diploid EG cell line derived from genital ridge of a pure 
129/Sv E l2.5 embryo (Durcova-Hills et al. 2002).
Stem cells were cultured on inactivated SNLs (SNL 76/7, mouse SIM strain 
embryonic fibroblast), a mouse primary embryonic fibroblast STO cell line containing 
Neomycin and L if transgenes, for several passages to maintain ES cells in their 
undifferentiated state before harvesting for DNA and RNA analysis. SNLs were 
inactivated by treating with 10 pg/ml Mitomycin C (Sigma) for 1 -  2 hrs. Mouse ES 
cells and SNLs were cultured on 0.1 % gelatin (Sigma) coated 10 cm tissue culture 
plates in Knockout DMEM (Invitrogen) supplemented with 10 % foetal calf serum 
(Globepharm), 2 mM L-glutamine (Invitrogen), 50 fig/ml Penicillin/Streptomycin 
(Invitrogen), 0.1 mM non-essential amino acids (Invitrogen), 1000 U/ml Leukaemia 
Inhibitory Factor (Chemicon Int) and 1 pM P-mercaptoethanol (Invitrogen). The
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addition of Leukaemia Inhibitory Factor (LIF) to the culture media and the production 
of LIF from the SNL feeder layer is required for long term proliferation potential of 
mouse primordial germ cells in culture and works in a dose dependent manner with a 
peak response at 1000 U/ml (Resnick et al. 1992).
Media was changed approximately every 24 hours and cells were passaged. 
Stem cells were split on to new gelatin coated 10 cm plates or equivalent in to flasks. 
For DNA and RNA analysis, feeder cells were removed by panning, allowing the 
trypsinised feeder cells to settle down for 20 min then removing the medium 
containing the remaining stem cells. Stem cells were differentiated by the removal of 
LIF from the media and cultured without feeders in suspension on non-tissue culture 
petri dishes. Cells formed aggregates called embryoid bodies (figure 2.1) and were 
passaged by harvesting the suspension culture into 15 ml falcon tubes and allowing 
the embryoid bodies to settle out for 15 min. The top 5 ml of medium was aspirated 
and replaced with 5 ml of fresh medium and added to a new plate. Cells were pelleted, 
frozen on dry ice and stored at -80 °C for RNA or DNA analysis or used directly to 
isolate chromatin.
Figure 2.1: ES cells and embryoid bodies in culture.
Mouse ES and EG cells were cultured and differentiated under the same conditions. 
A. ES cells were cultured on an inactivated mouse fibroblast feeder layer in the 
presence of LIF. B. ES cells were differentiated for one day in the absence of the 
feeder layer and LIF on non-tissue culture plastic to form cell aggregates. C. After 
one week of culture the embryoid bodies appear as hollow balls of cells. D. Large 
embryoid bodies can be seen after two weeks of culture. Scale bars = 50 pM
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2.2 Karyotyping
Normal karyotype was confirmed by analysing metaphase chromosomes. Stem 
cells were grown without feeders on gelatin coated plates until 90 % confluent then 
treated with ethidium bromide at a final concentration of 1.5 pg/ml two hours prior to 
harvesting. Colchicine (Sigma) was added to a final concentration of 0.1 pg/ml 80 
min before harvesting. Cells were harvested and resuspended in 1 ml pre-warmed 
37°C hypotonic solution containing 0.56 % Potassium Chloride. The cells were 
incubated for 5 min at 37 °C then fixed by the addition of 50 pi of a 3:1 solution of 
Methanol: Acetic Acid pre-cooled to 4 °C. Cells were centrifuged and resuspended in 
1 ml of fixative and left overnight at 4 °C. Cells were centrifuged and fixed with 1 ml 
of fixative for two more times. The cell suspension was dropped on to clean 
humidified microscopic slides from a height of 2-3 feet to allow metaphase 
chromosomes to spread. Slides were air-dried then mounted with Vectorshield 
containing DAPI. Metaphase chromosomes were viewed by fluorescent microscopy. 
For each cell line, ten metaphase cells were counted and the average number of 
chromosomes determined. All cells scored showed the normal number of 
chromosomes.
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Figure 2.2: Karyotype analysis of ES, AG and EG cells.
Metaphase chromosomes were counted from (A) CES3, (B) Sv6.1, (C) TMAS21G, 
(D) AKR1 cells. Ten metaphase spreads were scored for each cell line and the average 
number of chromosomes was determined. All cell lines showed the normal 
complement of chromosomes.
2.3 Real Time Quantitative RT-PCR
RNA was isolated from whole embryos, placentae (homogenised using an 
eppendorf pestle) or stem cell pellets using Tri reagent (Sigma) according to the 
manufacturer’s protocol. Precipitated RNA was resuspended in RNase free dE^O and 
DNase I treated (Promega) at 37 °C for 1 hr according to the manufacturer’s 
instructions. The DNAse I treated RNA was phenol-chloroform extracted and ethanol 
and sodium acetate precipitated. Purified RNA was quantified by spectrophotometry
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and used to make cDNA. Two independent reactions were set up for reverse 
transcriptase treated and non-treated samples. A known concentration of RNA (5 pg 
for RT + or 1 pg for RT-) was incubated with 25 pg random primers (Promega) for 10 
min then placed on ice. The reaction was then incubated with 5x M-MLV buffer 
(Promega), 20-40 units of RNase inhibitor (promega) and 0.5 mM dNTP mix (Roche) 
in 19 pi volume. Samples were incubated at 37 °C for 2 min. To the RT+ sample 100- 
200 units of M-MLV reverse transcriptase, RNase H minus (Promega) was added and 
1 pi of dt^O to the RT- sample as a negative control then incubated at 37 °C for 1 hr. 
Reaction was stopped by heating to 70 °C for 15 min. RT+ cDNA was diluted 1 in 20 
with 10 mM Tris-HCl (pH7.5) and 1 in 4 for RT- cDNA. A PCR was performed on 
RT+ and RT- to confirm the absence of contaminating genomic DNA in the cDNA, 
using primers designed to amplify Actin or GAPDH cDNA. PCR reaction was 
performed using Sigma Taq DNA polymerase (SIGMA) according to the 
manufacturer’s instructions. A basic PCR program was used: 95 °C for 3 min then 95 
°C for 30 sec, 60 °C for 30 sec, 72 °C for 30 sec repeated for 35 cycles followed by 
72 °C for 5 min.
Primers were designed using Primer3 (http://frodo.wi.mit.edu/cgi- 
bin/primer3/primer3 www.cgi) for several genes within the mouse distal chromosome 
7 imprinting cluster. Primers used are shown in table 2.1. 12.5 pi of SYBR green 
reaction mix (MJ research) was added to 5 pi (5 mM stock of forward and reverse 
primers) of primers and 7.5 pi of cDNA (1 in 7.5 dilution). Reaction was loaded on to 
the white 96-well non-skirted plate (Abgene) in triplicate. At least two sets of control 
primers, either GAPDH, Actin, or 18s rRNA were used for quantification of the 
samples. Data was collected by the Chromo4 real time machine (MJ research) and 
analysed using the Opticon monitor software v2.3 (MJ research). Fold changes were
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calculated as described in Livak and Schmittgen, 2001 using the 2 ~ AAC(T) method 
(Livak and Schmittgen 2001).
Table 2.1: Real time quantitative RT-PCR primers
Primer Number Primer Name Sequence Tm
EG36 Phlda2 forward tcagcgctcgagtctgaaa 60
EG37 Phlda2 reverse tcctgggctcctgtctgat 61
EG57a Gtl2 forward atgtgccaagttctgggttc 60
EG58 Gtl2 reverse caagagctacgcattcacca 60
EG59 Rasgrfl forward tgatcgtatccaatccagca 60
EG60 Rasgrfl reverse ctgaacaccacctggttcct 60
EG61 Zac1 forward aagtctcacgcggaagaaaa 60
EG62 Zac1 reverse ctctgggcacagaactgaca 60
EG63 Nnat forward agaaaagcagcaccgacaat 60
EG64 Nnat reverse ggctgttcgatcttcatggt 64
EG65 Gnas ex1 A forward gttgcttcaggtggctggta 64
EG66 Nesp55 forward gagggcccttagatcagga 59
EG67 Gnasxl forward atccgagtgtacccgatcac 64
EG68 Gnas Exon2 reverse gtgcttttgccagactctcc 64
EG71 Kcnql 3'UTR forward ggaacatagggatggggagt 60
EG72 Kcnql 3'UTR reverse gttccctgatggtctctgga 60
EG73 Rasgrfl A forward tggagatcacctcctccatc 60
EG74 Rasgrfl A reverse gtaattgggtgtcccctcct 60
EG75 Zac1 forward gagcagaggaaggagcagaa 60
EG76 Zac1 reverse cacaatgggcaacaagaaga 60
EG77 Hymai forward ctttggccacaaaaattgct 60
EG78 Hymai reverse aaccagaaactgggcagaga 59
R149 GAPDH forward cacagtcaaggccgagaatg 62
R150 GAPDH reverse tctcgtggttcacacccatc 62
R151 B actin forward cctgtatgcctctggtcgta 59
R152 B actin reverse ccatctcctgctcgaagtct 59
R161 Cdknlc exon 3-4 forward agagaactgcgcaggagaac 60
R162 Cdknlc exon 3-4 reverse tctggccgttagcctctaaa 60
R166 Slc22a18 forward acctgtgtccctgctaccac 60
R167 Slc22a18 reverse gatcccgaagaaggacatga 60
R168 IGF2 forward gtcgatgttggtgcttctca 60
R169 IGF2 reverse aagcagcactcttccacgat 60
R170 IGF2R forward gttggtgtagggccagtgtt 60
R171 IGF2R reverse agaaattctgccggggtact 60
R172 Dlk1 forward cacctgggttctctggaaag 60
R173 Dlk1 reverse aggggtacagctgttggttg 60
R174 Grb10 forward ctgcaccacttcttgaggat 60
R175 Grb10 reverse aactgctggtcttcctcctg 60
R190 LIT1 forward tggaatcgggtagagattcg 60
R191 LIT1 reverse agaccatcggaaaacacagg 60
R209 18s rRNA forward catggccgttcttagttggt 64
R210 18s rRNA reverse cgctgagccagtcagtgtag 64
R236 Nesp55 forward ggagagtctggcaaaagcac 60
R237 Nesp55 reverse tggggtaggacatagcgaag 60
R238 Nespas forward cactgagtgtcctccaagca 60
R239 Nespas reverse agaccccagcttctctcctc 60
R244 Ube3a forward tgctgtcacaaagaatctgg 57
R245 Ube3a reverse tcctccacaaccaactgaaa 59
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2.3 Methylation-Sensitive Restriction Enzyme-Coupled PCR 
(MSRE-PCR)
Genomic DNA was isolated from stem cell pellets by digesting overnight in 1 
ml lysis buffer (100 mM Tris-HCl (pH7.8), 50 mM EDTA, 0.2 % SDS, 200 mM 
NaCl) and 100 pg/ml proteinase K at 55 °C. DNA was then phenol-chloroform 
extracted and precipitated with ethanol and sodium acetate (pH6.0). Precipitated DNA 
was washed in 70 % ethanol and resuspended in 200 pi 10 mM Tris (pH7.5). DNA 
was stored at 4 °C until required.
Primers were designed to amplify genomic DNA around a methylation- 
sensitive restriction enzyme site. The list of primers is shown in table 2.2. Genomic 
DNA was digested either with EcoRl (NEB) alone or with a combination of EcoRl 
and the methylation-sensitive restriction enzyme Eagl or Notl (NEB) using the EcoRl 
buffer recommended by New England Biolabs for double digests. 1 pg of genomic 
DNA was digested overnight at 37 °C in a total volume of 20 pi. Using the nested 
primers, 1 pi of digested DNA was amplified using Red Taq DNA polymerase 
(SIGMA). The PCR conditions were as follows: an initial denaturation step of 95 °C 
for 4 min followed by 95 °C for 1 min, 55 °C for 2 min and 72 °C for 3 min repeated 
for 40 cycles.
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Table 2.2: Methylation sensitive restriction enzyme coupled PCR primers
Primer Number Primer Name Sequence Tm
EG01 Cdknlc promoter internal gcggtgttgttgaaactgaa 61
EG47 Cdknlc promoter reverse tgctctcagtcgggccta 61
EG81 Cdknlc promoter methylation ggaccgagggaccttcac 60
R89 Cdknlc intron II methylation tgagcaggtctctgagcagg 66
EG04 Cdknlc intron II reverse cttagctgcacccctaccag 60
R90 Cdknlc intron II internal aatccccgagagaggc 60
EG49 KvDMR region 2 methylation gcgggtttcttctctgagtc 60
EG50 KvDMR region 2 reverse gcccctcactctcagcatta 60
EG51 KvDMR region 2 internal ttacagaagcaggggtggtc 60
EG92 Gtl2 DMR methylation ggaggttcgccggtactaa 60
EG93 Gtl2 DMR internal agggaagggctgcattatt 60
EG94 Gtl2 DMR reverse tccatcaggaattccaaagc 60
EG95 H19 DMR methylation cggttcacctatggcaaact 60
EG96 H19 DMR internal gatcgatcggttcactctcc 60
EG97 H19 DMR reverse aatgcctgatccctttgttg 60
2.4 Bisulphite Sequencing
DNA was prepared for bisulphite treatment by digesting 1 pg of genomic 
DNA in a 50 pi reaction with an appropriate restriction enzyme that cuts around, but 
not within, the region of interest. 21 pi of the digested DNA was then denatured by 
heating to 95 °C for 6 min then by the addition of 4 pi of 2 M sodium hydroxide 
(NaOH), incubating at 37 °C for 30 min. Denatured DNA was mixed with 2 % low 
melting point agarose (SeaPlaque agarose) and kept at 50 °C. A saturated sodium 
bisulphite solution (5.20-5.69 M HSO3' (pH5.0) (Sigma) and 10 mM Hydroquinone, 
(Sigma)) was prepared and filter sterilised. 1 ml was added to an eppendorf tube, 
overlaid with cold mineral oil then chilled on ice for 20 min. 10 pi of agarose/DNA 
mix was pipetted into the oil to form beads, allowed to harden for 10 min, then pushed 
into the underlying aqueous solution. Beads were incubated for 30 min on ice, then 
for 3.5 hrs at 55 °C. At all stages bisulphite solution was protected from light. Beads 
were equilibrated to remove the bisulphite solution by incubating with 1 x TE buffer 
(10 mM Tris-HCl (pH 7.4), 1 mM EDTA) for 4 x 1 5  min at room temperature. Beads 
were then treated with 0.3 M NaOH for 2 x 15 min to perform the final
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desulphonation step. A final equilibration step (3 x 10 min) was performed with 1 x 
TE buffer to remove all traces of NaOH. Whole beads were used directly in the nested 
PCR or stored at 4 °C in dH20 until required.
Semi-nested primers were designed using the Methprimer program 
(http://www.urogene.org/methprimer/index 1 .htmfi to amplify regions within the 
Cdknlc promoter, Cdknlc intron II, and a CpG island upstream of Cdknlc. Primers 
are shown in table 2.3 and primer design is discussed in the results. In the first round 
PCR the following primers were used on whole beads: Cdknlc promoter EG 19 & 
EG20, Cdknlc intron II EG21 & EG22, upstream CpG island EG45 & EG24. In the 
second round PCR, 1 pi of the first round reaction was used with the following 
primers: Cdknlc promoter EG43 & EG20, Cdknlc intron II EG44 & EG 22, upstream 
CpG island EG23 & EG24. Round one PCR conditions: 94 °C for 2 min, 57 °C for 1 
min, 72 °C for 3 min (5 cycles) then 94 °C for 1 min, 57 °C for 1 min, 72 °C for 1 min 
(35 cycles) and a final extension step of 72 °C for 10 min. Round two PCR conditions: 
94 °C for 1 min, 57 °C for 1 min, 72 °C for 1 min (35 cycles) and a final extension 
step of 72 °C for 30 min. Red Taq DNA polymerase (SIGMA) was used in both of the 
nested PCRs according to the manufacturer’s protocol. The concentration of primer 
stock was 25 pM per oligonucleotide. 1 pi of primer mix was used per 25 pi reaction.
PCR products were resolved on a 2 % agarose/TAE gel and bands were 
excised and gel purified using the QIAquick Gel Extraction kit (QIAGEN). PCR 
products were eluted in 30 pi of 10 mM Tris-HCl (pH7.5) then cloned into the 
pGEM-Teasy vector (Promega) and transformed into JM109 chemically competent 
cells (Promega) for blue/white selection as per manufacturer’s instructions. Positive 
clones were checked for the presence of the insert by digesting a sample with EcoR\ 
(NEB) according to the manufacturer’s instructions. Confirmed positive plasmids
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were sent for sequencing (DNA Sequencing Core, Molecular Biology Unit, Cardiff 
University). Sequencing was analysed and processed by BiQ analyzer (Bock et a l 
2005).
Table 2,3: Bisulphite sequencing primers
Primer Primer Name Sequence Tm
Number
EG19 Cdknlc promoter forward round 1 tgggtgtagagggtggatttagtta 62
EG20 Cdknlc promoter reverse cccacaaaaaccctaccccc 64
EG21 Cdknlc intron II forward round 1 gaggaataggtttttgagtaggtttttgag 64
EG22 Cdknlc intron II reverse ccttaactacacccctaccaataaaaaaaa 64
EG23 Cdknlc upstream CpG island Fwd tgggttttgggtttagttaagttat 59
round 2
EG24 Cdknlc upstream CpG island reverse caaatctccaactcctaccctatta 59
EG43 Cdknlc promoter forward round 2 gtattgttaggattaggatttagttggtagtagt
an
63
EG44 Cdknlc intron II forward round 2
«y
ggtgatgagttgggaattgag 63
EG45 Cdknlc upstream CpG forward round ggggatgtttagtggttttgg 63
1
2.5 Chromatin immunoprecipitation
Stem cells were cultured on feeder cells until fully confluent. Cells were 
trypsinised and the feeders removed by panning the cells. Stem cells were collected 
and the formaldehyde mix (10 x stock: 0.5 mM EGTA, 1 mM EDTA, 50 mM HEPES 
pH8.0, 100 mM NaCl, 11 % formaldehyde) was added to a final concentration of 1 % 
and mixed for 10 min at room temperature. The reaction was stopped by the addition 
of glycine to 0.125 M final concentration. Cells were washed twice in 1 x PBS then 
harvested in 1 ml of Lysis buffer (1 % SDS, 10 mM EDTA, 10 mM Tris-HCl pH8.1 
and protease inhibitors) and incubated at 4 °C for 5 min then stored at -20 °C. Samples 
were sonicated using the bioruptor (Diagenode) sonicator on high output on cycles of 
30 sec on, 30 sec off for 10 min. A 50 pi sample of sonicated chromatin was checked 
for sonication efficiency by reversing the formaldehyde crosslinks and precipitating 
the DNA, as described later for the immunoprecipitated samples. Sample DNA was
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resuspended in 10 pi of 1 x TE then 10 pi was run out on a 1 % agarose TAE gel at 
100 V. DNA concentration was also determined by spectrophotometry. The sonicated 
chromatin was centrifuged for 20 min at 13,000 rpm at room temperature to prevent 
precipitation of SDS. Protein concentration was determined by spectrophotometry and 
100 pg was diluted in lysis buffer to 1 pg/pl. Samples were diluted 10 fold in dilution 
buffer (1 % Triton X-100, 2 mM EDTA pH8.0, 150 mM NaCl, 20 mM Tris-HCl 
pH8.1) containing complete mini protease inhibitors (1 tablet in 10 ml buffer) 
(Roche). The chromatin lysate was pre-cleared by adding 30 pi protein A sepharose 
beads (Invitrogen) (100 pg/ml protein A sepharose beads pre-incubated with 100 
pg/ml BSA (NEB) and 500 pg/ml sheared salmon sperm DNA (Invitrogen) diluted in 
5:1 ratio of dilution buffer and lysis buffer) and rotating for 1-2 hours at 4 °C. The 
chromatin-bead solution was centrifuged at 4000 rpm for 5 min then the supernatant 
was transferred to a new tube. Approximately 4 pg of antibody was added to the 
lysate and incubated overnight with rotation at 4 °C. 30 pi of sepharose beads was 
added to the IP reaction and incubated with rotation for 1-2 hrs at 4 °C. Beads were 
washed four times in wash buffer (0.1 % SDS, 1 % Triton X-100, 2 mM EDTA, 150 
mM NaCl, 20 mM Tris-HCl pH8.1 with protease inhibitors) centrifuging at low speed 
for 15 sec between washes, then once in final wash buffer (0.1 % SDS, 1 % Triton X- 
100, 2 mM EDTA, 500 mM NaCl, 20 mM Tris-HCl pH8.1 with protease inhibitors). 
Complexes were eluted in 450 pi of elution buffer (1 % SDS, 0.1 M NaHCC^) with 
500 pg/ml proteinase K and 500 pg/ml RNase A and incubated at 37 °C for 1-2 hrs. 
Crosslinks were reversed by heating the samples for at least six hrs at 65 °C. 
Immunoprecipitated DNA was phenol-chloroform extracted and ethanol and sodium 
acetone (pH5.2) precipitated with a glycogen carrier. DNA was resuspended in 80 pi
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TE and 2 pi were used in a standard PCR reaction. Primers used are shown in table 
2.4. Antibodies used are shown in table 2.5.
The ChIP assays shown in the results were performed using the Orange ChIP kit 
(Diagenode) according to the manufacturer’s instructions. Optimal sonication and 
fixing conditions were performed as described in the results.
Table 2,4: ChIP primers
Primer Number Primer Name Sequence Tm
EG01 Cdknlc promoter forward gcggtgttgttgaaactgaa 60
EG02 Cdknlc promoter reverse gtctggatcgcttgtcctgt 60
EG07 Lit1 promoter forward aagctcacccaatccaaatg 60
EG08 Lit1 promoter reverse ctcctagcgacaacgggtag 60
EG90 Kcnql promoter forward gctgccttcacctcagctc 65
EG91 Kcnql promoter reverse gctccagtgagaagggacac 64
EG11 Phlda2 promoter forward cctgcttgggattgagagtg 61
EG12 Phlda2 promoter reverse atacctggaacaqgctgtcg 60
Table 2,5: ChIP antibodies
Catalogue
number
Concentration Volume
used/IP
Supplier Name
Ab9045 1 pg/pl 4 pi Abeam Rabbit polyclonal to histone H3 
(mono-methyl K9)
Ab8898 0.5 pg/pl 4 pi Abeam Rabbit polyclonal to histone H3 
(tri-methyl K9)
Ab4441 1 pg/pi 2 pi Abeam Rabbit polyclonal to histone H3 
(acetyl K9)
Ab7766 0.5 pg/pl 4 pi Abeam Rabbit polyclonal to histone H3 
(di-methyl K4)
Ab6697 10 pg/pl 0.5 pi Abeam Rabbit polyclonal to goat IgG 
H&L
Kch-403-020 0.5 pg/pl 1 pi Diagenode Antibody anti-Histone H3 
(K4me3)
Ab6002 1 pg/pl 2 pi Abeam Rabbit polyclonal to histone 
H3K27me3
Ab1791 0.5 |jg/|jl 4 pi Abeam Rabbit polyclonal to histone H3
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CHAPTER 3:
Expression of IC2 domain imprinted genes in 
undifferentiated and differentiated mouse embryonic
germ (EG) cells
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3.1 Introduction
As described in Chapter 1, parental specific imprints are established during 
differentiation of PGCs. PGCs can be first identified in mice at around 7.5 dpc as 
approximately 100 alkaline phosphatase positive cells (Ginsburg et al. 1990). These 
PGCs proliferate as they migrate to the genital ridge and number around 25,000 by 
around 13.5 dpc (Matsui et a l 1992; Tam and Snow 1981). Although in vivo studies 
have been performed on these cells in order to examine their epigenetic status, PGCs 
are few in number and difficult to extract for analysis. For this reason, it is not 
practical to isolate large numbers of PGCs from very early stage mouse embryos 
which would be required to allow an in-depth analysis of specific imprinting domains.
Embryonic Germ (EG) cells are derived from primordial germ cells and are 
epigenetically similar to the cells from which they were derived, in the same way that 
Embryonic Stem (ES) cells are similar to the inner cell mass cells from which they are 
derived (Lee et al. 2002; Tada et al. 1998). EG cells have been used in many different 
studies and have been shown to be capable of forming chimeras when injected into 
mouse blastocysts (Labosky et al. 1994; Matsui et al. 1992; Stewart et al. 1994). EG 
cells derived from 11.5 and 12.5 dpc PGCs have been shown to colonise both the ICM 
and the germ line indicating that they have the same developmental potential as ES 
cells (Durcova-Hills et al. 2002; Matsui et al. 1992; Tada et al. 1998). They are also 
able to contribute to the extraembryonic lineages in some chimeric embryos and, 
when subcutaneously injected into nude mice, EG cells are able to give rise to 
teratomas containing a variety of cell types including neuron ganglia, epithelia and 
striated muscle (Durcova-Hills et al. 2002; Matsui et al. 1992). The morphology and 
behaviour of cultured EG cells is similar to that of ES cells and they are stably
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maintained in culture (Matsui et al. 1992; Resnick et a l 1992). Both EG and ES cells 
can be expanded in culture to give large numbers of cells for analysis. The 
differentiation of ES and EG cells in vitro as embryoid bodies mimics events that 
occur in the late pre- and early post-implantation embryo stages and develop cell 
types derived from all three germ layers (Rohwedel et al. 1996; Szabo and Mann 
1994).
In our model EG cells derived from 12.5 dpc PGCs were grown in culture 
along side an ES cell line. In this study we wished to use these EG cells in order to 
examine the state of non-imprinted chromatin within the mouse IC2 imprinting 
domain (figure 3.1) by comparing gene expression, DNA methylation and chromatin 
between ES and EG cells as they differentiate. Lee et al. (Lee et al. 2002) 
demonstrated the existence of a default state o f gene expression in imprint erased 
PGCs that is common in both male and female germ cells. In imprint erased PGCs 
(-12.5 dpc), the majority of the maternally expressed genes are silent while most 
paternally expressed genes are biallelically expressed (Lee et al. 2002). The 
exceptions were HI 9 and Dlkl leading the authors to suggest that there may be a 
different regulatory mechanism for these paternally expressed genes. They also 
observed a complete loss of monoallelic gene expression in clone embryos derived 
from 12.5 to 13.5 dpc PGCs. These clones were unable to support full-term 
development possibly due to the lack of imprinting which led to a loss in 
developmental potential (Yamazaki et al. 2005).
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Figure 3.1: Schematic of mouse distal chromosome 7 IC2 domain.
Mouse distal chromosome 7 cluster contains two independently regulated imprinting 
domains. The centromeric or IC2 domain is regulated by germ line maternal 
methylation of the promoter of Kcnq lo ti  /Lit 1, at a region known as KvDMR 1. This 
imprinting domain contains the imprinted genes Cdknlc, Phlda2 and Kcnql.
The aim of this study was to set up an in vitro system using embryonic germ 
(EG) cells in order to look at the expression states of imprinted genes in non­
imprinted chromatin to determine if our model reflects what is seen in vivo, that the 
domain is silent in imprint erased PGCs. We then aimed to examine the changes in 
expression that occur as ES and EG cells differentiate in culture to see if the IC2 
domain genes are expressed or are silenced in the EG cell line.
3.2 Results
Changes in gene expression occur as ES cells differentiate and new cell types 
appear. The gametic marks required to establish allele-specific gene expression are 
maintained in ES cells during culture (Szabo and Mann, 1994) making these cells 
useful for comparing how non-imprinted EG cell gene expression levels differ from 
levels in ES cells with monoallelic expression. For example, we would predict that, if 
an imprinted gene was active in the absence of an imprint, expression levels within 
the EG cells would be approximately twice that in the ES cells. Conversely, if the 
imprinted gene was silent in the absence of an imprint, expression levels would be
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substantially lower in the EG cells. We are only able to look at genes expressed in the 
embryo using this system since genes expressed only in the extraembryonic material 
would not be detectable in the ES cells. Within the IC2 domain on mouse distal 
chromosome 7 there are several genes that are predominantly expressed in the 
extraembryonic material such as Ascl2. It was expected that expression of this gene 
would be undetectable in ES cells. There are also a number of genes, such as Obphl, 
Tssc4 and Cd81, that are only imprinted in the placenta (Engemann et a l 2000; 
Paulsen et a l 2000). For this reason we decided to look at genes within the IC2 
domain that were known to be ubiquitously imprinted in both the placenta and the 
embryo and expressed in the embryo. Some genes, such as Kcnql are tissue specific 
and are predominantly expressed later on during development so may not be 
detectable in the ES cells.
The EG and ES cells can be differentiated in culture as embryoid bodies by 
removing the supporting feeder layer and culturing in the absence of LIF (as described 
in chapter 2). At some point during differentiation of the ES cells as embryoid bodies 
it is expected that levels of the imprinted genes will increase reflecting the emergence 
of cell types, such as neurons, in which the genes are expressed. For example, Cdknlc 
is not expressed in stem cells but is upregulated as cells differentiate, indicating that 
this gene is now expressed (John et a l  2001a). We know that both ES and EG cells 
can contribute to all three germ layers. However, there are differences in expression of 
imprinted genes which may alter the proportion of the somatic cell types within the 
embryoid bodies.
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3.2.1 Design and optimisation of real time quantitative PCR primers
The primers used in the gene expression study were designed 
specifically to amplify cDNA. Where possible each primer set was designed to span 
an intron. An in silico PCR was performed to confirm the specificity of the primers 
(Karolchik et a l 2003). Total RNA was extracted from wild type embryos, placentae 
and embryonic stem cells, treated with DNase I and reverse transcribed to produce 
cDNA. Each primer set was tested on ES cell cDNA and on either embryonic or 
placental cDNA in order to demonstrate that they produced a product of the correct 
size. A list of primers designed to amplify genes within the IC2 domain are shown in 
table 3.1. The primers were designed to have an annealing temperature of around 60 
°C and to amplify products that were between 100-300 bp in size. These primers were 
tested in the real time assay to ensure a product could be detected.
Two sets of primers were designed to amplify Kcnql. The initial primers 
(EG56/57) amplified a product that was too large for use in the real time assay. 
Primers were redesigned to give a smaller PCR product (EG71/72). Although a Kcnql 
could be detected in ES cell cDNA, the expression levels were very low and not ideal 
for the real time PCR. This suggested that Kcnql was not expressed in ES cells.
Slc22al8 (EG84/85) could not be amplified from either the embryonic or ES 
cell cDNA samples although we could amplify a product from the placental cDNA 
indicating that this gene was not highly expressed in the embryo or ES cell samples.
The initial Kcnqlotl/L itl primers (EG52/53) failed to amplify a product in 
real time PCR so were redesigned. The second set of primers (R190/191) amplified a 
product from the ES cell cDNA and the embryonic cDNA. Kcnqlotl/L itl is expressed 
in a variety of embryonic, neonatal and adult tissues including brain, kidney, lung, 
testis, placenta and in whole embryo but is only imprinted in fetal tissues (Mancini-
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DiNardo et al. 2003; Paulsen et al. 1998). It is biallelically expressed in most neonatal 
tissues suggesting that imprinting of this gene is relaxed later in development (Paulsen 
etal. 1998).
Primers were also designed to amplify Tssc4 (R248/249) but this produced 
two PCR products which could possibly be a result of alternative splicing. It was 
decided not to redesign primers for Tssc4. Cdknlc (R161/162) and Phlda2 (EG36/37) 
products could be detected in both embryonic and ES cDNA samples in the real time 
machine and Phlda2 could also be detected in placental cDNA.
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Table 3.1: List ofprimers designedfor use in real time quantitative RT-PCR for genes within the IC2 imprinting domain.
The primers were designed to amplify a product between 100 -  300 bp. The Pubmed accession numbers are shown for both RNA and 
DNA. An in silico PCR was performed for each primer set to determine the product size in genomic DNA. Primers were either tested on 
embryonic, placental or ES cell cDNA. (+) PCR product detected (-) PCR product absent.
Primers Primer
number
Sequence Tm Product
size
cDNA
Product
size
gDNA
Accession 
numbers: 
mRNA, gDNA
Tested
in
Embryo
Tested
in
Placenta
Tested 
in ES 
cells
Cdknlc R161 AGAGAACTGCGCAGGAGAAC 59.8 141 bp 231 bp NM 009876.3 Yes No Yes
R162 TCTGGCCGTTAGCCTCTAAA 60.0 NT 039453.2 + +
Phlda2 EG36 TCAGCGCTCTGAGTCTGAA 60.0 124 bp 364 bp NM 009434 Yes Yes Yes
EG37 TCCTGGGCTCCTGTCTGAT 60.8 NT 039453 + + +
Slc22al8 EG84 TGATGTCCAGTGTGCTCCAT 60.1 166 bp 1820 bp NM 001042760.1 Yes Yes Yes
EG85 AGAGTTCGGGTCAATGGTTG 60.0 NT 039453 - + -
Kcnql EG56 GATCACCACCCTGTACATTGG 60.0 516 bp 10906 NM 008434.2 Yes No Yes
EG57 CCAGGACTCATCCCATTATCC 60.0 bp NT 039451.1 + +
EG71 GG AAC AT AGGG AT GGGG AGT 60.0 151 bp 151 bp Yes No Yes
EG72 GTTCCCCTGATGGTCTCTGGA 60.0 + +
Kcnqlotl EG52 CTT AC AG AAGC AGGGGT GGTCT 61.9 300 bp 300 bp NR 001461.3 Yes No Yes
/Litl EG53 CTCAGTTCCACGATACCCTTCC 62.1 NT 039453 + -
R190 TCCAATCGGGTAGAGATTCG 60.0 245 bp 245 bp Yes No Yes
R191 AGACCATCGGAAAACACAGG 60.0 + +
Tssc4 R248 AAGCCACGAAAATCTGATCG 60.2 163 bp 404 bp NM 020285 Yes Yes No
R249 ATCCTAGCGCGCACAGATAC 60.4 NT 039451 + +
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Table 3.1: List o f primers continued..
Primers Primer
number
Sequence Tm Product
size
cDNA
Product
size
gDNA
Accession 
numbers: 
mRNA, gDNA
Tested
in
Embryo
Tested
in
Placenta
Tested 
in ES 
cells
GAPDH R149 CACAGTCAAGGCCGAGAATG 61.8 242 bp 211-246 NM 008084 Yes Yes Yes
R150 TCTCGTGGTTCACACCCATC 62.0 bp NT 03935307 + + +
P-Actin R151 CCTGTATGCCTCTGGTCGTA 58.7 262 bp 260 & NM 007393 Yes Yes Yes
R152 CCATCTCCTGCTCGAAGTCT 59.6 262 bp NT 081055.6 + + +
18s R209 CATGGCCGTTCTTAGTTGGT 60.0 218 bp 218 bp NR 003278 Yes Yes Yes
rRNA R210 CGCTGAGCCAGTCAGTGTAG 59.8 + + +
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3.2.2 Expression profiles of IC2 domain genes in undifferentiated 
and differentiated ES and EG cells
To determine how the expression levels of imprinted genes change during ES 
and EG cell differentiation, real time quantitative RT-PCR (qRT-PCR) was performed 
(as described in chapter 2). In the initial analysis, the relative expression levels of the 
imprinted genes during differentiation were calculated for the CES3 (ES cell line) and 
Sv6 .1 (EG cell line) cells. For both ES and EG cells there was very little difference in 
Cdknlc expression between day 0 and day 7 (figure 3.2). Between day 7 and 14 the 
expression of Cdknlc increased indicating that this gene was switched on in the 
differentiated cells after day 7. The same pattern was observed in both ES and EG 
cells suggesting that they could be going though similar developmental stages in 
culture (figure 3.2 A & B). Phlda2 levels remained constant in both EG and ES cells 
at all time points examined. As this gene is predominantly expressed in embryonic 
tissues it is likely that this gene was only expressed at low levels in ES cells. Kcnql 
and Slc22al8 expression was not analysed by real time quantitative RT-PCR as they 
were not detectable in undifferentiated and differentiated ES cells. Kcnqlotl/Litl 
expression was also examined by real time qRT-PCR. In ES cells the expression of 
Kcnqlotl/L itl was similar to that seen for Phlda2, the levels were low and constant 
throughout differentiation (figure 3.2 A). In EG cells, Kcnqlotl/L itl levels steadily 
increased over time (figure 3.2 B).
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B: Imprinted gene expression in Sv6.1 EG cells
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Figure 3.2: Expression of Cdknlc, Phlda2 and Kcnqlotl/Litl during
differentiation of the ES cell line CES3 and EG stem cell line Sv6.1.
A. Expression of the IC2 domain imprinted genes in CES3 ES stem cells. B. 
Expression in Sv6.1 EG stem cells.
Embryoid bodies were differentiated for 0, 7, 14 and 21 days. Mean fold change was 
calculated using the delta delta CT method (see chapter 2) comparing the CT values 
of differentiated ES or EG cells to undifferentiated cells so that expression at each 
data point is relative to expression at day 0 (i.e. 1) for each gene. Standard error is 
shown. At least two control genes (Actin, GAPDH or 18s rRNA) were included in the 
calculation.
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3.2.3 Comparison of gene expression between ES and EG cells
The previous data showed that the expression profiles of Cdknlc and Phlda2 
were similar between the two cell lines. The only difference appeared to be 
Kcnqlotl/Litl where the levels increased in the differentiating EG cells. The next step 
was to compare the expression levels in the EG cell line to the expression levels in the 
ES cell line (figure 3.3). This data indicated that Cdknlc and Phlda2 levels were 
suppressed in the EG cell line at all time points but that Kcnqlotl/Litl levels were 
higher in the EG cells compared to the ES cells.
To give a comparison of the relative expression in ES versus EG cells, we took 
the data presented in figure 3.2A, showing the expression levels of each gene over 
time in ES cells, and the data presented in figure 3.3, showing the expression in ES 
versus EG cells, and multiplied the two values together to give the relative expression 
in EG cells compared with ES cells for each gene.
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Figure 3.3: Relative expression of Cdknlc, Phlda2 and Kcnqlotl/L itl in
Sv6.1 EG cells compared to expression in CES3 ES cells at each time point.
Expression in Sv6.1 EG cells compared to expression in CES3 ES cells at each time 
point. The delta delta CT method (see chapter 2) was used to calculate the fold change 
in EG cells compared to ES cells. Standard error is shown. At least two control genes 
(Actin, GAPDH or 18s rRNA) were included in the calculation.
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Although a similarity was seen in the Cdknlc expression profile between ES 
and EG cells (shown in figure 3.2), the absolute levels were reduced in the EG cell 
line indicating that expression of Cdknlc was somehow repressed (figure 3.4). There 
was a slight increase in Cdknlc expression in the EG cell line at day 14 corresponding 
to the increase in gene expression also observed in the ES cell line that might indicate 
that the suppression of Cdknlc in the EG cells was not absolute.
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Figure 3.4: Calculated relative expression of Cdknlc in Sv6.1 EG cells
compared to expression in CES3 ES cells.
The relative expression of Cdknlc overtime in ES and EG cells was calculated by, 
firstly, comparing the expression level at each differentiation time point in ES cells to 
day 0 in ES cells. The expression in EG cells at each time point compared with ES 
cells was then calculated. The two values were then multiplied together to give the 
relative expression in EG cells compared to ES cells. Standard error is shown for the 
ES cell data. At least two control genes (Actin, GAPDH or 18s rRNA) were included 
in the calculation.
A similar result was observed for Phlda2 expression. Levels of Phlda2 were 
repressed in EG cells compared to ES cells and showed a low and constant level 
throughout differentiation (figure 3.5). There was an increase in Phlda2 expression at 
day 14 in ES cells which may indicate that the gene was expressed at this time point.
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Figure 3.5: Calculated relative expression of Phlda2 in Sv6.1 EG cells
compared to expression in CES3 ES cells.
The relative expression of Phlda2 overtime in ES and EG cells was calculated by, 
firstly, comparing the expression level at each time point in ES cells to day 0 in ES 
cells. The expression in EG cells at each time point compared with ES cells was then 
calculated. The two values were then multiplied together to give the relative 
expression in EG cells compared to ES cells. Standard error is shown for the ES cell 
data. At least two control genes (Actin, GAPDH or 18s rRNA) were included in the 
calculation.
Kcnqlotl/Litl expression was approximately 2-fold higher in the EG cells 
compared to the ES cells suggesting possible expression from both alleles (figure 
3.6). The level of Kcnqlotl/Litl expression in the ES cells appeared to be relatively 
constant throughout differentiation. In contrast, in the EG cells Kcnqlotl/Litl levels 
increased slightly as the cells differentiated. Expression was at least 2-fold higher than 
in the ES cells.
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Figure 3.6: Calculated relative expression of Kcnqlotl/Litl in Sv6.1 EG
cells compared to expression in CES3 ES cells.
Relative expression of Kcnqlotl/Litl overtime in ES and EG cells was calculated by, 
firstly, comparing the expression level at each time point in ES cells to day 0 in ES 
cells. The expression in EG cells at each time point compared with ES cells was then 
calculated. The two values were then multiplied together to give the relative 
expression in EG cells compared to ES cells. Standard error of the ES cell data is 
shown. At least two control genes (Actin, GAPDH or 18s rRNA) were included in the 
calculation.
3.2.4 Expression at early time points in Sv6.1 EG cells compared to 
CES3 ES cells
Our data suggested that Cdknlc and Phlda2 expression was suppressed in the 
differentiated Sv6.1 EG cells whereas Kcnqlotl/Litl expression was not repressed. If 
Cdknlc and Phlda2 were actively silenced during differentiation we might have 
observed an initial increase in Cdknlc and Phlda2 expression in the EG cells, similar 
to ES cells, prior to the silencing event. Therefore we examined earlier time points. 
We also examined Kcnqlotl/Litl expression at these early time points as this non­
coding RNA has been shown to play a role in silencing this domain (Mancini- 
DiNardo et al. 2006; Murakami et al. 2007; Shin et al. 2008).
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Figure 3.7 shows the combined results of the early time point Cdknlc 
expression levels and the later time points for comparison. Changes to gene 
expression were calculated as described previously. At early time points in the ES 
cells we observed a peak in Cdknlc expression on the first day of differentiation 
which is subsequently lost by day 3. This increase was not observed in the EG cell 
line where Cdknlc did not appear to be expressed at any time point until after day 7. 
This suggested that Cdknlc was not expressed at any time point from non-imprinted 
chromatin. However, we could not exclude the possibility that this lack of expression 
was due to the absence of a particular cell type in day 1 EG cells that was present in 
the day 1 ES cells. We also looked at Phlda2.
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Figure 3.7: Relative expression of Cdknlc in Sv6.1 EG cells compared to
expression in CES3 ES cells at both early and late time points.
The relative expression of Cdknlc overtime in ES and EG cells was calculated by, 
firstly, comparing the expression level at each differentiation time point in ES cells to 
day 0 in ES cells. The expression in EG cells at each time point compared with ES 
cells was then calculated. The two values were then multiplied together to give the 
relative expression in EG cells compared to ES cells. Standard error is shown for the 
ES cell data. Dashed line shows the separation between early and late time points 
(shown in figure 3.4). At least two control genes (Actin, GAPDH or 18s rRNA) were 
included in the calculation.
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A similar result was observed for Phlda2 (figure 3.8). This gene was not 
expressed at very high levels in differentiated ES cells. However, we did observe the 
same increase in expression at day one of differentiation for Phlda2 that we found for 
Cdknlc. No increase in expression at this time point was observed in the EG cells. 
Cdknlc and Phlda2 are not generally expressed in the same cell types. This lack of 
expression was unlikely to be due to the absence of a specific cell type and more 
likely to reflect the fact that both genes were silent from the earliest time point in EG 
cells.
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Figure 3.8: Relative expression of Phlda2 in Sv6.1 EG cells compared to
expression in CES3 ES cells at both early and late time points.
The relative expression of Phlda2 overtime in ES and EG cells was calculated by, 
firstly comparing the expression level at each differentiation time point in ES cells to 
day 0 in ES cells. The expression in EG cells at each time point compared with ES 
cells was then calculated. The two values were then multiplied together to give the 
relative expression in EG cells compared to ES cells. Standard error is shown for the 
ES cell data. Dashed line shows the separation between early and late time points 
(shown in figure 3.5). At least two control genes (Actin, GAPDH or 18s rRNA) were 
included in the calculation.
There were dynamic changes in Kcnqlotl/Litl expression levels at the early 
time points in both ES and EG cells (figure 3.9). Both the ES and the EG cells
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displayed roughly the same profile but there were differences in the absolute levels. In 
the EG cells we observed a 50 % decrease in Kcnqlotl/Litl levels at day 1 compared 
with day 0. Kcnqlotl/Litl levels then appeared to steadily increase to 2-fold levels by 
day 7. However, in the ES cell line the levels of Kcnqlotl/Litl decreased sharply to 
their lowest level at day 5 before returning to 1-fold levels at day 7. It is possible that 
the different expression patterns in the cell lines represent the different functions of 
Kcnqlotl/Litl in these cells. In EG cells, Kcnqlotl/Litl may be required to silence 
the IC2 domain whereas, in the ES cells, the domain has already undergone 
imprinting and no further role for Kcnqlotl/Litl is required.
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Figure 3.9: Relative expression of Kcnqlotl/Litl in Sv6.1 EG cells
compared to expression in CES3 ES cells at both early and late time points.
The relative expression of Kcnqlotl/Litl overtime in ES and EG cells was calculated 
by, firstly comparing the expression level at each differentiation time point in ES cells 
to day 0 in ES cells. The expression in EG cells at each time point compared with ES 
cells was then calculated. The two values were then multiplied together to give the 
relative expression in EG cells compared to ES cells. Standard error is shown for the 
ES cell data. Dashed line shows the separation between early and late time points 
(shown in figure 3.6). At least two control genes (Actin, GAPDH or 18s rRNA) were 
included in the calculation.
The results so far suggested that the IC2 domain maternally expressed genes 
were low or silent in the absence of an imprint. This concurs with what was seen in
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the Lee et a l and Tada et a l studies and indicated that there was default silencing of 
this domain in EG cells (Lee et a l 2002; Tada et a l 1998). The presence of a somatic 
DMR on the promoter of Cdknlc suggested that DNA methylation was a likely 
candidate for establishing silencing of this gene. The cells used in this study are 
imprint erased which means all of the germ line methylation marks are erased. In the 
absence of the germ line methylation mark, the IC2 domain is silent. Several studies 
have shown that KvDMRl methylation is required for expression of the surrounding 
imprinted genes. Loss of methylation at KvDMRl often results in loss of expression 
of the IC2 domain imprinted genes (Howell et a l 2001). Also, deletion of the 
maternal KvDMRl results in biallelic expression of the imprinted genes 
demonstrating the importance of the region for establishing and maintaining imprinted 
gene expression (Fitzpatrick et a l 2002; Horike et a l 2000; Mancini-DiNardo et a l 
2003).
3.2.5 Confirmation that Kcnq1ot1/Lit1 expression is not the 
unspliced Kcnql transcript
The Kcnqlotl/Litl gene overlaps and is antisense to the Kcnql gene. It was 
therefore possible that the primers designed to amplify the K cnqlotl/L itl gene were 
picking up unspliced Kcnql transcript. To resolve this issue, we looked for a 
polymorphism within the Kcnqlotl/Litl transcript. A published polymorphism exists 
between C57BL/6 and PWK mouse strains and results in G/C change (Yatsuki et a l
2002). In 129sv and C57BL/6 mice the polymorphism results in the presence of a Neil 
cut site, whereas in PWK mice (a highly inbred mouse strain derived from wild mice 
of mus musculus musculus subspecies) this Neil cut site is absent (Gregorova and 
Forejt 2000; Yatsuki et a l 2002) (figure 3.10a). Our aim was to determine if  this 
polymorphism was also present in M.Spretus to allow us to identify allele specific
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expression in SF1-1 ES cells. SF1-1 ES cells were derived from embryos produced as 
a result of in vitro fertilization of (C57BL/6 x CBA/Ca) FI eggs with M. spretus 
sperm (Dean et a l 1998; Feil et a l 1997). If the polymorphism was present then it 
should be detected in these ES cells as a 195 bp band. Genomic DNA from SF1-1 and 
CES3 ES cells was amplified using the Kcnqlotl/Litl real time PCR primers 
(EG52/53). Figure 3.10b shows the result of digesting the PCR product with Neil. 
There were strong bands at 67 bp, 106 bp and 127 bp indicating the presence of the 
106 bp and 173 bp Neil cut sites in both the 129Sv ES cells and the SF1-1 cells. If the 
polymorphism was present, we would have expected a 195 bp band in the SF1-1 
sample.
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100
67/68 bp 127 bp
194/195 bp
SF1-1 CES3
195 bp Predicted M. Spnetus
127 bp 129Sv
106/7 bp M.Spretus l129Sv
67/68 bp 129Sv
Figure 3.10: Identification of a polymorphism at Kcnqlotl/L itl within SF1-
1 genomic DNA corresponding to the M.Spretus allele.
A The 300 bp PCR fragment produced after amplification with primers EG52 and 
EG53 showing the expected locations of the Neil cut sites and the expected fragment 
sizes in 129Sv and M.Spretus genomic DNA. The 173 bp Neil site is absent in PWK 
mice (AP001295; 103181 G/C change) and may also be absent from M. Spretus mice. 
B Digestion of the 300 bp PCR product by Neil in SF1-1 and CES3 ES cell gDNA.
As we were unable to locate the polymorphism within the SF1-1 cell line, 
RNA from undifferentiated and differentiated EG cells was sent to Professor Michael 
Higgins (Department of Cancer Genetics, Roswell Park Cancer Institute, New York) 
for use in a ribonuclease protection assay (RPA) and a Kcnqlotl/Litl strand-specific 
RT-PCR (figure 3.11; supplied by Professor Michael Higgins). A protected fragment 
corresponding to Kcnqlotl/Litl was detected in both the day 0 and day 5 EG samples 
and was absent in the negative controls (RNA from KvDMRl deletion and poly (A) 
truncation mice). A strand-specific RT-PCR was used to confirm the RPA results.
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Reverse transcription was carried out using a strand-specific primer so that RNA 
corresponding to the primary unspliced Kcnql transcript would not be converted into 
cDNA and detected. Significant expression of Kcnqlotl/Litl was detected in both 
undifferentiated and differentiated EG cells. These results confirmed what was seen in 
this study, that Kcnqlotl/Litl was expressed in the undifferentiated and differentiated 
EG cells.
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Figure 3.11: Strand specific RT-PCR and RPA on undifferentiated and
differentiated Sv6.1 EG cells.
A Schematic of the Kcnqlotl/Litl gene showing location of the primers used in the 
strand specific RT-PCR and the location of the RPA probe. B RPA assay on yeast 
RNA, liver RNA from KvDMRl deletion mice, liver RNA from poly (A) truncation 
mice, undifferentiated (EGO) and differentiated (EG5) EG cell RNA, and RNA from 
wild type liver. Cyclophilin was used as a control. C Strand-specific RT PCR 
showing amplification of Kcnqlotl/Litl in undifferentiated (EGO) and differentiated 
(EG5) EG cells. Figure from Professor Michael Higgins (Department of Cancer 
Genetics, Roswell Park Cancer Institute, New York).
3.2.6 Design of primers for the expression analysis of other 
imprinted genes
The data published by several groups including Lee et al. suggested that there 
are two types of imprinted genes, those that require an imprint to be expressed and 
those that require an imprint to be silenced (Lee et al. 2002). Our imprinted domain is 
one that requires an imprint for the maternal alleles to be expressed. To identify other
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imprinting domains that showed the same pattern and possibly rely on the same 
silencing mechanisms, we designed primers to amplify a number of imprinted genes 
and tested them in ES cells. As described in Section 3.2.1, primers were designed to 
specifically amplify cDNA and were tested on embryonic, placental or ES cell cDNA 
before use in the real time machine (table 3.2). Those that were found to be expressed 
in ES cells are shown in the results. Primer sets that failed to amplify a product in the 
ES cell cDNA were not included in the analysis.
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Table 3.2: Real time quantitative RT-PCR primers o f (other imprinted genes \
The primers were designed to amplify a product between 100 -  300 bp. The Pubmed accession numbers are shown for both RNA and 
DNA. Primers were either tested on embryo, placenta or ES cell cDNA. An in silico PCR was performed for each primer set to determine 
the product size in genomic DNA. (-) in product size gDNA indicates no product detected by in silico PCR. (+) PCR product detected (-) 
PCR product absent.
Primers Primer
number
Sequence Tm Product
size
cDNA
Product
size
gDNA
Accession numbers 
cDNA, gDNA
Tested
in
Embryo
Tested
in
Placenta
Tested 
in ES 
cells
Gtl2 EG57a ATGTGCCAAGTTCTGGGTTC 60.0 222 bp - NR 003633 Yes No Yes
(Meg3) EG58 CAAGAGCTACGCATTCACCA 60.0 NT_114989.1 + +
Rasgrfl EG59 TGATCGTATCCAATCCAGCA 60.0 189 bp 3042 bp NM 011245.2 Yes No Yes
EG60 CTGAACACCACCTGGTTCCT 60.0 NT 039476.7 + -
EG73 TGGAGATCACCTCCTCCATC 60.0 223 bp 7508 bp Yes No Yes
EG74 GTAATTGGGTGTCCCCTCCT 60.0 + -
Zacl EG61 AAGTCTCACGCGGAAGAAAA 60.0 158 bp 158 bp NM 009538 Yes No Yes
(Plagll) EG62 CTCTGGGCACAGAACTGACA 60.0 NT 039492.7 + +
EG75 GAGCAGAGGAAGGAGCAGAA 59.8 178 bp 807 bp Yes No Yes
EG76 C AC AAT GGGC A AC A AG A AG 57.7 + +
Nnat EG63 AGAAAAGCAGCACCGACAAT 60.0 204 bp 204 bp NM 010923 Yes No Yes
EG64 GGCTGTTCGATCTTCATGGT 60.0 AC 000024 + +
Dlkl R172 CACCTGGGTTCTCTGGAAAG 59.7 188 bp 1579 bp NT 114989.1 Yes No Yes
R173 AGGGGT AC AGCT GTT GGTT G 60.0 NM_010052.4 + +
GrblO R174 CT GC ACC ACTT CTT G AGG AT 57.9 151 bp 2888 bp NT 039515.6 Yes No Yes
R175 AACTGCTGGTCTTCCTCCT 59.4 NM_010345 + +
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Primers Primer
number
Sequence Tm Product
size
cDNA
Product
size
gDNA
Accession numbers 
cDNA, gDNA
Tested
in
Embryo
Tested
in
Placenta
Tested 
in ES 
cells
Igf2r R170 GTT GGT GT AGGGCC AGT GTT 59.9 181 bp - NM 010515 Yes No Yes
R171 AGAAATTCTGCGGGGTACT 58.2 NT 039638.7 + +
IgP R168 GTCGATGTTGGTGCTTCTCA 59.8 195 bp 1400 bp NM 010514 Yes No Yes
R169 AAGCAGCACTCTTCCACGAT 60.0 NT 039437.7 + +
Ube3a R244 TGCTGTCACAAAGAATCTGG 57.4 288 bp 7953 bp NM 001033962.1 Yes Yes Yes
R245 TCCTCCACAACCAACTGAAA 59.1 + + -
Hymai EG77 CTTTGGCCACAAAAATTGCT 60.1 227 bp - AF 314094 Yes No Yes
EG78 AACCAGAAACTGGGCAGAGA 59.8 - -
Gnasxl EG67 ATCCGAGTGTACCCGATCAC 60.0 225 bp 34219 NM 010309.3 Yes No Yes
EG68 CTGCTTTTGCCAGACTCTCC 60.0 bp + +
Gnas Ex EG65 GTTGCTTCAGGTGGCTGGTA 61.2 194 bp 6464 bp NR 003258.1 Yes No Yes
1A EG68 CTGCTTTTGCCAGACTCTCC 60.0 BC 062654 + +
Nesp55 EG66 GAGGGCCCTTAGATCAGGA 59.2 234 bp - NM 019690 Yes No Yes
EG68 CTGCTTTGCCAGACTCTCC 60.0 - -
R236 GGAGAGTCTGGCAAAAGCAC 60.0 173 bp 3464 bp NM 022000.2 Yes No Yes
R237 T GGGGT AGG AC AT AGCG AAG 60.1 + -
Nespas R238 CACTGAGTGTCCTCCAAGCA 60.0 241 bp 1715 bp NR 002846.2 Yes No Yes
R239 AGACCCCAGCTTCTCTCCTC 60.0 + +
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3.2.7 Maternally expressed genes Igf2r and GrMO
Mouse Igf2r is a maternally expressed gene that requires a maternal 
methylation mark to be expressed and is a negative regulator of embryonic growth 
(Labosky et a l 1994; Wutz et a l 1997). The model for imprinting of this gene is 
described in Chapter 1.2.1. Like Cdknlc, Igf2r is only expressed in ES cells after 
differentiating the cells as embryoid bodies (Szabo and Mann 1994).
Mouse GrblO is an important inhibitor of embryonic growth and it has been 
shown that a maternally inherited loss of function mutation in GrblO results in 
embryonic overgrowth in mice (Charalambous et a l 2003). The upstream region of  
GrblO contains two CpG islands and is highly conserved between mice and humans 
(Amaud et a l 2003). In humans, GRB10 is biallelically expressed in the majority of 
tissues except for maternal-specific expression in skeletal muscle and paternal- 
specific expression in the brain (Blagitko et a l 2000). In the mouse, GrblO is 
maternally expressed in the majority of tissues except for an isoform specifically 
expressed in the brain (Blagitko et a l 2000; Miyoshi et a l 1998; Yamasaki-Ishizaki et 
al 2007) (figure 3.12). The germ line DMR is found within the GrblO gene at a 
maternally methylated CpG island (Amaud et a l 2003). On the paternal allele, CTCF 
binds the unmethylated DMR and insulates the major isoform promoter of GrblO 
from downstream enhancers. On the maternal allele, methylation of the DMR 
prevents CTCF binding so GrblO is expressed (Hikichi et a l  2003; Yamasaki- 
Ishizaki et a l 2007). There are two other CpG islands in the mouse, one of which is 
located over the promoter of the brain specific isoform of GrblO (Amaud et a l 2003; 
Yamasaki-Ishizaki et a l 2007).
87
Chapter 3: IC2 gene expression in EG cells
The expression of Igf2r and GrblO was analysed by qRT-PCR in both ES and 
EG cells as described previously. Figure 3.13 shows the difference in expression of 
Igf2r and GrblO between the ES and EG cell line in undifferentiated and 
differentiated cells. As seen with the Cdknlc results earlier, Igf2r and GrblO 
expression was low in the EG cell lines after differentiating for 14 days. In the 
undifferentiated ES and EG cells Igf2r expression was also low. GrblO expression 
was at levels similar to ES cell levels. The results indicated that, like Cdknlc an 
imprint is required for these genes to be expressed.
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Figure 3.12: Organisation of the mouse Igf2r and GrblO loci and location of
the differentially methylated regions.
A Igf2r is predominantly expressed from the maternal allele. Maternal methylation of 
the intronic DMR prevents expression of the paternally expressed antisense non­
coding transcript Air and allows expression of Igf2r.
B Maternal expression of the predominant isoform GrblOS is found and maintained in 
all tissues. The germ line DMR is methylated on the maternal allele. A brain specific 
isoform of GrblO is expressed from a second CpG island to give paternal expression 
of GrblO.
Orange boxes are maternally expressed genes, blue boxes are paternally expressed 
genes and arrows indicate transcription. Pink boxes with lolly pops indicate location 
of a methylated DMR. Pat = paternal allele, Mat = maternal allele.
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Figure 3.13: Expression of Igf2r and GrblO in differentiated CES3 ES and 
Sv6.1 EG cells.
Expression of the imprinted gene (A) Igf2r and (B) GrblO in undifferentiated and 
differentiated ES and EG cells using the delta delta CT method described in chapter 2. 
The relative expression of each gene at each time point in ES and EG cells was 
calculated by, firstly comparing the expression level at day 14 in ES cells to day 0 in 
ES cells. The expression in EG cells at day 0 and day 14 compared with ES cells was 
then calculated. The two values were then multiplied together to give the relative 
expression in EG cells compared to ES cells. Standard error is shown for the ES cell 
data. At least two control genes (Actin, GAPDH or 18s rRNA) were included in the 
calculation.
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3.2.8 Paternally expressed genes Nnat, Zac1, Gnas Ex1A, Gnasxl, 
Dlk1 and lgf2
Zacl encodes a zinc finger transcription factor that is found to play a role in 
embryonic growth, possibly by interacting with other imprinted genes such as Cdknlc 
(Valente et a l  2005). Zacl and Cdknlc appear to be expressed in many of the same 
tissues (Arima et a l  2005). There is a zinc-fmger motif within the Zacl protein which 
suggests that it has DNA binding capacity (Arima et a l 2005; Varrault et a l 2006). 
Human CDKN1C contains two ZAC1 binding sites and there are eight potential 
binding sites within the KvDMRl CpG island, possibly indicating a role for ZACl in 
regulating CDKN1C imprinted expression. Human ZAC1 has been shown to bind to 
unmethylated KCNQ lO Tl/LITl promoter and can function as a transcriptional 
activator acting on the unmethylated paternal allele in vivo (Arima et a l 2005). Zacl 
is located on mouse chromosome 10 and is expressed in a variety o f embryonic and 
adult mouse tissues. It is found physically linked to one other imprinted gene 
Sgce/Hymai, a non-coding RNA that has no known function (Arima et a l 2006; 
Arima et a l  2005; Varrault et a l  2006) (figure 3.14).
Neuronatin (Nnat) is a paternally expressed gene involved in neural 
development and differentiation (Kikyo et a l  1997). It is an isolated imprinted gene 
found on mouse distal chromosome 2 within the biallelically expressed gene BC10 
(John et a l  2001b). From an early stage, Nnat expression is restricted to neural tissue 
in the embryo and loss o f Nnat results in decreased cerebella folding (Kikyo et a l
1997).
Lee et a l  suggested a model whereby, in the absence o f an imprint, some 
maternally expressed genes are silent and paternally expressed genes are biallelically 
expressed (Lee et a l 2002). Nnat was expressed in EG cells at two fold the level
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found in ES cells in both undifferentiated and differentiated cells, which suggested 
that this gene is expressed in the absence of an imprint. Zacl appeared to be 
suppressed in the undifferentiated cells. After differentiation, we observed two fold 
expression in EG cells compared with ES cells indicating that this gene is also 
expressed in the absence of an imprint. There was a four fold increase in Zacl 
expression between day 0 and day 14 in the ES cells indicating that, like Cdknlc, 
Zacl is upregulated during differentiation (figure 3.15).
Hymai
Pat 
Mat
Nnat
Pat 
Mat
Figure 3.14: Organisation of the mouse Zacl and Nnat loci and location of
the differentially methylated regions.
A Zacl and its alternative transcript Hymai are predominantly expressed from the 
paternal allele. Maternal methylation of the DMR located within exon 1 of the non­
coding gene Hymai is associated with silencing of both Zacl and Hymai.
B Nnat is paternally expressed. Maternal methylation of the DMR is associated with 
suppression of Nnat.
Blue boxes are paternally expressed genes and arrows indicate transcription. Pink 
boxes with lolly pops indicate location of a methylated DMR. Pat = paternal allele, 
Mat = maternal allele.
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Figure 3.15: Expression of Nnat and Zacl in undifferentiated and
differentiated CES3 ES and Sv6.1 EG cells.
Expression of the imprinted genes Nnat (A) and Zacl (B) in undifferentiated and 
differentiated ES and EG cells using the delta delta CT method described in chapter 2. 
The relative expression of each gene at each time point in ES and EG cells was 
calculated by, firstly comparing the expression level at day 14 in ES cells to day 0 in 
ES cells. The expression in EG cells at day 0 and day 14 compared with ES cells was 
then calculated. The two values were then multiplied together to give the relative 
expression in EG cells compared to ES cells. Standard error is shown for the ES cell 
data. At least two control genes (Actin, GAPDH or 18s rRNA) were included in the 
calculation.
The Gnas cluster, found on mouse distal chromosome 2, has been shown to be 
involved in regulating neonatal behaviour and growth (Holmes et al. 2003) (figure
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3.16). The cluster contains a number o f imprinted genes such as Nesp55 and Gnas 
which play different roles in embryonic and neonatal development. Nesp55 also has a 
role in adult behaviour. The Gnas locus consists of several imprinted alternatively 
spliced transcripts, all differing in the first exon, some of which are non-coding and 
are possibly involved in the regulation o f the imprinting domain (Holmes et al. 2003). 
An antisense transcript (Nespas) is also found within the Nesp55 gene and is possibly 
involved in regulating Nesp55 expression (Holmes et al. 2003). There are three DMRs 
found within the promoter regions o f Nesp55, Nespas and Exon 1A however only the 
Nesp55 DMR is believed to be the ICR for this region (Liu et al. 2000). Gnasxl is one 
of the alternative splice forms o f Gnas, has a role in growth and is paternally 
expressed. The protein is structurally identical to the Gnassa protein but has a longer 
amino terminal extension and is involved in regulating cAMP synthesis (Holmes et al.
2003). Gnas ExonlA generates an untranslated transcript from the paternal allele and 
is ubiquitously expressed in all tissues and possibly has a role in controlling 
imprinting o f this domain. However, deletion o f the ExonlA DMR has no effect on 
imprinting o f the Gnas domain (Holmes et al. 2003; Liu et al. 2000).
Expression within the Gnas cluster is complicated and involves multiple 
DMRs and non-coding RNA transcripts. The results from two genes within this 
cluster are shown in figure 3.17. Gnas ExlA expression appeared to remain constant 
in the ES cell line at both time points whereas in the EG cell line expression increased 
more than 11 -fold in the differentiated cells. This dramatic increase in Gnas ExlA 
expression levels was unexpected but it could be an indication o f its involvement in 
establishing silencing o f the Gnas cluster in EG cells (figure 3.17A). As with Zacl 
we observed low expression o f Gnas ExlA in the undifferentiated EG and ES cells. 
Both Zacl and Gnas ExlA appeared to be expressed in the EG cells only after
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differentiation. Gnasxl expression was more than 2-fold higher in the EG cell line at 
both time points (figure 3.17B). The levels appeared to decrease slightly in 
differentiated cells yet still maintained the two-fold difference between ES and EG 
cells and indicated that Gnasxl is expressed in the absence of an imprint.
Nespas Gnasxl
Mat
Figure 3.16: Organisation of the Gnas cluster and location of the DMRs.
Gnasxl and the two non-coding imprinted genes Nespas and ExonlA are expressed 
predominantly from the paternal allele. Nesp is the first exon for the Nesp55 protein 
and is expressed from the maternal allele. Gnasxl, ExonlA, Gnas and Nesp are 
alternatively spliced transcripts that share exons 2-13. Differential expression of the 
imprinted genes is controlled by DMRs located at the promoters of Nesp, Gnasxl and 
ExonlA. The germ line DMR is found within the Nesp promoter. Orange boxes are 
maternally expressed genes, blue boxes are paternally expressed genes and arrows 
indicate transcription. White boxes are biallelic expressed genes. Pink boxes with 
lolly pops indicate location of a methylated DMR. Yellow boxes with lolly pops show 
location of somatic DMRs.
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Figure 3.17: Expression of Gnas ExlA  and Gnasxl in undifferentiated and
differentiated CES3 ES and Sv6.1 EG cells.
Expression of the imprinted genes Gnas ExlA  (A) and Gnasxl (B) in ES and EG cells 
using the delta delta CT method described in chapter 2. The relative expression of 
each gene at each time point in ES and EG cells was calculated by, firstly comparing 
the expression level at day 14 in ES cells to day 0 in ES cells. The expression in EG 
cells at day 0 and day 14 compared with ES cells was then calculated. The two values 
were then multiplied together to give the relative expression in EG cells compared to 
ES cells. Standard error is shown for the ES cell data. At least two control genes 
(Actin, GAPDH or 18s rRNA) were included in the calculation.
The Dlkl paternally expressed gene is found within an imprinting cluster on 
mouse distal chromosome 14 and includes the genes Gtl2, Pegl 1 and Dio3 (Takada et 
al. 2002). Reciprocal imprinting of Gtl2 and Dlkl is regulated by a paternally 
methylated DMR that lies between the two genes (Hiura et al. 2007). Dlkl is
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expressed in numerous embryonic tissues including the placenta. Gtl2 is a non-coding 
RNA transcript that possibly plays a role in regulating imprinting of Dlkl (Lin et al. 
2003; Takada et al. 2002) (figure 3.18 A).
The H19-Igf2 cluster is found within the mouse distal chromosome 7 
imprinting domain and contains a number o f imprinted genes involved in embryonic 
growth. The mechanism of imprinting o f this domain is described in detail in chapter 
1.2.1. Briefly, a paternally methylated DMR lies within the promoter region of the 
non-coding RNA transcript HI 9 which acts as a transcriptional switch between HI 9 
and Ig/2 expression (Davis et al. 1999; Leighton et al. 1995; Thorvaldsen et al. 1998). 
Methylation o f the DMR correlates with HI 9 expression and suppression of Igf2 
(Thorvaldsen et al. 1998) (figure 3.18 B).
The Lee study (Lee et al. 2002) demonstrated that Gtl2, Dlkl and HI 9 were 
exceptions to the rule that paternally expressed genes are found at biallelic levels and 
maternally expressed genes are silent in imprint erased PGCs. Our results for Dlkl are 
similar to the Lee study as, in the absence o f the paternal imprint, this gene is 
suppressed compared to that seen in ES cells (figure 3.19A). Igf2 is found within the 
same cluster o f imprinted genes as H19. Paternal methylation of the ICR results in 
expression o f Igf2 and suppression o f HI 9. In the absence of an imprint we would 
expect biallelic levels o f HI 9 (a maternally expressed gene) and suppression of Igf2 (a 
paternally expressed gene). However, Lee et al. showed that H I9 was not found at 
biallelic levels in non-imprinted PGCs. We did not see any suppression o f Ig/2 in this 
study, in fact there was increased Igf2 expression in the EG cell line (figure 3.17B). 
Both o f these genes appeared to be expressed only after differentiation of the stem 
cells as embryoid bodies.
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Figure 3.18: Organisation of the Dlkl-Gt!2 and H19-Igf2 imprinting
clusters and the location of the DMRs.
A Imprinting of the Dlkl-Gtl2 cluster is regulated by an intragenic DMR located 
upstream of the Gtl2 promoter. Paternal methylation of the ICR results in paternal 
expression of Dlkl and silencing of the maternally expressed gene Gtl2.
B The ICR for the Igf2-H19 cluster lies within the promoter region of the H I9 gene. 
Paternal methylation results in silencing of the maternal H I9 non-coding transcript 
and expression of paternal Igf2. Maternal Ig/2 expression is further suppressed by 
maternal methylation of the Ig/2 promoter.
Orange boxes are maternally expressed genes, blue boxes are paternally expressed 
genes and arrows indicate transcription. Pink boxes with lolly pops indicate location 
of a methylated DMR. Yellow boxes with lolly pops show location of somatic DMRs.
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Figure 3.19: Expression of Dlkl and Ig/2 in undifferentiated and
differentiated CES3 ES and Sv6.1 EG cells.
Expression of the imprinted genes Dlkl (A) and Ig/2 (B) in undifferentiated and 
differentiated ES and EG cells using the delta delta CT method described in chapter 2. 
The relative expression of each gene at each time point in ES and EG cells was 
calculated by, firstly comparing the expression level at day 14 in ES cells to day 0 in 
ES cells. The expression in EG cells at day 0 and day 14 compared with ES cells was 
then calculated. The two values were then multiplied together to give the relative 
expression in EG cells compared to ES cells. Standard error is shown for the ES cell 
data. At least two control genes (Actin, GAPDH or 18s rRNA) were included in the 
calculation.
We have shown here that the maternally expressed genes are suppressed in the 
EG cell lines whereas the paternally expressed genes are expressed at more than 2- 
fold levels compared to ES cells with the exceptions of Ig/2 and Dlkl. A summary of
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the data is shown in table 3.3. These results were similar to that reported in vivo (Lee 
et a l  2002). This indicated that in vivo differentiated EG cells were a good model for 
determining the expression status o f any imprinted gene in the absence o f an imprint
Table 3.3: Summary o f  the expression o f imprinted genes in undifferentiated 
and differentiated EG cells.
The summary o f the expression o f a number o f imprinted genes in undifferentiated 
and differentiated EG cells calculated relative to expression in ES cells. Suppressed 
meant that the expression o f the gene was less than that in ES cells. Fold changes are 
the expression relative to expression in the ES cells so 1 -fold = same, 2-fold = approx. 
biallelic levels.
Gene Parental 
origin of 
expression
Germ line 
DMR
Expression 
in imprint- 
erased EGs
Expression in 
differentiated 
EGs
Expressed 
in absence 
of imprint
Cdknlc Mat Mat Suppressed Suppressed No
Phlda2 Mat Mat Suppressed Suppressed No
lgf2r Mat Mat Suppressed Suppressed No
GrblO Mat Mat -  1-fold Suppressed No
K cnqlotl Pat Mat -  2-fold -  2-fold Yes
Nnat Pat Mat -3-fold -3-fold Yes
Zacl Pat Mat Suppressed 2-fold Yes
Gnas ExlA Pat Mat Suppressed 11-fold Yes
Gnas xl Pat Mat - 3 -fold - 3 -fold Yes
Dlkl Pat Pat Suppressed Suppressed No
Ig/2 Pat Pat -  1-fold - 1.4-fold ?
3.2.9 Confirmation of expression results in second EG cell line 
TMAS21G
A control EG cell line was used to confirm our results. The relative expression 
of a number o f imprinted genes was determined and compared to that seen in the ES 
and EG cell lines used earlier (figure 3.14). All o f the imprinted genes that were silent 
in the Sv6.1 cell line were similarly suppressed in the absence o f an imprint after 
differentiation o f the TMAS21G stem cells for 14 days. There were some slight 
differences in the absolute expression levels between the two cell lines such as a
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lower Cdknlc expression in the TMAS21G cell line compared to the Sv6.1 cell line. 
The TMAS21G cell line was from a different genetic background which may account 
for the differences between the two cell lines. The TMAS21G cell line also contains a 
Rosa 26 reporter gene that could somehow affect expression of the imprinted genes.
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Figure 3.20: Relative expression of Cdknlc, Ph/da2, Igf2r, GrblO and
K cnqlotl/L itl in differentiated CES3, Sv6.1 and TMAS21G EG cells.
Embryoid bodies were differentiated for 0 and 14 days. The fold change difference 
between ES and EG cells was first calculated using the delta delta CT method for each 
imprinted gene as described in chapter 2. The relative expression of each gene at each 
time point in ES and EG cells was calculated by, firstly comparing the expression 
level at day 14 in ES cells to day 0 in ES cells. The expression in EG cells at day 0 
and day 14 compared with ES cells was then calculated. The two values were then 
multiplied together to give the relative expression in EG cells compared to ES cells. 
Standard error is shown for the ES cell data. At least two control genes (Actin, 
GAPDH or 18s rRNA) were included in the calculation.
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3.3 Discussion
As described in section 3.1, epigenetic studies o f silencing in the germ line 
usually involve using primordial germ cells taken from early stage mouse embryos. 
As these PGCs are few in number, it is technically difficult to isolate large numbers in 
order to perform such in-depth analyses o f specific imprinting domains. We, 
therefore, aimed to determine if in vitro differentiated EG cell lines could be a useful 
model for studying the expression o f imprinted genes from non-imprinted chromatin.
3.3.1 Comparing EG and ES cells
EG cells provide a convenient model system in which we can study silencing 
as they can be grown in culture in large numbers and are developmentally similar to 
ES cells (Tada et a l  1998). Our analysis showed that three genes within the IC2 
domain in both ES and EG cells show similarities in the timing o f expression during 
differentiation.
Cdknlc and Phlda2 showed similar expression patterns between ES and EG 
cells implying that, as the cells differentiate, the imprinted genes were expressed at 
the same time points in both the ES and EG cells indicating that the cells were 
comparable. In this study we have to presume that the expression o f the imprinted 
genes in the ES cells was from one allele only. As there are no polymorphisms in this 
cell line we were unable to confirm this. Many studies have reported the expression of 
imprinted genes in ES cells. Lewis et a l have shown that, in ES cells, Phlda2 and 
Cdknlc are expressed monoallelically whereas OsbplS and Tssc4 are expressed 
biallelically. Only basal levels o f Kcnql and Ascl2 were detected in ES cells (Lewis et 
a l 2006). This concurs with our results where Kcnql expression could not be detected 
by real time PCR. We also analysed K cnqlotl/L itl which appeared to be expressed at
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constant levels throughout differentiation in both ES and EG cells. K cnqlotl/L itl has 
been shown to be expressed from the two-cell embryo stage in mice and to be 
paternally expressed (Lewis et a l  2006).
3.3.2 Cdknlc and Phlda2 expression in EG and ES cells
The only difference between undifferentiated ES cells and undifferentiated EG 
cells is thought to be the imprinting status o f the genome. ES cells show full 
imprinting o f the IC2 domain resulting in allele-specific gene expression. Conversely, 
the EG cells are derived from imprint erased PGCs so should show no differences 
between the maternal and paternal genomes that would result in allele-specific gene 
expression. We predicted that we would see 2-fold levels o f gene expression if the 
imprinted gene was expressed from both alleles. This then allowed us to determine if  
a particular gene was expressed in the EG cells by comparing its expression relative to 
that in the ES cell line (equivalent to one-fold for monoallelic expression). Generally, 
if  the gene was silent in the EG cells then expression would be less than the ES cells 
but if the gene is active then expression will be greater than that in the ES cells.
Our study showed that there was a significant reduction in the level o f  
expression o f the Cdknlc gene in the EG cells indicating that this gene was 
suppressed in some way. This suppression o f gene expression was present in the 
undifferentiated cells and maintained throughout differentiation. A similar result was 
observed for the Phlda2 gene however, expression from this gene is relatively stable 
in ES cells at all time points compared to Cdknlc which showed a dramatic increase 
in expression from day 7. Phlda2 is highly expressed in the extraembryonic lineages 
and is only expressed in the embryonic kidney and liver (Frank et al. 2002) whereas 
Cdknlc plays a role in controlling the cell cycle and in differentiation and is expressed
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in a variety o f embryonic tissues (Hatada and Mukai 1995; Zhang et a l  1997). Our 
analysis o f the early time points showed that Cdknlc and Phlda2 were suppressed 
throughout differentiation o f EG cells from the very early time points indicating that 
these genes are silent in the EG cells and remain silent throughout differentiation.
3.3.3 Kcnq1ot1/Lit1 expression in ES and EG cells
Our analysis showed that K cnqlotl/L itl expression was at equivalent to 
biallelic levels in the EG cells and this was maintained throughout differentiation. 
However, when we examined the early time points, we observed dynamic changes in 
K cnqlotl/L itl expression in the ES and EG cells. The two different expression 
patterns in these cells could possibly relate to the potential different functions of 
K cnqlotl/L itl in the two cell lines. For example, establishing silencing in the EG 
cells and maintaining silencing in the ES cells. Recent data has shown that 
transcription o f full length K cn qlo tl/L itl is required for normal imprinting in the 
germ line (Mancini-DiNardo et al. 2006; Murakami et a l  2007; Shin et a l 2008). 
Deletion o f the KvDMRl imprinting centre or the K cnqlotl/L itl promoter results in 
biallelic expression o f at least six imprinted genes within the IC2 domain and loss of 
K cn qlo tl/L itl expression, a result similar to that seen in Dnmtl-/- stem cells 
(Fitzpatrick et a l  2002; Horike et a l 2000; Mancini-DiNardo et a l  2006). Deletion of 
the ICR has no effect on imprinting o f the IC1 domain (Horike et a l 2000; Murakami 
et a l  2007). Deletion o f the human paternal KCNQlOTl/LITl gene in BWS patients 
is also associated with loss o f imprinting o f CDKN1C (Niemitz et a l 2004).
The K cnqlo tl/L itl transcript itself is also important as truncation o f the full 
length transcript results in loss o f silencing o f all KvDMRl-controlled genes in both 
the placenta and in many embryonic lineages (Kanduri et a l 2006; Mancini-DiNardo
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et a l  2006; Shin et a l  2008). This is similar to the observation by Sleutels et a l  in 
which premature termination o f the Air transcript resulted in biallelic expression of 
the imprinted genes (Sleutels et a l  2002). The length of the K cn qlo tl/L itl truncation 
has even been shown to give different phenotypes. Mancini-DiNardo et a l  showed 
that a 1.5 kb truncation gave a similar result as deleting the KvDMRl, whereas Shin 
et a l showed that a longer 2.6 kb transcript resulted in loss o f imprinting o f most of  
the IC2 domain imprinted genes but Cdknlc maternal-specific expression was 
maintained in several embryonic tissues including kidney, lung and liver but lost in 
brain, placenta and heart (Mancini-DiNardo et a l  2006; Shin et a l  2008). The 2.6 kb 
truncation mutant also resulted in a less severe growth deficiency at 4 weeks o f age 
compared to the KvDMRl knockout, possibly as a result o f retention of normal 
Cdknlc expression levels in some tissues (Shin et a l  2008). The difference in the two 
phenotypes could be due to the loss o f other sequences in the KvDMRl that are 
important for Cdknlc silencing or because the longer transcript is capable of paternal 
silencing o f Cdknlc in some tissues whereas the shorter transcript is not. Shin et a l 
showed loss o f methylation at the Cdknlc promoter in the truncation mutants 
irrespective o f  whether the gene retained imprinting or not. Their results suggested 
that the 2.6 kb transcript was sufficient to maintain imprinting o f Cdknlc in a subset 
o f tissues in the absence o f DNA methylation (Shin et a l  2008). Kanduri et a l also 
demonstrated that different lengths o f the K cnqlotl/L itl transcripts have different 
effects on silencing o f a transgene, particularly in the ability to initiate bi-directional 
silencing (Kanduri et a l  2006). They postulate that the longer time taken for the RNA 
polymerase to transcribe the full length K cn qlo tl/L itl gene allows the nascent 
transcript to interact with the local chromatin machinery, providing an opportunity for 
the transcript to spread inactive chromatin structures in cis (Kanduri et a l 2006).
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Other studies have shown that K cnqlotl/L itl co-localises with the IC2 domain during 
the cell cycle at least on the Slc22al8  and Cdknlc regions which are several kb 
outside o f its transcriptional region, possibly indicating a role in silencing these genes 
(Mancini-DiNardo et a l  2006; Murakami et a l  2007). This same phenomenon has 
been observed with another imprinted gene cluster, Igf2r-Air, where co-localisation of 
the non-coding RNA Air transcript has been observed along the silent domain (Seidl 
et a l 2006). This is analogous to that seen during X chromosome inactivation where 
the non-coding RNA Xist coats the inactive X chromosome (Clemson et a l 1996). 
These results strongly suggest that non-coding RNAs such as Air and K cnqlotl/L itl 
have an active role in establishing silencing within their domains although how the 
non-coding transcript mediates this silencing in cis is still unknown.
Several mechanisms have been proposed for how K cnqlotl/L itl is involved in 
the silencing o f the IC2 domain. Firstly, K cn qlo tl/L itl could participate in a RNA- 
dependent transcriptional silencing mechanism where the non-coding RNA attracts 
DNA methyltransferases and repressive chromatin proteins to the domain in a similar 
way that Xist is involved in recruiting DNA methylation and repressive chromatin 
modifications to the inactive X chromosome (Kanduri et a l  2006; Mancini-DiNardo 
et a l  2006). Secondly, as transcription o f the full length RNA is required for 
silencing, it could be that repression o f the IC2 domain is occurring because of the 
movement o f RNA polymerase through the gene causing topological changes that 
attracts repressive chromatin (Kanduri et a l 2006; Mancini-DiNardo et a l 2006). 
Finally, it could be that an RNA interference mechanism is responsible for silencing 
the domain by processing the K cn qlo tl/L itl transcript into small RNAs that then base 
pair with the mRNA or DNA o f the imprinted genes within the cluster (Mancini- 
DiNardo et a l 2006). The dynamic changes in K cnqlotl/L itl expression that we
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observe at the early time points could be evidence o f this RNA processing involved in 
setting up the early silencing of Cdknlc and Phlda2. Whatever the mechanism, it is 
likely that DNA methylation and repressive chromatin are involved in propagating 
silencing along the domain allowing silencing to be stably inherited and maintained.
3.3.4 Establishing silencing in PGCs
We considered the possibility that the suppression in Cdknlc and Phlda2 
expression that we observed could be a result o f the normal silencing mechanism 
already initiated in male PGCs cells and would result in establishing silencing of the 
IC2 domain. The EG cells used in this study were derived from 12.5 dpc male PGCs 
and several studies have shown that there are no differences between male and female 
PGCs at this stage o f PGC development (Adams and McLaren 2002; Tada et al.
1998). PGCs derived from mouse embryos before 13.5 dpc have the developmental 
potential to differentiate as either oocytes or as prospermatogonia. After 13.5 dpc, 
signals from the somatic cells in the male genital ridge direct the PGCs to a 
spermatogenic fate but in the absence o f this masculising signal PGCs develop as 
oocytes (Adams and McLaren 2002; McLaren and Southee 1997). The differentiation 
of PGCs as oocytes or prospermatogonia depends, not on the sex o f the PGCs, but on 
the sex o f the supporting stromal cells in the gonad as 11.5 dpc female PGCs can 
develop as prospermatogonia when cultured as an aggregate with a male genital ridge 
(Adams and McLaren 2002). Also, male PGCs will develop as oocytes when cultured 
with a female genital ridge, a result similar to that seen when male PGCs are cultured 
with lung aggregates (McLaren and Southee 1997). However, after 12.5 dpc male 
PGCs become committed to prospermatogonia development, whereas female PGCs 
remain sexually dimorphic up to 13.5 dpc (Adams and McLaren 2002). Tada et al.
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(Tada et a l  1998) also demonstrated that male and female EG cell lines were 
equivalent by creating chimeras then characterising the differences in epigenotype. 
They showed that the 12.5 dpc EG cells were capable o f forming chimeras and 
showed the same developmental abnormalities irrespective o f the sex o f the EG cell 
line. PGCs taken from 13.5 dpc onwards will continue to pursue their germ line 
pathway o f differentiation for several days when cultured as EG cells, suggesting that 
differentiation as oocytes and prospermatogonia is a cell-autonomous process once 
the mascularising signal has been received and sex-specific differences have begun to 
arise. Site-specific methylation in male germ cells, but not female germ cells, is also 
autonomous and it may be that the number o f X chromosomes or the presence of the 
Y chromosome somehow controls this process (Durcova-Hills et a l 2004; Durcova- 
Hills et a l  2006).
From what we know about 12.5 dpc PGCs, the suppression of Cdknlc 
expression in differentiated EG cells is unlikely to be due to paternal imprinting of the 
genome as the cells do not receive the required mascularising signal. Instead we 
suspect that we are observing a default state for silencing that is established in the 
absence o f signals from the genital ridge.
3.3.5 Other imprinted genes
Our observations o f the IC2 cluster are not unique. Indeed, we observe a 
similar pattern for a number o f imprinted genes, both maternal and paternal, that are 
silent in the absence o f an imprint. We also identified some genes where the opposite 
is true, they are expressed in the absence o f an imprint and require passage through 
the germ line to be silent. This data also confirms that the cells are not establishing 
paternal specific imprints as some o f the genes examined, such as Dlkl, are paternally
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expressed yet their expression is suppressed in differentiated EG cells indicating that 
they require passage through the male germ line to be expressed. The data also 
confirms what has been noted before that there are two types o f imprinted genes, 
those that require an imprint to be expressed and those that require an imprint to be 
silenced.
Several studies have looked at the expression of imprinted genes in imprint- 
erased PGCs. As mentioned in the introduction Lee et a l (Lee et a l  2002) 
demonstrated the existence o f a default state o f gene expression in imprint erased 
PGCs where, in the absence o f an imprint, maternally expressed genes are silent and 
most paternally expressed genes are biallelically expressed. The exceptions were HI 9, 
Meg3/Gtl2 and Dlkl which require a paternal imprint to be expressed. Other studies 
have shown similar results. For example, in 11.5 dpc PGCs, lgf2r, HI 9, Ig/2 and 
Snrpn have been shown to be expressed biallelically (Szabo et a l 2002; Szabo and 
Mann 1995). Analysis o f imprinted gene expression has also been conducted at 12.5- 
15.5 dpc at a stage when sex-specific differences arise and imprinting normally begins 
to be established (Szabo and Mann 1995). In the ovary and testis at this stage, biallelic 
expression o f Igf2r and Snrpn is observed but monoallelic expression o f HI 9 and Igf2 
was seen implying that the HI 9 imprint is established differently than at Igf2r and 
Snrpn (Szabo and Mann 1995). In pre-migratory PGCs the expression o f the 
imprinted genes is skewed. The majority o f the genes appear to be monoallelically 
expressed as imprints have yet to be erased apart from Igf2r which appears to be 
biallelically expressed at all PGC time points (Szabo et a l 2002; Szabo and Mann 
1995). However, our data showed that in the absence o f an imprint Igf2r is 
suppressed. It is possible that, in the 11.5 dpc PGCs, the imprints have not been fully 
erased for the lgf2r locus. From what we know about this domain, methylation of the
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DMR results in silencing o f the non-coding RNA transcript Air and expression of the 
surrounding imprinted genes. We would expect from this information that in the 
absence o f an imprint (i.e. the maternal methylation mark) there would be biallelic 
expression o f the Air transcript and silencing of Igf2r.
HI 9 and Igf2 are expressed reciprocally so it seemed unlikely that we would 
observe monoallelic expression o f both imprinted genes in the imprint erased EG 
cells. From the model o f this domain, paternal methylation of the HI 9 DMR induces a 
transcriptional switch to Igf2 expression. In the absence of paternal methylation o f the 
DMR we could expect that the domain would take on the appearance o f the maternal 
allele. So, in imprint-erased PGCs, we might expect biallelic expression of HI 9 and 
suppression o f Igf2. However, studies have indicated that HI 9 silencing is the default 
state and only becomes activated after passage through the female germ line 
(Ainscough et al. 1997). In our study we observed levels of Igf2 that are around 1.4- 
fold so could be an indication that this gene is biallelically expressed. This would 
confirm the results shown in Szabo et al. 1995 and Szabo et al. 2002. As we do not 
see 2- fold levels o f expression o f Igf2, it is possible that the imprint for this domain 
has not been completely erased, even in the 12.5 dpc PGCs, or has already begun to 
be re-established.
What we have noted from our study is that, for a number o f imprinted genes, 
the expression levels in the undifferentiated ES and EG cells are significantly lower 
than in the differentiated cells indicating that they are not expressed in the stem cells. 
Igf2 is one such imprinted gene where the expression in the differentiated cells 
increases more than 250-fold indicating that this gene is upregulated during 
differentiation. It is possible that the expression levels in the PGCs, shown by Szabo 
and Mann 1995 and Szabo et al. 2002, could be leaky expression from the gene and in
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fact the imprinted gene is not expressed. This demonstrates the usefulness of EG cells 
for these sorts o f studies as they can be differentiated in vitro to demonstrate the 
actual status o f the gene in the absence of an imprint even for genes that are not 
expressed in PGCs or stem cells.
An alternative method for looking at the status of the imprint-erased genes is 
using parthenogenetic embryos containing the pronuclei from a non-growing (ng) 
oocyte (imprint-erased) and a pronucleus from a fully grown (fg) oocyte (maternal 
imprints) (Obata et a l  1998). These parthenogenetic embryos survive to around 13.5 
dpc, significantly longer than the parthenogenetic embryos created from two fully 
imprinted maternal pronuclei (Obata et al. 1998). Analysis of the imprinted genes has 
shown that the paternally expressed genes Pegl and Peg3 are expressed from the non­
growing oocyte genome allele indicating that these genes are expressed in the absence 
of an imprint and are silenced after passage through the maternal germ line (Obata et 
a l 1998). The maternally expressed genes Igf2r and Cdknlc are expressed from the 
fully grown oocyte genome allele only confirming our results that, in the absence of 
an imprint, these genes are not expressed and are only expressed after passage through 
the maternal genome. HI 9 was expressed from both alleles as H I9 is a maternally 
expressed gene that is silenced by passage through the male germ line (Obata et a l
1998). This data corroborates the results shown in our study where Igf2r and Cdknlc 
are not expressed in undifferentiated EG cells and remain suppressed after 
differentiation o f the EG cells as they have not passed through the maternal germ line 
which is required for their activation. Pegl and Peg3 are paternal expressed genes so 
we might predict these genes to be at biallelic levels in the differentiated EG cells as 
they require a maternal imprint to be silenced. This study is more comparable to ours
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as it looks at the expression levels o f imprinted genes in differentiated cells and not 
just in the PGCs.
We confirmed that the suppression of maternally expressed genes is not 
restricted to our cell line by also looking in an alternative cell line that has been 
extensively studied by others (Tada et al. 1998). We observed the same pattern that 
maternally expressed imprinted genes in the EG cells are suppressed relative to levels 
in the ES cells.
The majority o f the imprinted genes examined in this study required maternal 
methylation o f the DMR to either be expressed or silenced. The two exceptions that 
we looked at were the D lkl-Gtl2  and the H19-Igf2 clusters which require paternal 
methylation. Surani et al. suggested that the failure o f parthenogenetic embryos to 
develop to term is due to the loss o f specific parental imprinting (Surani et al. 1984). 
This is because the majority o f the differential DNA methylation marks are maternal 
resulting in biallelic expression o f all the maternally expressed genes {Cdknlc, Igf2r, 
GrblO) and silencing o f all the paternally expressed genes {Gnasxl, Zacl, Nnat), 
except those regulated by a paternal methylation mark {Dlkl, lgf2). In the absence of  
this maternal methylation the EG cells appear to take on a paternal expression profile 
in the absence o f any imprints that may correspond to a default silencing mechanism 
of the maternally expressed genes. Why silencing o f the maternally expressed genes is 
more important than the paternally expressed genes is not yet known but it may be 
related to the fact that a number of the maternally expressed genes are negative 
regulators of growth including Cdknlc and GrblO whereas some paternally expressed 
genes such as Ig/2 are growth promoting.
3.3.6 Conclusion
i l l
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Our results have shown that the maternally expressed genes Cdknlc and 
Phlda2 are suppressed in EG cells and this silencing is maintained throughout 
differentiation suggesting that silencing of this imprinted domain is a passive process. 
The dynamic changes in K cnqlotl/L itl expression indicated a possible role in 
establishing or maintaining this silencing. Our EG cell model has been used to 
determine whether an imprinted gene is suppressed in imprint erased EG cells that re­
capitulates what is observed in vivo. From this data we can determine what 
classification an imprinted gene falls into, whether it requires an imprint to be 
expressed or an imprint to be silenced.
3.3.7 Summary of findings
• The IC2 domain imprinted genes Cdknlc and Phlda2 are suppressed in the EG 
cell line compared to the ES cell line at all time points.
•  Suppression o f Cdknlc is already established in the imprint erased EG cells 
and is maintained throughout differentiation suggesting that silencing o f the 
IC2 domain is a passive process.
•  There are two types o f imprinted genes, those that require an imprint to be 
expressed and those that require an imprint to be silenced. Our model is able to 
determine which category an imprinted gene belongs too and re-capitulates 
what is observed in vivo.
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CHAPTER 4:
Methylation analysis of IC2 domain differentially
methylated regions
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4.1 Introduction
Methylation o f CpG islands is normally associated with gene silencing. These 
CpG islands are mainly found within the promoters of genes. They are also associated 
with imprinted clusters where they are thought to be involved in controlling allelic- 
specific gene expression. While the CpG islands in these clusters can be associated 
with the promoter region o f an imprinted gene, they can also be part o f an ICR. When 
methylated, these differentially methylated CpG islands can either be involved in 
activating or in silencing imprinted genes.
The mouse distal chromosome 7 IC2 domain is an imprinted domain which 
has been shown to require maternal methylation of the KvDMRl for the maternal 
expression o f the surrounding imprinted genes. Conversely, on the paternal allele the 
lack o f DNA methylation correlates with suppression of the surrounding genes. Three 
paternal specific regions o f DNasel hypersensitivity are located immediately 5’ of the 
transcriptional start site o f K cn qlo tl/L itl that correspond to the location o f the 
KvDMRl (Mancini-DiNardo et a l  2003). The KvDMRl lies over the promoter 
region o f the non-coding gene K cnqlotl/L itl. DNA methylation plays an obvious 
direct role in silencing o f the K cnqlotl/L itl gene, by preventing transcription. 
Methylation o f the KvDMRl must indirectly affect the other genes. This would also 
involve recruiting silencing trans-factors such as methyl-CpG binding proteins and 
histone modifying enzymes to modify the local chromatin environment. However, it is 
still unclear how localised DNA methylation at the KvDMRl signals to the distantly 
located genes.
We know that the KvDMRl is part of the ICR as deleting this region disrupts 
silencing o f six of the imprinted genes within the IC2 domain (Fitzpatrick et a l 2002;
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Horike et a l  2000; Mancini-DiNardo et a l 2003). In mouse ES cells, with a targeted 
paternal deletion o f the KvDMRl CpG island, expression of the Kcnqlotl/L itl 
transcript can no longer be detected. Paternal transmission o f this deletion results in 
biallelic expression o f the IC2 imprinted genes due to a lack o f imprinting in the male 
germ line (Fitzpatrick et a l  2002; Mancini-DiNardo et a l  2006). Normal gene 
expression is detected when the mutation is inherited maternally suggesting that the 
KvDMRl CpG island is required for imprinting in the male, but not the female, germ 
line (Fitzpatrick et a l  2002; Mancini-DiNardo et a l  2006). Deletion o f the KvDMRl 
has no impact on the imprinting o f genes in the IC1 domain which is regulated by a 
separate ICR.
Loss o f methylation at ICRs is often associated with loss o f imprinting o f the 
surrounding genes suggesting that correct methylation of the DMRs is essential for 
normal regulation of these genes (Diaz-Meyer et a l  2003). Loss o f methylation at 
DMRs has been associated with a number o f developmental disorders and cancers. A 
common cause o f Beckwith Wiedemann syndrome is loss of imprinting o f IGF2 and 
CDKN1C which can occur as a result o f a disruption to the H I9 and KvDMRl ICRs 
either through gain or loss o f methylation or because o f deletions or translocations, 
demonstrating the importance o f these regions in establishing and maintaining 
imprinting.
Within the IC2 domain, there is a second DMR located within the promoter 
region and extending into the second intron o f the Cdknlc gene. This is a somatic 
DMR and is not methylated in the germ line (Bhogal et a l 2004). Methylation of this 
DMR in somatic tissues is thought to be required to completely suppress and maintain 
silencing o f Cdknlc from the paternal allele. Human CDKN1C does not have any
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methylation and this probably corresponds to the small amount o f expression 
observed from the paternal allele in humans (John et a l 1999).
Most o f the information we have on how imprints in the germ line are 
established comes from looking at the methylation patterns in sperm and oocytes. In 
the germ cells, DNA methylation has been established but many o f the events that 
lead to permanent silencing or activation of the target genes, such as histone 
modifications, have not taken place. There have been some studies that have looked at 
earlier time points in PGCs but have mainly focused on examining global DNA 
methylation patterns and histone modifications to try to determine what epigenetic 
changes occur in vivo. A number o f these studies are also involved in looking later on 
in sex-specific PGC development when imprints have already begun to be established. 
These studies are technically challenging because isolation of the PGCs from the 
genital ridges o f mouse embryos yields very few cells for the analysis, particularly at 
early embryonic stages.
Germ line and somatic DMRs are erased in EG cell lines derived from 12.5 
dpc PGCs (Lee et al. 2002; Tada et a l  1998). In the Tada study, they showed that the 
DMR at the Cdknlc promoter was unmethylated in EG cells derived from 12.5 dpc 
PGCs but also that this region acquired de novo methylation after differentiation in 
chimeras. None o f the other DMRs looked at in the Tada study acquired de novo 
methylation when differentiated (Tada et a l 1998). This suggested that germ line 
DMRs require passage through the germ line to become methylated but methylation 
of somatic DMRs, like Cdknlc promoter, may occur much later as a result of a default 
silencing mechanism.
In this study we looked at the methylation status of the Cdknlc and KvDMRl 
CpG islands in EG cells differentiated in vitro. The aim was to confirm that the germ
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line methylation o f the KvDMRl and Cdknlc DMRs was absent in the 12.5 dpc Sv6.1 
EG cells and to determine if  methylation of Cdknlc was acquired during EG cell 
differentiation in vitro. The key differences between our study and that in the Tada 
paper is that the EG cells would be cultured and differentiated in vitro. In the Tada 
study, EG cells were differentiated in chimeras to mid-gestation, primary embryonic 
fibroblasts were isolated from these chimeras and these were then grown in culture for 
several days before DNA methylation was examined. In our EG experiment the cells 
were differentiated entirely 6in vitro\ It was necessary to determine whether EG cells 
would perform in culture as they had done ‘in vivo ’ i.e. methylate Cdknlc.
4.2 Results
4.2.1 Methylation sensitive restriction enzyme coupled PCR 
(MSRE-PCR) analysis of the KvDMRl and Cdknlc DMRs in 
ES and EG cell lines
The accurate mapping o f methylation in the genome is important for 
understanding how this methylation is established and maintained. There have been 
many methods designed to do this, the majority o f which are based on Southern 
hybridisation approaches (Ariel 2002). An alternative way to assess DNA methylation 
at a few critical CpG dinucleotides is using methylation sensitive restriction enzyme 
coupled PCR (MSRE-PCR) [for review see (Rein et a l  1998)]. This PCR-based 
methylation analysis requires smaller amounts of DNA than conventional methods 
and can be technically simple and rapid (Ariel 2002). In this protocol, the genomic 
DNA is digested with a methylation sensitive restriction enzyme followed by PCR 
spanning the site. If the CpG dinucleotide is unmethylated, the restriction enzyme cuts 
the DNA and the sequence can no longer be amplified, however, if the CpG is 
methylated the DNA remains uncut and the PCR product can be amplified. For this
117
Chapter 4: Methylation o f IC2 DMRs
method to work there must be a restriction site available within the region o f interest 
and, to prevent the appearance o f false positives, complete cleavage o f the DNA is 
required. Again the design o f the primers is critical to the success o f this assay. Nested 
primers were designed so that one set serves as an internal control.
A methylation sensitive restriction site was identified within the KvDMRl that 
also corresponded to a potentially methylated CpG dinucleotide (figure 4.1). Primers 
were designed around this site to amplify a product of 525 bp and the control primers 
were designed to amplify a product outside this site to amplify a product o f 249 bp. 
Both primer sets were tested on genomic DNA to ensure that they amplified the 
correct sized product when used together. The method described by Ariel (Ariel 2002) 
was modified to allow for double restriction enzyme digests as an alternative for 
dialysis o f the digested DNA. The location o f the primers and cut sites is shown in 
figure 4.2.
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Figure 4.1: MSRE coupled PCR protocol schematic.
Genomic DNA is digested with an enzyme sensitive to the methylation status of the 
DNA so will not cut when DNA methylation is present. 1 In the absence of DNA 
methylation the enzyme will cut the DNA and the PCR will fail to amplify product B. 
2 If methylation is present then the enzyme will not cut and the PCR will amplify 
product B. A control PCR (product A) is included that is unaffected by the 
methylation status of the DNA.
Methylation of KvDMRl has been studied in depth by a number of groups. 
Beatty et al. showed that KvDMRl is methylated throughout the maternal CpG island 
whereas the paternal allele is not methylated (Beatty et al. 2006). The MSRE-PCR 
method was used to determine that the EG cells used in this study had the correct 
methylation pattern. As a control, ES cells were used which were predicted to be 
methylated on one allele. The androgenetic cell line was used as a control for the 
complete absence of maternal DNA methylation. As described in chapter 3 the lack of 
polymorphisms in our samples meant we could not determine which allele was 
methylated so we only looked for the presence or absence of methylation in these 
samples. Undigested samples were included as a further control.
Genomic DNA from ES and EG cells was digested overnight with Eagl and 
used as the template in a PCR reaction. The methylated (undigested) band amplified
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from both undifferentiated and differentiated CES3 and SF1-1 ES cells (figure 4.3). 
The AKR1 ES cells are androgenetic stem cells containing two paternal genomes and 
did not show any methylation o f the KvDMRl, which is normally restricted to the 
maternal genome. The methylation band was also absent in the undifferentiated and 
differentiated Sv6.1 EG cells and in the undifferentiated TMAS21G EG cells lines. 
This suggested appropriate methylation o f the KvDMRl in the ES cell lines used in 
this study and predicted absence in the imprint erased EG cells at that particular CpG 
dinucleotide sequence.
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Figure 4.2: Location of CpG islands within K cnqlotl/L itl and Cdknlc.
A The differentially methylated imprint control region (KvDMRl) is located within 
the promoter region of Kcnqlotl/Litl) and is methylated only on the maternal allele. 
K cnqlotl/Litl is a non-coding RNA transcript expressed only from the paternal allele. 
Dashed line represents the location of Kcnql intron 10 antisense to Kcnqlotl/Litl. HS 
= hypersensitivity sites. Orange box represents the Kcnqlotl/Litl transcript. Red bar 
represents the KvDMRl CpG island region. Blue lines represent the cut sites of 
restriction enzymes. PubMed accession number NT 039453 from 527668-532398 bp 
B The Cdknlc promoter DMR is methylated only on the paternal allele in somatic 
cells. Differential methylation extends into intron II of Cdknlc. The methylation 
status of the upstream CpG island is unknown.
Pink boxes show the locations of the CpG islands. Orange boxes are gene exons. The 
green box indicates the location of the predicted Cdknlc promoter. Regions examined 
for methylation by bisulphite sequencing or MSRE-PCR are indicated by the red bars. 
Blue lines represent the cut sites of restriction enzymes. PubMed accession number 
NT 039437.
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Figure 4.3: Methylation status of the KvDMRl in a variety of ES and EG 
cell lines.
In the absence of DNA methylation the methylated band is lost (red arrow). The PCR 
control is indicated by the blue arrow. Undigested samples were used as a control for 
methylation. Genomic DNA samples from ES cell lines CES3 and SF1-1, EG cell 
lines Sv6.1 and TMAS21G and androgenetic cell lines AKR1 were digested with the 
methylation sensitive restriction enzyme EagI before PCR amplification. (1) CES3 
dO, (2) CES3 day 21, (3) Sv6.1 day 0, (4) Sv6.1 day 7, (5) Sv6.1 day 14, (6) Sv6.1 day 
21, (7) SF1-1 day 0 (8) SF1-1 day 7, (9) TMAS21G day 0, (10) AKR1 day 0.
Methylation of the CpG dinucleotide looked at in this experiment has also 
been examined using Southern blotting. Previous studies have shown that this CpG 
dinucleotide is differentially methylated in the germ line and is stably maintained 
throughout development (Tada et al. 1998). The fact that we did not see any 
methylation of this CpG dinucleotide in the differentiated EG cells confirmed the 
absence of methylation at this site in undifferentiated cells and demonstrated that 
DNA methylation was not acquired at this site during in vitro differentiation.
A number of non-specific bands are seen in the KvDMRl methylation 
analysis, which was probably due to non-specific binding of the primers. After
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optimising the PCR, by increasing the annealing temperature in the PCR program, we 
were able to lose the non-specific bands (figure 4.4) and confirm the results shown in 
figure 4.3. A weak band was observed in the undifferentiated Sv6.1 EG sample which 
may have been due to incomplete digestion of the DNA or possibly contamination 
ffom the feeder layer but essentially the result confirmed previous reports.
CES3 Sv6 TMAS AKR1 SF1 CES3 Sv6 TMAS AKR1 SF1
Methylated
Figure 4.4: Methylation status of the KvDMRl in undifferentiated ES and 
EG cell lines.
In the absence of DNA methylation the methylated band is lost. Undigested samples 
were used as a control. Genomic DNA samples ffom ES cell lines CES3 and SF1-1, 
EG cell lines Sv6.1 and TMAS21G and androgenetic cell line AKR1 were digested 
with the methylation sensitive restriction enzyme EagI before PCR amplification.
A set of primers were designed to examine Cdknlc DMR by this method. 
Initially the primers failed to amplify products of the correct size and repeatedly 
amplified a number of non-specific bands. This may have been due to the GC rich 
nature of this particular gene making amplification by PCR more difficult. A number 
of methods were attempted in order to amplify products of the correct size ffom 
around the methylation sensitive restriction site including adding DMSO and Betaine 
to the PCR reaction and re-designing primers. Using the GC rich kit ffom Roche we 
were eventually able to amplify products from the promoter region and intron II of 
Cdknlc ffom a bacterial artificial chromosome (BAC) containing the Cdknlc gene
Undigested Digested
Control
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and from genomic DNA isolated from adult mouse brain (figure 4.5). An internal 
primer control was also designed as described earlier. In figure 4.5 A, amplification 
of the undigested genomic sample was inefficient, however a product was amplified 
in a second analysis using these primers. Figure 4.5 B showed that the internal 
control primers were able to amplify a product in both BAC and genomic DNA 
samples.
BAC DNA
Mouse 
somatic DNA
A= Cdknlc  promoter B= Cdknlc  intron
B
BAC gDNA
water
200
100
L
Figure 4.5: Amplification of the mouse Cdknlc promoter and intron II
CpG islands from undigested BAC and mouse brain somatic DNA.
A Amplification of the methylated band of Cdknlc promoter (A) and intron II CpG 
(B) in undigested bacterial artificial chromosome (BAC) containing the Cdknlc gene 
and undigested mouse brain genomic DNA. B A combined PCR for Cdknlc promoter 
using both the methylated and the control primers in both the undigested BAC and 
genomic DNA. (1= methylation primers only, 2= internal primers only, 3= 
methylation primers + internal primers).
The primers were used to look at the methylation status of two potentially 
methylated CpG dinucleotide located within the promoter of Cdknlc that are located 
in an Eagl site. Studies have shown that these CpGs are differentially methylated in
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somatic cells (John et al. 1999; Tada et al. 1998). We looked at the methylation status 
of a number of ES and EG cell lines as well as the mouse brain somatic genomic 
DNA (figure 4.6).
Undigested
Somatic
DNA CES3 dO Sv6 dO TMAS dO SF1 dO
Methylated
Control
Digested
Somatic
DNA CES3 dO Sv6 dO TMAS dO SF1 dO
Methylated
Control
Figure 4.6: Methylation of the Cdknlc promoter DMR in the ES and EG 
cell lines.
MSRE-PCR analysis of the Cdknlc promoter in ES and EG cells. In the absence of 
DNA methylation the methylated band is lost. A control PCR was also performed on 
the ES cells that amplifies a product, irrespective of DNA methylation status, located 
within the methylated primer product. Undigested samples were used as a control for 
methylation. Genomic DNA samples from ES cell lines CES3 and SF1-1, EG cell 
lines Sv6.1 and TMAS21G and mouse brain somatic DNA were digested with EcoRX 
or the methylation sensitive restriction enzyme Eagl before PCR amplification. dO = 
undifferentiated.
In the undigested (digested with EcoRl only) controls the methylated band 
and the control band was amplified confirming that there was DNA present in the 
digested samples and that both primer sets amplified a product. In the samples 
digested with Eagl, there are methylated bands present for the mouse somatic 
genomic DNA and the two ES cell lines (CES3 and SF1-1) but the two EG cell lines
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(Sv6.1 and TMAS21G) appear unmethylated as suggested by the absence of a 
methylated band on the gel. The control primers showed that the absence of the 
methylated band was not due to the lack of DNA in the digests. These results confirm 
what was observed with the KvDMRl and in the Tada experiments, that methylation 
is erased in the EG cells but some is present in the ES cell lines. We then repeated the 
results but looking at the methylation status of the intron II region of the Cdknlc CpG 
island (figure 4.7).
Undigested
Mouse
Brain CES3 SF1 TMAS Sv6
Methylated
Control
Digested
Mouse
Brain CES3 SF1 TMAS Sv6 Blank
Methylated
Control
Figure 4.7: Methylation of the Cdknlc intron II DMR in the ES and EG cell 
lines.
MSRE-PCR analysis of the Cdknlc intron II in undifferentiated ES and EG cells. In 
the absence of DNA methylation the methylated band is lost. A control PCR was also 
performed on the ES cells that amplifies a product, irrespective of DNA methylation 
status, located within the methylated primer product. Undigested samples were used 
as a control for methylation. Genomic DNA samples from ES cell lines CES3 and 
SF1-1, EG cell lines Sv6.1 and TMAS21G and mouse brain somatic DNA were 
digested with EcoRl or the methylation sensitive restriction enzyme Eagl.
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The results suggested that the intron II CpG island o f Cdknlc was weakly 
methylated in both the ES and EG cell lines at at least one CpG dinucleotide. The 
extent of the DNA methylation can not be accurately ascertained with this method. It 
was possible that the methylation observed was residual from incomplete de- 
methylation of this region in the PGCs. There was also a possibility that re- 
methylation of the Cdknlc region was initially initiated at a few CpG dinucleotides 
within intron II o f the gene and this then spreads to the promoter as the cells 
differentiate.
The MSRE-PCR method only tells us the methylation status of a few CpG 
dinucleotides within the CpG island. It does not indicate the extent of the methylation. 
Importantly, PCR is a very sensitive method and the smallest amount of undigested 
DNA would appear as a methylated band. In order to examine additional sites and to 
test the possibility that partial digestion had occurred, we used a second method that 
did not rely on methylation sensitive restriction digestion.
4.2.2 Design and optimisation of the bisulphite sequencing 
protocol
Methylation sensitive restriction enzyme coupled PCR only looks at the 
methylation o f one CpG site within the sequences of interest. It does not show the 
extent o f methylation within these sequences. Methylation at the Cdknlc promoter is a 
somatic methylation mark that is only present on the paternal allele. Differential DNA 
methylation at this site is only acquired after the genome wide methylation event that 
occurs in the early embryo (Bhogal et al. 2004; Monk et a l  1987). How this 
methylation mark is established is still unclear. It may be that methylation is initially 
initiated at a few CpG sites and then spreads across the entire promoter. Data 
published during the course o f this project showed that promoter methylation was
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extensive across the paternal allele in somatic cells (Bhogal et a l 2004; Yatsuki et a l 
2002) and that the CpG site we showed to be methylated by MSRE-PCR was 
methylated in the embryo. Bisulphite sequencing is a more exhaustive method for 
looking at DNA methylation as it looks at all the CpG sites within a particular region 
[reviewed in (Hayatsu 2006)]. It would allow us to determine the precise location o f 5 
methylcytosine (5meC) within CpG islands.
A saturated bisulphite solution is used to convert cytosine to cytosine 
sulphonate. Cytosine sulphonate is then irreversibly deaminated to uracil sulphonate 
and finally desulphonated to uracil by the addition of sodium hydroxide. The 
converted DNA is subsequently amplified by PCR and can then be either directly 
sequenced or cloned into vectors for colony screening. Methylated cytosine is much 
more resistant to bisulphite treatment and remains unchanged. The location of the 
CpG islands within Cdknlc was identified by the Methprimer CpG prediction 
software (Li and Dahiya 2002), that examines the DNA sequence to identify regions 
of more than 100 bp with a GC content greater than 50 % (software found at 
http://www.urogene.org/methprimer/index 1 .htmP. This software, which is based on 
the primer3 program, also allows the design of primers specific for bisulphite 
converted DNA. Unlike normal primer selection, bisulphite primers have extra 
constraints, for example they can not contain a CpG site and are selected to eliminate 
differences in Tm and to remove mononucleotide repeats o f more than 5 bases (8 
bases for T repeat to account for the bisulphite converted DNA) (Li and Dahiya 
2002). Complete conversion of cytosine to uracil is essential for subsequent 
amplification o f the DNA. The bisulphite treatment only works on single stranded 
DNA and, under the right conditions, 5meC remains unreactive. Amplified products
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can then be sequenced to identify the CpG dinucleotides that were methylated in the 
original sequence by looking for unconverted cytosines.
Cdknlc contains four exons that are highly conserved between mice and 
humans (John et al. 1999). A CpG island spanning the entire gene has been shown 
previously to be fully methylated in somatic tissues on the paternal allele (John et al.
1999). Using the Methprimer program, it was apparent that this CpG rich region was 
actually two CpG islands one over the promoter and one in intron II. There was also a 
small island more than 3 Kb upstream of Cdknlc which was also reported by Yatsuki 
et al. (Yatsuki et al. 2002) (figure 4.8).
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Figure 4.8: Schematic and location of CpG islands within Cdknlc.
Mouse Cdknlc consists of four exons (shown in orange). The location of the predicted 
promoter sequence is shown in green. A CpG island spans then length of the gene
from the predicted promoter region to intron 3. A second CpG island is located
approximately 3 Kb upstream of the promoter. Blue diamonds show the location of 
individual CpG dinucleotides. Pink boxes show the regions of the CpG islands 
examined. The two CpG islands spanning the promoter and intron II are shown as one 
in this figure.
Primers were designed against the promoter CpG island, the intron CpG island 
and the uncharacterised upstream CpG island. Initially the bisulphite sequencing 
protocol used was based on the method described by Wamecke and colleagues 
(Wamecke et al. 2002). Problems were encountered with PCR amplification of the
Cdknlc
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bisulphite converted DNA. It was thought to be caused by re-annealing of the DNA 
prior to the bisulphite conversion. This problem was resolved by embedding 
denatured genomic DNA in low melting point agarose (LMP) as described in several 
publications (Engemann et a l  2002; Gratchev 2004; Olek et a l  1996).
The early bisulphite sequencing results suggested extensive methylation 
throughout the DMRs in Cdknlc. However, closer analysis revealed inefficient 
conversion o f the DNA. Only around 40-60 % o f the non-CpG cytosines within the 
amplified sequences had converted to uracil. This was thought to be due to the highly 
GC-rich CpG island spanning the gene which is resistant to heat denaturation. Several 
approaches were used to rectify this problem including using a variety of restriction 
enzymes to cut around the sequence o f interest to produce shorter fragments, adding 
betaine during the denaturation step to prevent reannealing o f the DNA, heat 
treatments of various lengths and incubation with sodium hydroxide for up to 30 min. 
A urea based method for bisulphite conversion was also used in an attempt to get full 
conversion. To test all o f these methods, plasmid DNA containing the cloned Cdknlc 
promoter was used as a control for conversion. Plasmid DNA normally does not 
acquire CpG methylation so 5meC would not be present in these sequences. All the 
cytosines within the sequence should completely convert. The urea based protocol 
was used along side the previously used agarose bead protocol on the control DNA. In 
this protocol the denaturing o f the DNA was done as with the agarose bead protocol, 
however, 6.24 M urea was also added to the bisulphite solution (Paulin et a l 1998). 
This method failed to completely convert the DNA however, by varying the 
denaturing conditions, we were ultimately successful in obtaining complete bisulphite 
conversion o f the plasmid DNA using the bisulphite agarose protocol. The following 
modifications to the protocol were used. The DNA was digested with an enzyme that
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cut around the region o f interest then was denatured by heating at 95 °C for 6 min. 
The DNA solution was incubated on dry ice for three minutes. A final concentration 
of 0.3 M sodium hydroxide was added and incubated at 37 °C for 30 min to ensure 
that the DNA was completely denatured. The control plasmid DNA showed complete 
bisulphite conversion o f nearly 100 %.
The same protocol was then applied to genomic DNA of the two 
undifferentiated EG cell lines (TMAS21G and Sv6.1). Complete bisulphite 
conversion was observed. Bisulphite conversion was analysed using the BiQanalyzer 
program (Bock et al. 2005) which removes sequences that are less than 90 % 
converted, show less than 80 % homology to the parent sequence and controls for 
PCR bias.
4.2.3 Methylation at the Cdknlc promoter
Figure 4.9 shows the results for the bisulphite converted Cdknlc promoter in 
the control plasmid DNA and in the two undifferentiated EG cell lines. Hypo- 
methylation o f the CpG dinucleotides was observed indicating that Cdknlc promoter 
methylation was completely erased in the undifferentiated EG cell lines as suggested 
by southern data (Tada et al. 1998) and our MSRE method. The Cdknlc promoter was 
then analysed in differentiated EG cells to determine if methylation was acquired 
during differentiation which was reported in the EG cell derived fibroblasts (Tada et 
al. 1998). Methylation at the promoter region o f Cdknlc could account for the 
silencing o f this gene observed in our differentiated EG cells and reported in the Tada 
paper.
Figure 4.10 shows the methylation status o f the Cdknlc promoter in 
differentiated EG cells (Sv6.1). No increase in DNA methylation was apparent.
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Therefore, unlike the EG-derived PEFs, which were derived from TMAS cells, no 
DNA methylation was acquired. Nonetheless, Cdknlc was silenced suggesting that 
other mechanisms were at work. It is possible that DNA methylation was present at 
other regions associated with Cdknlc. Intron II and the upstream CpG island were 
also analysed to determine if DNA methylation was present.
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Figure 4.9: Bisulphite sequencing analysis of the Cdknlc promoter region
in plasmid DNA and genomic DNA from undifferentiated Sv6.1 and
TMAS21G EG cells.
Genomic DNA was extracted from undifferentiated Sv6.1 and TMAS21G cells and 
modified by the addition of sodium bisulphite. DNA was amplified by primers 
specific to bisulphite converted DNA. PCR products were cloned into a vector and 
sequenced. Each row represents an individually sequenced clone; each column 
represents a potentially methylated CpG dinucleotide. Red squares are methylated 
cytosines. Asterisks (*) represents the location of the Eag\ site in genomic DNA 
analysed by MSRE-PCR and southern blot.
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Sv6.1 differentiated embryoid bodies (day 21)
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Figure 4.10: Bisulphite sequencing analysis of the Cdknlc promoter region
in genomic DNA from differentiated Sv6.1 EG cells.
Sv6.1 cells were differentiated for 21 days by culturing as embryoid bodies. Genomic 
DNA was extracted differentiated Sv6.1 cells and modified by the addition of sodium 
bisulphite. DNA was amplified by primers specific to bisulphite converted DNA. PCR 
products were cloned into a vector and sequenced. Each row represents an 
individually sequenced clone; each column represents a potentially methylated CpG 
dinucleotide. Red squares are methylated cytosines. Asterisks (*) represents the 
location of the Eagl site in genomic DNA analysed by MSRE-PCR and southern blot.
4.2.4 DNA m ethylation w ithin other CpG islands in Cd knlc
Differential DNA methylation has now been shown to extend throughout the 
Cdknlc CpG region as well as located to a region upstream of the transcriptional start 
site (Bhogal et al. 2004). The intron II and the upstream CpG islands were analysed 
by bisulphite sequencing in order to determine if these regions become methylated as 
the EG cells differentiate. Figure 4.11 shows the result for the intron II region. The 
undifferentiated cells were hypo-methylated as would be expected for imprint erased 
cells. After differentiation this region was also hypo-methylated indicating that 
methylation o f Cdknlc  was not responsible for suppressing Cdknlc expression.
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Figure 4.11: Bisulphite sequencing analysis of the Cdknlc intron II region
in undifferentiated and differentiated Sv6.1 cells.
Sv6.1 cells were differentiated for 21 days by culturing as embryoid bodies. Genomic 
DNA was extracted from undifferentiated and differentiated Sv6.1 cells and modified 
by the addition of sodium bisulphite. DNA was amplified by primers specific to 
bisulphite converted DNA. PCR products were cloned into a vector and sequenced. 
Each row represents an individually sequenced clone; each column represents a 
potentially methylated CpG dinucleotide. Red squares are methylated cytosines. 
Asterisks (*) represents the location of the Eagl site in genomic DNA analysed by 
MSRE-PCR and southern blot.
The upstream CpG island was also examined and was found to be hyper- 
methylated in undifferentiated EG cells (figure 4.12). The function of this region is 
unknown, however it was possible that erasure of methylation at this site had not 
occurred. After differentiation this region became hypo-methylated indicating that 
methylation of this region was lost during differentiation. These data were for line 
Sv6.1. This line was not the same as the line tested in the Tada paper and it was 
possible that subtle differences between the Sv6.1 line, which is a pure 129/Sv derived 
stem cell, and the TMAS21G line, which was a mixed genetic background, accounted
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for the absence of DNA methylation after differentiation. We therefore examined 
TMAS21G, the line in the Tada paper (Tada et al. 1998).
Sv6.1 undifferentiated embryonic germ cells (day 0)
Sv6.1 differentiated embryoid bodies (day 21)
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Figure 4.12: Bisulphite sequencing analysis of the Cdknlc upstream CpG
region in undifferentiated and differentiated Sv6.1 cells.
Sv6.1 cells were differentiated for 21 days by culturing as embryoid bodies. Genomic 
DNA was extracted from undifferentiated and differentiated Sv6.1 cells and modified 
by the addition of sodium bisulphite. DNA was amplified by primers specific to 
bisulphite converted DNA. PCR products were cloned into a vector and sequenced. 
Each row represents an individually sequenced clone; each column represents a 
potentially methylated CpG dinucleotide. Red squares are methylated cytosines.
Hypo-methylation o f the Cdknlc  intron II region was confirmed in the 
TMAS21G cell line (figure 4.13). The upstream CpG island region was also analysed 
in these cells (figure 4.14). Unlike the Sv6.1 EG cells, this cell line did show 
complete erasure of DNA methylation of this region. After differentiation, some DNA 
methylation was seen at this region in some of the clones sequenced. The data was not 
consistant with the Sv6.1 data for this island indicating that there are subtle 
differences between the two EG cell lines. Recently is has been shown that this island
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is methylated on both alleles in somatic cells making it an unlikely candidate for an 
imprint control element (Bhogal et al. 2004).
TMAS21G undifferentiated embryonic germ cells (day 0)
1 2 3 4 6I
1
I 1 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 130 31 32|33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50
TMAS21G differentiated embryoid bodies (day 21)
Figure 4.13: Bisulphite sequencing analysis of the Cdknlc intron II region
in undifferentiated TMAS21G cells.
TMAS21G cells were differentiated for 21 days by culturing as embryoid bodies. 
Genomic DNA was extracted from undifferentiated and differentiated TMAS21G and 
modified by the addition of sodium bisulphite. DNA was amplified by primers 
specific to bisulphite converted DNA. PCR products were cloned into a vector and 
sequenced. Each row represents an individually sequenced clone; each column 
represents a potentially methylated CpG dinucleotide. Red squares are methylated 
cytosines. Asterisks (*) represents the location of the Eag\ site in genomic DNA 
analysed by MSRE-PCR and southern blot.
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TMAS21G undifferentiated embryonic germ cells (day 0)
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TMAS21G differentiated embryoid bodies (day 21)
Figure 4.14: Bisulphite sequencing analysis of the Cdknlc upstream CpG
region in undifferentiated and differentiated TMAS21G cells.
TMAS21G cells were differentiated for 21 days by culturing as embryoid bodies. 
Genomic DNA was extracted from undifferentiated and differentiated TMAS21G 
cells and modified by the addition of sodium bisulphite. DNA was amplified by 
primers specific to bisulphite converted DNA. PCR products were cloned into a 
vector and sequenced. Each row represents an individually sequenced clone; each 
column represents a potentially methylated CpG dinucleotide. Red squares are 
methylated cytosines.
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4.2.5 Methylation analysis of Cdknlc CpG islands in ES cells
The Cdknlc promoter CpG island was hypo-methylated in the EG cells. We 
also examined the methylation pattern in the undifferentiated and differentiated ES 
cells. These cells were expected to show differential DNA methylation of the Cdknlc 
promoter as they contain the normal genomic imprints. The cell line we used was 
from a pure 129sv strain o f mouse and so did not contain any polymorphisms that we 
could use to analyse parental origin o f methylation. We would, however, expect a 
50:50 ratio o f non-methylated clones to methylated clones which would reflect the 
hypo- and hyper-methylated alleles that should be present in this cell line. DNA 
methylation was analysed as described previously using bisulphite sequencing. In 
undifferentiated ES cells there was suprisingly very little methylation at the Cdknlc 
promoter (figure 4.15). There was a lot less methylation than expected in these cells, 
especially when we compare the levels to that observed in somatic cells in the Bhogal 
study (Bhogal et a l  2004). This could suggest that methylation at this DMR was not 
stable in culture.
We looked at the methylation status of other regions within the Cdknlc DMR. 
Figure 4.16 shows the analysis of the intron II region of Cdknlc which showed the 
same hypo-methylation in undifferentiated and differentiated ES cells. The same 
result was seen for the upstream CpG island (figure 4.17). Even in the differentiated 
cells this region appeared hypo-methylated. All of the regions analysed in the CES3 
cells were hypo-methylated although there were more methylated CpGs observed in 
the ES cells than seen in the EG cells.
138
Chapter 4: Methylation o f IC2 DMRs
CES3 undifferentiated ES cells (day 0)
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Figure 4.15: Bisulphite sequencing analysis of the Cdknlc promoter domain
in undifferentiated CES3 cells.
Genomic DNA was extracted undifferentiated CES3 cells and modified by the 
addition of sodium bisulphite. DNA was amplified by primers specific to bisulphite 
converted DNA. PCR products were cloned into a vector and sequenced. Each row 
represents an individually sequenced clone; each column represents a potentially 
methylated CpG dinucleotide. Red squares are methylated cytosines. Asterisks (*) 
represents the location of the Eagl site in genomic DNA analysed by MSRE-PCR and 
southern blot.
We also looked at the methylation pattern in an androgenetic cell line. 
Androgenetic cells contain two paternal genomes. The Cdknlc promoter DMR was 
first analysed by methylation sensitive restriction enzyme-coupled PCR which 
showed that the DMR was apparently methylated in undifferentiated androgenetic 
stem cells (figure 4.18). Two different cell lines were tested, those used in these 
studies and a separate cell line obtained from Dr Nick Allen. As the DMR appears to 
be methylated we went on to analyse the extent of the methylation by bisulphite 
sequencing. Figure 4.19 shows the results from the bisulphite analysis at the Cdknlc 
promoter and upstream CpG island regions. The androgenetic cell line showed the 
same result as seen with the ES cells. Both the Cdknlc promoter and upstream CpG 
island were hypo-methylated. Again this could suggest loss of methylation at the 
Cdknlc promoter in culture. We therefore designed assays to examine other DMRs 
that were germ line DMRs and potentially more stable in culture.
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Figure 4.16: Bisulphite sequencing analysis of the Cdknlc intron II domain
in undifferentiated and differentiated CES3 cells.
CES3 cells were differentiated for 21 days by culturing as embryoid bodies. Genomic 
DNA was extracted from undifferentiated and differentiated CES3 cells and modified 
by the addition of sodium bisulphite. DNA was amplified by primers specific to 
bisulphite converted DNA. PCR products were cloned into a vector and sequenced. 
Each row represents an individually sequenced clone; each column represents a 
potentially methylated CpG dinucleotide. Red squares are methylated cytosines. 
Asterisks (*) represents the location of the Eagl site in genomic DNA analysed by 
MSRE-PCR and southern blot.
The results from the bisulphite and MSRE-PCR data appeared to contradict 
each other. The MSRE-PCR assay appeared to indicate that there was methylation of 
the promoter in ES and AG cells. However, the MSRE-PCR is highly sensitive to the 
presence of residual methylation and, as it is not quantitative, can result in false 
positive results or an over estimate of the amount of methylation present. It could also 
be picking up somatic methylation from feeder cells. In contrast bisulphite sequencing 
can result in false positives if the sequence fails to fully convert. We, however, see a
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negative result for all our bisulphite methylation data and as 5meC is unlikely to be 
converted it is highly likely that the Cdknlc promoter is truly unmethylated.
CES3 undifferentiated embryonic germ cells (day 0)
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CES3 differentiated embryoid bodies (day 21)
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Figure 4.17: Bisulphite sequencing analysis of the Cdknlc upstream CpG
region in undifferentiated and differentiated CES3 cells.
Genomic DNA was extracted undifferentiated CES3 cells and modified by the 
addition of sodium bisulphite. DNA was amplified by primers specific to bisulphite 
converted DNA. PCR products were cloned into a vector and sequenced. Each row 
represents an individually sequenced clone; each column represents a potentially 
methylated CpG dinucleotide. Red squares are methylated cytosines.
Undigested Digested
AKR1 dO
AKR1 dO 
New AKR1 dO
AKR1 dO 
New
Methylated
Control
Figure 4.18: MSRE analysis of the Cdknlc promoter CpG region in
undifferentiated AKR1 cells.
The methylation sensitive restriction enzyme coupled PCR was applied to the 
androgenetic ES cells to determine if there is methylation at the Cdknlc promoter. 
Two cell lines are analysed the androgenetic ES cell line used in this study AKR1 and 
a replacement AKR1 cell line (AKR1 New).
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AKR1 undifferentiated embryonic stem cells (day 0)
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Figure 4.19: Bisulphite sequencing analysis of the Cdknlc promoter and 
upstream CpG differentially methylated regions in undifferentiated AKR1 
stem cells.
Genomic DNA was extracted from undifferentiated AKR1 cells and modified by the 
addition of sodium bisulphite. A Cdknlc promoter, B Cdknlc upstream CpG island. 
Each row represents an individually sequenced clone; each column represents a 
potentially methylated CpG dinucleotide. Red squares are methylated cytosines. 
Asterisks (*) represent the location of the Eagl site in genomic DNA analysed by 
MSRE-PCR and southern blot.
4.2.6 Methylation analysis of other germ line DMRs
We designed primers to paternal germ line DMRs by MSRE-PCR. Although 
this only tests two methylated CpGs it is a convenient tool in order to ascertain the 
methylation status of these cells. Figure 4.20 shows that the AKR1 cell line did have 
methylation at both the H I9 and Gtl2 germ line DMRs. Methylation was also present 
in the wild type ES cell line. Conversely the EG cell line showed no methylation at 
the Gtl2 DMR, however methylation remained at the H I9 DMR indicating that this
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DMR is still methylated in these cells. The methylation status of the G//2-DMR 
corresponded to that expected for these cell lines and indicated that the paternal 
methylation marks were intact for the androgenetic and ES cell lines and with the 
expected pattern. This then suggested loss of DNA methylation was specific to the 
Cdknlc locus in the stem cells.
AKR1 dO CES3 dO TMAS dO
H19 Gtl2 H19 Gtl2 H19 Gtl2 water
500bp 
300bp
Figure 4.20: Methylation sensitive restriction enzyme coupled-PCR on
androgenetic (AKR1), wild type (CES3) and germ line (TMAS21G)
embryonic stem cells.
Methylation of the paternal DMRs HI 9 and Gtl2 was confirmed in the androgenetic 
and wild type ES cell lines. PubMed accession number for H19 DMR is AF 049091. 
H I9 primers were designed around a Hhal site within the region 3308-3611 bp 
(Ishizaki et al. 2003). PubMed accession number for Gtl2/Dlkl IG-DMR is 
AJ320506. Gtl2 primers were designed around a Hhal site within the region 79751- 
82320 bp (Takada et a l 2002).
The H I9 DMR was further analysed in the different cell lines to confirm the 
result seen above and to determine if methylation was lost in differentiated cells at 
this region. Figure 4.21 shows the methylation status of the H I9 DMR in both 
undifferentiated and differentiated ES and EG cells. The data appeared to indicate that 
the H I9 DMR was methylated in all cell lines so may not be completely erased in the 
EG cells. As we were only looking at a single potentially methylated CpG 
dinucleotide in this region it could be that this is the only CpG that remains
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methylated in these cells. Other studies have shown similar results at this locus (Tada
etal. 1998).
________________ U nd igested______________________
CES3 CES3 Sv6.1 Sv6.1 TMAS TMAS
dO d21 dO d21 dO d21
Methylated
Control
D igested
TMAS
d21
Sv6.1 
dO
Sv6.1
d21
TMAS
Methylated
Control
Figure 4.21: Methylation analysis of the H19 DMR.
Methylation at the H19 DMR was analysed by MSRE-PCR in both ES (CES3) and 
EG (Sv6.1, TMAS21G) cell lines in undifferentiated and differentiated cells. 
Undigested samples are shown as a control.
Although the MSRE-PCR assay is a useful assay for quickly determining the 
methylation status of a CpG dinucleotide, it has several limitations. Firstly, the result 
depends on the efficient digestion of the DNA by the methylation sensitive restriction 
enzyme. Secondly, PCR is very sensitive and can amplify low copy number 
sequences with great efficiency, so if  any residual uncut strands are present or 
contaminating DNA exists in the samples then this may result in a false positive 
result. Only samples that show a complete absence of the methylated band (but still 
amplify the internal control) can be confirmed. In figure 4.20, the same TMAS21G 
digested DNA was used to amplify both the H I9 and the Gtl2 DMRs, one of which 
appeared positive for DNA methylation and one that appeared negative. In this case 
because the Gtl2 DMR did not show a methylated band it suggests that this DNA
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sample was fully digested and free from contamination so the H I9 DMR result is 
likely to be true methylation.
4.2.7 Combined bisulphite and restriction enzyme assay
As a further methylation assay, we designed a combined bisulphite and 
restriction enzyme assay (COBRA) (Xiong and Laird 1997). COBRA can be used to 
look at the ratio o f methylated to unmethylated alleles in the bisulphite converted 
genomic DNA samples. This is useful since it excludes a possible cloning bias in the 
standard bisulphite protocol. We first tested this technique using genomic DNA 
isolated from mouse brain as this DNA was known to be differentially methylated at 
the promoter region o f Cdknlc. The protocol involved bisulphite converting the DNA, 
amplifying the Cdknlc intron II DMR, as before, then digesting the DNA with a 
restriction enzyme that only cuts at an unconverted CpG dinucleotide. Like the 
MSRE-PCR method, this only shows us if  particular CpG dinucleotides are 
methylated or not but it does have the advantage that we can determine how much 
methylation there is as a ratio. The results for the mouse brain somatic DNA digest 
are shown in figure 4.22. Within the PCR fragment there are three Hhal cut sites 
which, when the DNA is fully methylated, would produce fragments of various sizes 
the largest being 248 bp. However, partial methylation of the domain would produce 
several other larger fragments. The amount o f DNA we amplified was low by this 
protocol. We were unable to quantify the ratio but it was clear that some o f the DNA 
had been digested indicating that there was at least some methylation of the Cdknlc 
DMR in the somatic DNA.
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Figure 4.22: Combined bisulphite and restriction enzyme assay (COBRA)
of mouse brain somatic genomic DNA.
Somatic genomic DNA was converted using bisulphite solution as described 
previously. Cdknlc intron II was amplified using the nested bisulphite primers. The 
DNA was then digested with Hhal confirming that the DNA was indeed differentially 
methylated in somatic cells. The size o f the faint bands are indicated which 
correspond to partially digested and fully digested alleles.
The absence of the DNA methylation at the Cdknlc gene in ES cells, shown 
by several methods was unexpected. However, during the project a paper was 
published which suggested that Cdknlc is unmethylated in the early embryo (Bhogal 
et al. 2004) and does not acquire differential methylation until after 8.5 dpc. One 
possible explanation for our results was that the somatic methylation of the silent 
paternal allele occurs after the time point at which ES cells are derived. If this were 
the case, we might expect other ES cell lines to show a similar pattern. In 
collaboration with Dr Tatyana Nesterova, we used southern blotting to examine this 
further.
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4.2.8 Southern hybridisation methylation analysis of the Cdknlc 
promoter in undifferentiated and differentiated ES, AG and 
EG cells
We decided to confirm the methylation status of our ES and EG cells using 
Southern blotting. Although this technique could only tell us the methylation status of  
a few CpG dinucleotides within the CpG island, it allowed us to confirm the 
methylation analysis done by bisulphite sequencing and also to determine the ratio of  
methylated to unmethylated DNA. A probe was designed to hybridise with a 2.9 kb 
BamHl digested genomic DNA fragment within the Cdknlc DMR. The BamHl- 
digested genomic DNA fragment contains several Eagl site (figure 4.23). This 
methylation sensitive enzyme will not cut the DNA if the binding site overlaps a 
methylated CpG dinucleotide. Ten micrograms of genomic DNA from 
undifferentiated and differentiated ES and EG cells was digested with BamHl and 
Eagl, run out on a TBE gel, transferred to a nitrocellulose membrane then probed with 
the radioactive DNA probe (southern blotting was performed by Tatyana Nesterova). 
If the Eagl site was methylated then a 2.9 kb band would be visible on the blot. An 
unmethylated product would be visible as a 332 bp fragment. The ratio between the 
two bands would allow us to determine the extent, if  any, of the differential DNA 
methylation.
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Figure 4.23: Location of the Southern blot probe.
Schematic of the Cdknlc gene showing locations of the BamHl and Eagl cut sites. A 
2.9 Kb fragment is released by digesting with BamHl which contains the site the 
probe hybridises with. Within the fragment there are several Eagl cut sites. The 
methylation status of this site can be determined from the size of the hybridised 
fragment. A methylated site will appear as a 2.9 Kb hybridised band on the gel 
whereas unmethylated sites appear as a 332 bp hybridised fragment.
1 2 BamHl
$** *  - ^  V ' I
Methylated
Unmethylated
Figure 4.24: Southern blotting on genomic DNA from androgenetic ES 
cells.
1 undifferentiated AKR1 ES cells and 2 differentiated (21 day) AKR1 ES cells 
digested with BamH 1 and Eagl. A control digest is included where genomic DNA is 
digested with BamHl only.
The Southern blotting was performed on our samples by Tatyana Nesterova. 
The data supported our findings by bisulphite sequencing that the Cdknlc locus was 
unmethylated in ES cells. Only the fully digested (unmethylated) fragment was
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observed in the undifferentiated androgenetic ES cells where both alleles of Cdknlc 
are silent (figure 4.24 lane 1). No methylation was observed even after differentiation 
of the cells for 21 days (figure 4.24 lane 2).
BamHl 1 2  3
I A *  A  Unmethylated
Figure 4.25: Southern blotting on genomic DNA from wild type ES cells.
1 undifferentiated 129/1 ES cells; 2 undifferentiated Pgkl2.1 ES cells and 3 
differentiated CES3 ES cells digested with BamHl and Eagl. A control digest is 
included where genomic DNA is digested with BamHl only.
Similarly, no apparent DNA methylation was observed in the differentiated ES 
cell line CES3 (figure 4.25 lane 3). We were able to eliminate the possibility that it 
was our culturing conditions that somehow resulted in the loss of Cdknlc methylation 
as the two independent cell lines cultured by Dr Nesterova also showed a lack of 
DNA methylation at Cdknlc (figure 4.25 lanes 1 and 2). Unfortunately, we were 
unable to determine the methylation status o f the EG cells lines in this experiment due 
to high background staining overlapping the location of the 2.9 kb fragment. 
However, the lack of DNA methylation in even the differentiated androgenetic ES 
cells strongly supports our conclusion that Cdknlc is unmethylated in stem cells and, 
unlike the in vivo situation, DNA methylation is not acquired as the cells differentiate.
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This could suggest that stem cells lack a critical trans-factor that is required for the 
further epigenetic modification o f this locus after silencing by histone modifications.
This experiment convincingly confirmed the absence of DNA methylation in all 
three ES cell lines. This suggested that DNA methylation is never fully established at 
the Cdknlc locus in ES cells. Despite this, allele specific expression of Cdknlc 
occurs.
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4.3 Discussion
The association o f differentially methylated regions and ICRs makes DNA 
methylation a good candidate for controlling differential gene expression of imprinted 
genes. DNA methylation at germ line DMRs is established in the germ line during 
gametogenesis and is thought to be the primary imprinting mark. During post­
implantation development, DNA methylation is also established at some somatic 
DMRs (Santos et a l 2002), such as that found at the promoter of Cdknlc which is 
believed to completely repress expression o f this gene. In EG cells, derived from 12.5 
dpc PGCs, the methylation marks at both the KvDMRl and the Cdknlc DMRs have 
been shown to be completely erased (Tada et a l  1998). In the Tada et a l  study, EG 
cells were differentiated in vivo as PEFs in chimeras and the methylation status of 
DMRs at several imprinted loci was examined (Tada et a l  1998). Most of the germ 
line DMRs remained unmethylated after differentiation; however they observed that 
the somatic DMR at the Cdknlc promoter became de novo methylated in 
differentiated PEFs. The aim o f this study was to determine if  de novo methylation of 
the Cdknlc DMR would occur after differentiating EG cells in vitro and to determine 
the extent and timing o f this methylation mark in more detail than that reported in the 
Tada paper.
4.3.1 Methylation analysis of the KvDMRl in EG cells
The results for the methylation analysis o f the KvDMRl by MSRE-PCR 
indicated that methylation was absent in undifferentiated EG cells reflecting the 
methylation status o f the imprint-erased PGCs from which they were derived. The 
KvDMRl was also un-methylated even after differentiating the EG cells as embryoid
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bodies. This was expected for the KvDMRl as methylation of this region only occurs 
after passage through the female germ line.
Methylation o f the KvDMRl was observed in both undifferentiated and 
differentiated ES cells. We have to assume that methylation in the cells is maternal in 
origin as we have no polymorphisms in which we could study allele specific 
methylation patterns. However, evidence from other studies has shown that germ line 
DNA methylation marks, like KvDMRl, are epigenetically stable in culture 
(Humphreys et a l  2001; Szabo and Mann 1994) and it is unlikely that the paternal 
KvDMRl would become de novo methylated in culture. Methylation at the KvDMRl 
was maintained even after differentiating the cells for 21 days confirming that this 
germ line DNA methylation mark was stable. The specificity o f the methylation assay 
was confirmed in androgenetic ES cells, which contain two paternal genomes and 
showed no methylation o f  the KvDM Rl.
4.3.2 Methylation analysis of Cdknlc promoter and intron II DMRs 
in EG cells
Methylation o f the somatic DMR at the Cdknlc promoter was shown by Tada 
et a l to occur in differentiated PEFs isolated from chimeras created from imprint 
erased EG cells (Tada et a l  1998). In the Tada study, methylation o f the Cdknlc 
promoter was examined by southern blotting which only examined the methylation 
status o f a few CpG dinucleotides within the DMR. They showed that in 
undifferentiated EG cells, derived from at 11.5 and 12.5 dpc PGCs, the Cdknlc 
promoter was unmethylated, however the cells showed full methylation of both 
Cdknlc alleles after differentiation in vivo as PEFs (Tada et a l 1998). In our initial 
analysis we looked at the methylation status o f the same CpG dinucleotide in 
undifferentiated EG cells and confirmed what was seen in the Tada study, that Cdknlc
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was unmethylated in imprint erased EG cells. Some weak methylation was observed 
in the ES cell line samples and was absent from both EG cell lines looked in this 
study. It was possible that the single CpG dinucleotide examined in this study and the 
Tada study is the only CpG dinucleotide within the whole promoter CpG island that 
was not methylated in the undifferentiated EG cells. For this reason we examined the 
methylation status o f approximately 50 potentially methylated CpG dinucleotides 
within the promoter o f Cdknlc, one o f which corresponds to the differentially 
methylated CpG examined in the MSRE-PCR experiment. Our analysis showed that 
Cdknlc promoter was hypomethylated in the undifferentiated and in the differentiated 
EG cells, indicating that the suppression o f Cdknlc expression observed in chapter 3 
was not due to de novo DNA methylation of the Cdknlc promoter. There was always 
a possibility that DNA methylation at other regions within the Cdknlc CpG island 
was causing the Cdknlc suppression. In fact, when we used MSRE-PCR to look at the 
methylation o f a CpG dinucleotide within the intron II region o f the DMR, this region 
did appear to be methylated, albeit to a lesser extent in the EG cell lines, possibly 
indicating that DNA methylation o f the DMR is initially initiated at a few discrete 
dinucleotides which then spreads to the entire CpG island later in development. 
However, when we looked at this region by bisulphite sequencing we did not see 
methylation in either o f the EG cell lines. This region also appeared to be relatively 
hypomethylated in the ES cells and in the androgenetic cell line which had been 
shown by the MSRE-PCR method to be methylated.
We now have an explanation for these findings. Essentially, in collaboration 
with Dr Tatyana Nesterova, we have shown that three ES cells lines are unmethylated 
at Cdknlc despite maintaining differential methylation at other DMRs. A paper by 
Bhogal et a l  determined that the DNA methylation at Cdknlc is not acquired until 8.5
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dpc, several days after ES cells are derived (Bhogal et a l 2004). It seems likely that 
the ES cells have not lost DNA methylation in culture -  they have not yet acquired it. 
Nonetheless, in the case o f the Bhogal study and as suggested by our qRT-PCR 
analysis, the Cdknlc locus is still silenced i.e. DNA methylation is not required to 
keep Cdknlc off, at least at these time points. The methylation we detected by the 
MSRE assay may reflect a very low level of DNA methylation in some cells but it 
seems more likely that it was due to partial digestion of the sample or, potentially, 
contamination from the feeder layer, highlighting the importance of using several 
approaches to study DNA methylation.
No other studies have reported the methylation status of the Cdknlc DMR in 
ES cells so we have no idea o f what the extent o f the methylation is supposed to be. 
Bhogal et a l  (Bhogal et a l  2004) have analysed part of this region and did show 
extensive methylation on the paternal allele in neonatal liver and adult tail somatic 
tissue derived from a cross between C57BL/6J (B6) and either Mus musculus 
castaneus (CAST) or B6(CAST7) mice.
ES and AG cells are both derived from the ICM of blastocyst stage embryos 
so should be epigenetically similar to the cells from which they were derived i.e. 
relatively de-methylated except at germ line DMRs. As the androgenetic ES cells 
were derived at the same time point as ES cells it is therefore likely that, like ES cells, 
the two paternal Cdknlc alleles had not yet acquired DNA methylation. As with the 
ES cells, the two paternal alleles would be predicted to acquire de novo methylation at 
Cdknlc during post-implantation embryonic development.
Our ES and AG cells are derived from the inner cell mass of blastocyst stage 
embryos so have yet to undergo the post-implantation re-methylation event. Several 
studies have shown that CpG islands are generally unmethylated in the early embryo.
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Prissette et al. looked at the methylation o f the DxPas34 locus, a controlling element 
that plays a role in X inactivation. They showed that in the early embryo up to the 
blastocyst stage this gene was unmethylated and did not acquire de novo methylation 
until around 7.5 dpc (Prissette et al. 2001). In ES cells, derived from 129sv male 
mice, there were only low levels o f methylation at the locus which increased during 
differentiation o f the cells as embryoid bodies but the methylation remained limited 
and heterogeneous (Prissette et al. 2001). This is similar to what we observed at the 
Cdknlc DMR.
The data indicated that methylation o f the Cdknlc DMR was not important for 
suppressing Cdknlc expression in ES and AG cells. Cdknlc was not expressed in 
undifferentiated ES cells, so methylation o f the paternal allele of Cdknlc was 
probably not essential at this stage. Tucker et al. demonstrated that ES cell lines 
derived from embryos with a targeted deletion in Dnmtl (Dnmtl-/-) could be 
maintained in culture and proliferate normally (Tucker et a l 1996). The authors 
indicated that methylation o f the genome was only an issue when the cells were 
differentiated in culture as they showed that ES cells lacking Dnmtl die upon 
differentiation. Dnmtl-/- embryos are embryonic lethal and death is likely due to mis- 
regulation o f gene expression as expression o f Dnmtl cDNA in mutant ES cells was 
able to restore normal global methylation patterns and these cells were able to 
differentiate normally in culture. However, DNA methylation at imprinted loci was 
not re-established and imprinting was lost at several loci (Tucker et a l 1996).
Differentiating the ES cells as embryoid bodies mimics post-implantation 
events. After only 3-8 days o f culture, the embryoid bodies differentiate into tissues 
that represent all three germ layers and are morphologically similar to the 6-8 dpc egg 
cylinder stage (Doetschman et a l  1985). By 8-10 days of differentiation as embryoid
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bodies, approximately half o f the embryoid bodies have been shown to develop into 
large cystic structures that show similarities to the visceral yolk sac of post­
implantation embryos (Doetschman et a l  1985). The promoter region of the Cdknlc 
DMR was shown to be hypomethylated until the 7.5 dpc stage of embryonic 
development then slowly becomes fully methylated until at least 9.5 dpc (Bhogal et 
a l  2004). We differentiated Sv6.1 EG cells for 21 days in culture but Cdknlc did not 
become methylated. It may be that the embryoid bodies do not reach the same stage in 
development at which de novo methylation o f the Cdknlc DMR would occur in vivo. 
In our study we did observe a slight increase in methylation in differentiated ES cells 
compared to undifferentiated ES cells which may reflect that there is some 
methylation activity occurring. Our differentiation system produced a heterogeneous 
population o f embryoid bodies as they were not seeded out as hanging drops. This 
resulted in production o f embryoid bodies o f various sizes which may represent 
different differentiation stages and so may have differing methylation potentials.
In the Tada study (Tada et a l  1998) Cdknlc was shown to become methylated 
on both parental alleles indicating that in the imprint-erased EG cells there is an 
epigenetic mark present on both chromosomes that is recognised in somatic cells as a 
region in to which de novo DNA methylation is attracted. The difference between our 
study and the Tada study is that our cells do not undergo full embryonic development 
whereas the Tada EG cells do, as part o f the chimeric mouse. The interesting result of 
this study is that DNA methylation does not appear to be the reason that Cdknlc is 
repressed in the EG cells. Therefore perhaps repressive histone marks were 
responsible for this silencing. These repressive marks might also be responsible in 
marking out the silent allele so that in the post-implantation embryo, de novo DNA 
methylation is recruited to the Cdknlc promoter as a late event.
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4.3.3 Methylation analysis of the Cdknlc upstream DMR in ES and 
EG celis
We observed hypomethylation of both the promoter and the intron II DMR of 
the Cdknlc gene in both the Sv6.1 and TMAS21G cell lines indicating that 
methylation was not acquired during in vitro differentiation of these cells. We did, 
however, observe differences in the methylation status of the upstream CpG island 
which was hypermethylated in the undifferentiated Sv6.1 EG cells and 
hypomethylated after differentiation. The opposite was observed for the TMAS21G 
EG cells. Bhogal et al. also looked at a region upstream of the Cdknlc promoter 
(Bhogal et a l  2004). The Bhogal study showed that outside of the Cdknlc gene CpG 
island, both parental alleles were equally hyper-methylated in somatic tissue, this 
analysis extended up to 2 Kb upstream o f the transcriptional start site. We analysed 
the methylation status o f a CpG island that was more than 3 Kb upstream of the 
Cdknlc start o f transcription so was out o f the range examined in the Bhogal et a l 
study. Even in ES and AG cells, this region was only partially methylated with no 
clear pattern in which CpG dinucleotides were methylated. The methylation of this 
region appeared to be sporadic in both cell lines. The differences between the two EG 
cell lines could be due to differences in genotype as the TMAS21G cells are 
genetically modified, however we do not know why we would see de-methylation of  
this region in one cell line and de novo methylation in another except perhaps if they 
were at a different developmental stage. For example, migrating PGCs do not arrive at 
the developing gonadal ridge at exactly the same time point so consist of a 
heterogeneous population o f cells possibly resulting in epigenetic differences between 
cells. As methylation o f the upstream DMR appears so inconsistent it is unlikely to 
play a role in silencing o f Cdknlc expression in the EG cell lines.
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4.3.4 Methylation at other germ line DMRs
We examined other DMRs in our stem cells to see if they were stable. We had 
already analysed the KvDMRl maternal methylation mark in these cells. Very few 
germ line DMRs are known to be methylated in the male germ line, however those 
established at the Igf2-H19, and Dlkl-Gtl2 ICRs have been well characterised. 
Primers were designed for MSRE-PCR to amplify the HI 9 and Gtl2 DMRs in ES 
cells. These regions were expected to be differentially methylated in ES cells but 
methylated on both alleles in AG cells and absent from both alleles in EG cells. The 
lack o f polymorphisms in our cell lines meant that we could not determine allele- 
specific methylation, we could only detect the presence or absence of methylation at 
the DMR. We confirmed that the Gtl2 DMR was indeed methylated in both the AG 
and ES cells but was absent in the EG cells indicating that the cells had maintained 
the methylation profile we expected. We also expected to see the same pattern for the 
HI 9 DMR however in all cell lines examined, methylation appeared to be retained. 
These results were confirmed in both undifferentiated and differentiated ES and EG 
cells. The data indicated that the HI 9 DMR is not erased in EG cells confirming what 
is seen in the Tada study. Tada et a l  showed that the H I9 DMR is partially 
methylated in the 12.5 dpc male EG cells possibly indicating that this germ line DMR 
is not completely erased in these cells or that they have already begun to acquire 
parental specific methylation at this DMR (Tada et a l  1998).
In the previous chapter we observed that expression of Igf2 was higher than 
expected. Several studies have shown that Igf2 is suppressed in the absence of an 
imprint (Kato et a l  1999; Lee et a l  2002). As the EG cells appeared to be at least 
partially methylated at the HI 9 DMR then this could account for the high levels of  
Igf2 expression observed in the differentiated EG cells. Methylation of the H19 DMR
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blocks binding o f CTCF allowing Igf2 to access its downstream enhancers whereas, in 
the absence o f methylation, CTCF can bind the DMR and lgf2 is repressed. As we 
observe levels o f Igf2 expression that are around 1.4 fold of that seen in ES cells it is 
likely that the methylation o f the HI 9 DMR that we observe is only partial in EG cells 
so may not be able to completely block CTCF binding. The HI 9 and Gtl2 DMRs were 
analysed using the MSRE-PCR assay which, as has been previously discussed, is at 
risk from displaying false positives. This assay could, therefore, be picking up a 
subset o f methylated strands within the gDNA that represent a minority so the HI 9 
DMR could be generally unmethylated. To confirm this data we would need to 
perform another assay, such as bisulphite sequencing or southern blotting, that could 
accurately quantify the methylation status o f this DMR.
The timing o f imprint erasure and establishment has been studied extensively 
in mouse PGCs. The exact timing o f erasure appears to vary between imprinted gene 
clusters and within PGC populations. Genomic imprints are erased in migrating PGCs 
and is usually completed by the time the cells colonise the genital ridge at around 
11.5-12.5 dpc. Several studies have examined the timing of imprint erasure in germ 
cells and striking differences in the timing of the erasure process between genes and 
between PGCs have been observed. In 9.5 dpc PGCs the H I9 DMR is predominantly 
methylated on the paternal allele whereas the maternal allele is still relatively 
unmethylated in both male and female germ cells indicating that the imprints for this 
imprinting cluster have yet to be erased (Yamazaki et al. 2005). The Snrpn DMR also 
appears to be fully methylated in these cells, however the DMRs of Igf2r and Cdknlc 
were shown to be completely unmethylated indicating that these DMRs are probably 
de-methylated earlier in PGCs (Durcova-Hills et al. 2001; Yamazaki et al. 2005). 
There appears to be some discrepancy in the timing o f erasure o f the KvDMRl
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methylation mark which, in one study, was suggested to occur before 9.5 dpc 
(Durcova-Hills et a l 2001) yet another study suggested that this DMR was still 
methylated by 10.5 dpc (Hajkova et a l 2002). The HI 9 and Snrpn DMRs were shown 
to be methylated in 10.5 dpc PGCs albeit to a lesser extent compared to that observed 
in 9.5 dpc PGCs (Li et a l  2004a; Yamazaki et a l 2005). The Gtl2-DMR also appears 
to have retained its imprints at this stage (Li et a l 2004a). By 11.5 dpc, the 
methylation at the HI 9 DMR appears to vary between studies. Yamazaki et a l 
showed that the H19 DMR was more than 50 % methylated on only around 25 % of 
the clones analysed compared with 88 % observed in the 9.5 dpc PGCs (Yamazaki et 
a l  2005). This data appeared to indicate that the H19 DMR is progressively de- 
methylated overtime in PGCs. However, this data contrasts with that observed in 
other studies which showed that HI 9 is in fact more methylated at this stage than in
9.5 dpc PGCs (Durcova-Hills et a l  2001). Lee et a l has also shown that there is 
significant variation in the methylation status o f the HI 9 gene in clones derived from
11.5 dpc PGCs (Lee et a l  2002). This is probably due to the fact that some PGCs 
initiate de-methylation earlier during migration and not all PGCs arrive at the genital 
ridge at the same time, possibly resulting in epigenetic differences between PGC 
clones. At other DMRs within 11.5 dpc PGCs, methylation appears to be completely 
erased at least from Igf2r, Cdknlc, Kcnq lo ti/L it 1, Pegl, Nnat and Peg3 (Durcova- 
Hills et a l  2001; Tada et a l  1998) indicating that there are differences in timing of 
erasure between imprinted genes as well as between PGCs. Partial methylation o f the 
H I9 and Snrpn DMRs was also observed by Li et a l and Ueda et a l in 12.5 dpc 
PGCs (Li et a l  2004a; Ueda et a l  2000). This partial methylation appears to persist as 
it is also found at the H I9 DMR in 13.5-14.5 dpc PGCs (Davis et a l  2000; Ueda et a l 
2000). This partial methylation is mainly restricted to the paternal allele in male PGCs
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(some methylation is observed on the paternal allele in female PGCs and this is 
subsequently lost before entry into meiosis) and this methylation may still be present 
in male germ cells when re-methylation of the male genome begins. In contrast, 
Iwahashi et a l  showed that both the Snrpn and HI 9 DMRs were completely erased in
13.5 dpc PGCs (Iwahashi et al. 2007).
The HI 9 DMR is a very well studied ICR and its timing o f erasure during 
germ line reprogramming appears to indicate that de-methylation of this region is 
progressive and may not be completely erased in 12.5 dpc PGCs. These ‘imprint- 
erased’ PGCs may in fact possess residual DNA methylation at the HI 9 DMR either 
due to incomplete erasure o f the imprint or as a result o f early re-methylation of the 
DMR in male PGCs. This could account for the methylation of the HI 9 DMR that we 
observed in our EG cells however, without using bisulphite sequencing, we can not 
determine the extent o f the methylation at this DMR.
4.3.5. Conclusion
In this study we wanted to determine if  de novo methylation of the Cdknlc 
promoter occurred during differentiation of imprint erased EG cells, similar to that 
observed when EG cells are differentiated in vivo (Tada et al. 1998). Our studies 
indicated that the Cdknlc promoter remains unmethylated in the EG cells even after 
prolonged differentiation in culture. This suggested that DNA methylation was not 
responsible for the repression o f Cdknlc expression observed in chapter 3. Our data 
also indicated that the Cdknlc DMR was relatively hypomethylated even in ES and 
AG cells, an unexpected finding. Recent data suggests this may be because 
methylation o f this DMR occurs during post-implantation development in the embryo.
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As Cdknlc expression is imprinted in ES cells, which has been confirmed in many 
studies, then monoallelic gene expression must be maintained through other factors. 
Tada et al. observed de novo methylation of the Cdknlc DMR after in vivo 
differentiation, indicating that there is a default sequence of epigenetic events that is 
either already pre-set or become established in the imprint erased PGCs during 
differentiation and is required to direct de novo methylation to the silent Cdknlc allele 
in the developing embryo (Tada et a l 1998). As DNA methylation does not appear to 
be acquired then histone modifications and other transfactors must be responsible for 
silencing.
4.3.6 Summary of findings
• KvDMRl showed the correct methylation status in all o f the cell lines used in 
this study indicating that this germ line methylation mark was stable in culture 
and that the EG cells were ‘imprint erased’.
•  Cdknlc DMR was unmethylated in imprint erased EG cells and did not 
become methylated even after differentiation in vitro, contrary to that observed 
in EG cells differentiated in vivo. This implied that chromatin modifications 
and other DNA binding proteins are probably responsible for repressing 
Cdknlc expression in differentiated EG cells.
•  Cdknlc DMRs were relatively unmethylated in differentiated ES and AG cells 
supporting the idea that methylation o f this DMR was a late event during 
embryogenesis.
• The CpG island located upstream of the Cdknlc DMR showed variable 
methylation patterns in EG, ES and AG cells so was probably not involved in 
establishing silencing o f the Cdknlc gene.
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• The Gtl2 DMR was unmethylated in the EG cells but methylated in the AG 
and ES cells confirming that the EG cells are ‘imprint erased’ and that some 
germline DMRs were stable in culture.
• Methylation o f the HI 9 DMR was observed in all cell lines indicating that this 
DMR was either not completely erased in EG cells or was being re-established 
implying that, at at least one germ line DMR, 12.5 dpc PGCs can not be 
considered to be completely ‘imprint erased’.
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CHAPTER 5:
Analysis of the histone modifications at IC2 domain
promoters
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5.1 Introduction
Many imprinted genes are found within large imprinting domains that can span 
several kilobases. These domains contain reciprocally imprinted genes as well as non­
imprinted genes implying that there is a more complex regulation system that can not 
be explained from discrete DNA methylation at an ICR alone. The spreading of 
silencing or activation could be perpetuated by a spreading of open or closed 
chromatin from the ICR to the promoters and enhancer elements o f the surrounding 
imprinted genes. Allele specific histone modifications have been shown to regulate 
imprinting at several domains (Carr et a l 2007; Li et a l 2004b; Umlauf et a l  2004; 
Yamasaki-Ishizaki et a l  2007). Within the IC2 domain of mouse distal chromosome 
7, DNA methylation at KvDMRl correlates with silencing of the non-coding 
transcript Kcnq lo ti/L it 1, and expression of the surrounding genes. It is possible that 
methylation of KvDMRl recruits histone modifying enzymes to alter the chromatin 
structure in female PGCs, and are passed on through the maternal germ line to the 
somatic cell. Or it could be that KvDMRl methylation is only required to silence 
K cnqlotl/L itl and that it is the non-coding RNA that recruits histone modifying 
enzymes to silence the domain in the male germ line. Parallels have been drawn with 
dosage compensation that exists in females and results in imprinted X chromosome 
inactivation, particularly as a number of features on the silent X chromosome, such as 
DNA methylation, repressive histone modifications, replication asynchrony and the 
presence o f non-coding RNA are all found within imprinted domains (Boggs and 
Chinault 1994; Jeppesen and Turner 1993; McDonald et a l 1998; Ohhata et a l  2008).
The final chromatin structure for the IC2 domain of mouse distal chromosome 7 
is well documented and has been shown to be similar in both mice and humans
165
Chapter 5: Histone modifications
(Umlauf et a l 2004). A variety of histone modifications have been shown to be 
associated with the promoter regions of the imprinted genes to give either an open or 
closed chromatin conformation. A number of histone modifying enzyme complexes 
have also been shown to bind to imprinted genes within this domain and to the 
KvDMRl (Fitzpatrick et a l  2007; Umlauf et a l 2004; Wagschal et a l  2008). Having 
shown that silencing of the maternally expressed genes was maintained in in vitro 
differentiated EG cells, we next sought to characterise the histone modifications at the 
KvDMRl locus and at several key promoters; Cdknlc, Phlda2 and Kcnql. There 
were two possibilities. The silencing histone marks would be present in both the 
undifferentiated and differentiated cells, in which case the domain could be regarded 
as pre-silenced in EG cells. Alternatively, histone marks could be recruited to the 
silent genes during differentiation, which would suggest that silencing o f the genes 
was an active, dynamic process that takes place during differentiation of the EG cells 
(figure 5.1).
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EG epigenetically different to AG 
i.e. actively recruits repressive 
chromatin
EG > Silent 
domain
■» AG
EG
EG epigenetically similar to AG 
i.e. domain already silent and no 
further steps required
Figure 5.1: Comparison of the IC2 domain in AG and EG cells.
The analysis of the histone modifications associated with the IC2 domain in AG and 
EG cells would allow the comparison of the histone marks associated with silent 
chromatin to determine if this silencing was an active or passive process. If AG and 
EG cells had similar patterns of histone modifications then the domain could be 
considered to be already silent in undifferentiated EG cells. If, however, repressive 
histone modification marks were absent in the undifferentiated EG cells but present in 
the differentiated EG cells and both undifferentiated and differentiated AG cells then 
it could be concluded that silencing is an active process that occurs during 
differentiation of the EG cells.
5.2 Design and optimisation of the Chromatin 
Immunoprecipitation (ChIP) assay
5.2.1 Optimisation of crosslinking and sonication parameters
Chromatin immunoprecipitation (ChIP) can be used to identify the location of 
various histone modifications along the imprinted domain. The protocol involves 
crosslinking proteins to DNA by the addition of formaldehyde to the cultured cells. 
The crosslinked DNA is then sonicated to yield fragments of approximately 100-500 
bp. The DNA-protein complexes are incubated with an antibody that binds the protein 
(or in this case histone modification) of interest, purified by protein sepharose A 
beads and the antibody bound DNA is eluted. A PCR reaction can then be performed 
on the eluate and on the input chromatin fraction to determine the relative
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‘enrichment’ o f the protein of interest in the DNA region amplified. This crosslinking 
procedure is known as X-ChIP and is more widely used than native ChIP (N-ChIP) as 
it allows a much broader analysis of chromatin associated factors (Cuthbert and 
Bannister 2005). Crosslinking of DNA and proteins is often required to stabilise their 
interactions before analysis. The aim of crosslinking is to fix the antigen of interest in 
its chromatin binding site (Orlando 2000). Histones do not need to be crosslinked as 
they are already tightly associated with the DNA. Other DNA binding proteins that 
are not as tightly bound to DNA or histones may need to be crosslinked. Crosslinking 
holds them in place and prevents the proteins from dissociating or moving from the 
chromatin binding site (Orlando 2000). The further away from the DNA the 
interaction o f interest lies, then the less effective ChIP will be without crosslinking. 
Formaldehyde is used as the links it forms are reversible with mild heat treatment. 
After crosslinking, the chromatin can be either enzymatically digested or can be 
mechanically sheered to generate chromatin fragments of around 300 bp (Cuthbert 
and Bannister 2005).
Crosslinking o f proteins to DNA is an important step in the ChIP protocol. 
Variables include the percentage o f formaldehyde used, the duration o f incubation and 
the temperature. Formaldehyde is a tight crosslinking agent that efficiently produces 
both protein-protein and protein-DNA complexes in vivo within minutes after it is 
added to living cells (Orlando 2000). In the standard fixation protocol for cell lines, 
formaldehyde is added to the cell culture media at a final concentration o f 1 % for 10 
min at room temperature. Other variations on the protocol include varying the 
formaldehyde concentration from 0.75 % to 1.5 %, shortening the fixation time and 
performing the fixation reaction at 37 °C. Crosslinking is a time critical procedure and 
should generally be only carried out for a few minutes. Too much crosslinking can
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lead to an increase in the amount of non-specific protein bound to the DNA and even 
loss of antibody recognition of the epitope (O'Neill and Turner 2003; Orlando 2000). 
Normally, a time-course experiment is performed to optimise crosslinking conditions 
(Orlando 2000).
Fragmentation o f the chromatin is necessary to break down the DNA into 
small fragments in order to increase the resolution of the ChIP assay and to make the 
crosslinked proteins accessible to the antibodies. With Micrococcal endonuclease 
digestion it is possible to generate single monosomes (-175 bp). Nucleosomes, 
however, are dynamic and it is possible that they may rearrange during the enzymatic 
digestion. Enzymatic cleavage will not produce ‘random’ chromatin fragments but 
will digest certain areas of genome sequence preferentially over others. Sonication is 
necessary for X-ChIP as formaldehyde crosslinking restricts the access of 
endonuclease enzymes to their targets so is inefficient on crosslinked samples 
(Orlando 2000). Sonication generates randomly sized DNA. The fragments obtained 
are usually larger than those obtained with enzymatic digestion resulting in a lower 
resolution, however, sonication is the best way to fragment crosslinked chromatin 
efficiently. Over-fixed cells are resistant to sonication and can result in the loss of up 
to 90 % chromatin (Orlando 2000).
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Fixing
1% 0.8%
Mins 5 10 5 10
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Figure 5.2: Optimisation of formaldehyde concentration on sonication 
efficiency.
SNL cells were fixed with either 1 % or 0.8 % formaldehyde for either 5 or 10 
minutes. Lysate was then sonicated for cycles of 30 sec on, 1 min off for 15 min using 
the Bioruptor (Diagenode). Crosslinking was then reversed and the DNA extracted 
and runout on a 1 % agarose TAE gel at 100 V as described in chapter 2. The desired 
size range for the sonicated DNA was between 100 and 500 bp as indicated by the 
box.
The first step was to optimise the crosslinking of the chromatin. The 
embryonic fibroblast cell line SNL was used to optimise the formaldehyde 
crosslinking as they could be grown quickly and in large numbers. The cells were 
treated with either 1 % or 0.8 % formaldehyde for five or ten minutes then sonicated 
using the bioruptor (diagenode) using the standard protocol of 10 cycles of 30 sec of 
sonication and 1 min off for 15 min. Samples of the sheared chromatin were run on a 
1 % agarose TAE gel in order to determine the efficiency of shearing. The results 
indicated that none of the fixing conditions adversely affected the chromatin shearing 
efficiency as the range of fragments was concentrated around 100-500 bp (figure 5.2).
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We then tested to see if  the crosslinking conditions had any effect on the 
immunoprecipitation efficiency o f the DNA-bound chromatin. A control antibody that 
binds Histone H3 was used as a positive control as it is a key part o f nucleosome core 
proteins and should be present at all o f the promoter regions. A negative control was 
also included. Anti-goat IgG should fail to recognise any of the mouse proteins and 
will be an indicator o f any background signal. Another background control using no 
antibody was also included to check for non-specific binding to the beads. Fixed 
chromatin was immunoprecipitated and the resulting bound DNA was used in a PCR 
reaction with primers designed to amplify the promoter region of Cdknlc and the fi- 
actin primers used in qPCR. All the crosslinking conditions showed efficient binding 
of the H3 antibody and little or no background noise was observed in the two negative 
controls (figure 5.3). As a comparison for the efficiency o f enrichment, the input 
DNA was included. 1 %  formaldehyde treatment worked better at five minutes 
incubation time rather than ten minutes as a higher background binding signal was 
observed in these samples. 0.8 % formaldehyde for both five and ten minutes gave a 
much higher H3 binding efficiency compared to background possibly indicating that 
the higher concentration o f formaldehyde may somehow be inhibiting binding o f the 
Histone H3 antibody. These initial results indicated that the optimal condition for 
fixing the chromatin seemed to be 0.8 % formaldehyde for 10 min at room 
temperature. We did not optimise the temperature for this experiment as the majority 
of the protocols available incubate the cells at room temperature while fixing and the 
efficiency o f crosslinking at this temperature appeared sufficient for our needs. If we 
were to look at bound protein complexes it may be necessary to optimise the 
temperature, however, as we are focusing on histone modifications it does not seem 
necessary and a higher temperature would likely result in over-crosslinking.
171
Chapter 5: Histone modifications
o
<
o
<
1%; 5 mins
B C
1%; 10 mins 
B C~
actin 
cDNA Blank
0.8%; 5 mins
B C
0.8%; 10 mins
\  B cT actin
cDNA Blank
Figure 5.3: Chromatin immunoprecipitation on sonicated lysate from
formaldehyde treated SNL cells.
ChIP was performed on chromatin lysate fixed with either 0.8 % or 1 % formaldehyde 
for either five or ten minutes. Chromatin was sonicated for 10 cyles of 30 sec on/ 1 
min off using the bioruptor from diagenode. ChIP was performed on the sonicated 
chromatin and the DNA was extracted as described in chapter 2. (A) Input chromatin, 
(B) histone H3 IP, (C) anti-goat IgG IP, (D) no antibody IP. PCR was performed to 
amplify the Cdknlc promoter and Actin genes to determine the efficiency of 
enrichment using the different fixing parameters.
The bioruptor (Diagenode) sonicator system was used to sonicate all the 
samples within this study. There is a basic program suggested by the manufacturers 
which involves sonicating for ten minutes at 30 second intervals. All of the chromatin 
samples sonicated well on this basic program, however, sonication must be optimised 
to ensure efficient shearing of the DNA. The Bioruptor system is a water bath with a 
high power ultrasound generator located below the tank. The ultrasound energy 
causes vibration and alteration of pressure within the water to produce small bubbles 
from the dissolved gases. These bubbles vibrate and are sufficient to break up cells
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and DNA (Diagenode 2006). The three major advantages of this system are that up to 
twelve samples can be processed at one time reducing time taken and variability, no 
probe is used so there is no chance of cross contamination and, most importantly, 
small quantities o f starting material can be sonicated efficiently.
Initially the protocol was optimised to determine the optimal sonication 
parameters such as cycle length and refractory period (to prevent overheating). 
Sample concentration is also a key factor required to calibrate the sonication 
efficiency as the viscosity o f the sample can hamper the ultrasound energy 
(Diagenode 2006). The concentration suggested by the manufacturer was used 
throughout this study and corresponded to approximately 10,000 cells/pl. The 
sonication parameters should be reproducible to give an optimal and uniformal 
fragment size.
SNL chromatin was crosslinked for 10 minutes with 1 % formaldehyde as this 
concentration was shown previously not to impede sonication efficiency. Sonication 
time and refractory period was varied to determine the effects on shearing efficiency. 
Figure 5.4 shows sonication o f crosslinked DNA with increasing sonication time. All 
of the sonication parameters produced DNA fragments in the desired range o f 100- 
500 bp including the sonication parameters suggested by the manufacturer. A 
sonication time o f 15 minutes with intervals of 30 sec on/ 30 sec off repeated after 30 
min on ice seemed to be the most optimal as it gave a fragment size within 100-500 
bp without any higher molecular weight smears. A smear at high molecular weights 
can indicate that the DNA has not been sonicated effectively due to over-crosslinking 
of the DNA to protein. Over sonicating the DNA, however, can result in degradation 
of the DNA. All of the sonication protocols used here produced fragments in the 
correct range. We chose to use a lower formaldehyde concentration with the standard
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sonication parameters suggested by the manufacturer. The concentration used in these 
optimisation protocols correlated to approximately 2 x 106 SNL cells in 200 pi 
(10,000 cells/pl) of sonication buffer.
b p
1000
500
300
200
100
Figure 5.4: Optimisation of sonication parameters using the Bioruptor 
from Diagenode.
SNL cells were treated with 1 % formaldehyde for 10 min. Crosslinked chromatin 
was harvested then six 200 pi samples were sonicated using the bioruptor. Parameters 
were varied to identify the optimum conditions for sonication. (A) Sonicated for 30 
sec on/ 30 sec off for 15 min, then 30 min on ice followed by 30 sec on/ 30 sec off for 
another 15 min. (B) Sonicated for 30 sec on/ 30 sec off for 15 min. (C) Sonicated for 
2 min on/ 30 sec off, followed by 30 min on ice then 2 min on/ 30 sec off. (D) 2 min 
on/ 30 sec off for 15 min. (E) 2 min on/ 2 min off for 15 min. (F) 45 sec on/ 45 sec off 
for 15 min. Crosslinking was then reversed and the DNA extracted and runout on a 1 
% agarose TAE gel at 100 V as described in chapter 2. The box indicates the desired 
fragment sizes for the sonicated chromatin in the range 100-500 bp.
5.2.2 Design of the chromatin immunoprecipitation protocol
There are several reasons why we chose to use crosslinking rather than native 
ChIP. Firstly, the amount of chromatin required per native ChIP experiment was a lot 
higher than that required using crosslinked chromatin and secondly, we wanted the 
option of looking at chromatin associated factors such as Eed in the future. The
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chromatin immunoprecipitation protocol used in the crosslinking and optimisation 
experiments was designed from a number o f protocols from the literature (protocol 
described in detail in Chapter 2). The plan was to look at a range of histone 
modifications that had been reported at the promoter regions of imprinted genes. 
These included markers for open chromatin such as H3K9Ac, H3K4Me2 and 
H3K4me3, and markers for closed chromatin such as H3K9Me3 and H3K27Me3. A 
negative control (anti-goat IgG) would be included to control for background and 
non-specific binding and a positive control (Anti-Histone H3) to ensure that the 
immunoprecipitation experiment was working.
The chromatin modifications associated with the IC2 domain in the EG cells 
could not be directly compared to our ES cells in this case as there were no 
polymorphisms in which to determine allele-specific differences. Instead, we decided 
to compare the chromatin structure in EG cells to that seen in the AKR1 cell line 
which contains two paternal genomes. This should be representative o f the chromatin 
modifications found at the paternal allele only and so should be enriched for markers 
of silent chromatin.
We examined the promoter regions of Cdknlc, Phlda2, Kcnqlotl/L itl and 
Kcnql to allow us to look at the spread of chromatin across the domain. Primers were 
designed using the Primer3 program to amplify the promoter regions of the IC2 
domain genes. There are many published primers available that have been shown to 
work efficiently in ChIP. However, most of these are designed to amplify DNA over 
polymorphisms in order to determine allelic specific differences in enrichment. The 
regions amplified do not necessarily correlate with the promoter regions o f the 
imprinted genes and are often several hundred base pairs from the transcriptional start 
sites of the genes. We designed primers specifically for the promoters so that we
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could correlate the expression status of these genes with the enrichment o f histone 
marks at their promoters. The primers were first tested on SNL input chromatin to 
determine whether they amplified a product of the correct size in a normal PCR 
reaction. Primers were also designed to amplify the upstream CpG island o f CdknJc 
and the intron II region o f Cdknlc to determine if  there were changes to these regions 
over time. However, the primer sets designed for these regions failed to amplify a 
product possibly due to the GC rich nature of the DNA associated with these regions. 
Primers that were shown to work on SNL input DNA were then tested on 
immunoprecipitated DNA from crosslinked undifferentiated TMAS21G chromatin. 
Figure 5.5 shows the results from testing the PCR primers using sonicated 
undifferentiated TMAS21G EG cells in input samples, H3 immunoprecipitated 
samples and negative control IgG IP samples. The results showed that the PCR 
primers amplified products o f the correct size. The results also showed that there was 
an enrichment of the DNA in the immunoprecipitated samples. The differences in the 
intensities of the bands relates to the difference in the amplification efficiencies o f the 
primer sets.
When designing and optimising this protocol, a number of problems were 
identified. Firstly, the number o f ChIP experiments that can be done was limited to 
three per 2 x 106 cells. This is the maximum number of cells that we were able to 
yield from one confluent 10 cm plate of stem cells. At least six IPs per time point 
were required which would correspond to two full confluent plates of ES cells. Input 
samples o f chromatin would also be required. The first protocol used was designed 
from a variety o f sources (see chapter 2 materials and methods). However, there were 
problems with efficiency with this method. Due to time constraints we looked into 
using ChIP kits in order to boost efficiency and save time (table 5.1).
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Input DNA
A B C D E F
Histone H3
A B C D E F
Goat IgG
A B C  D E F
Figure 5.5: Chromatin immunoprecipitation on undifferentiated EG cells
to show that the primers amplify the immunoprecipitated and input DNA.
(A) Cdknlc, (B) Phlda2, (C) K cnqlo tl, (D) Kcnql, (E) Actin. TMAS21G cells were 
cultured in the presence of a feeder layer and LIF until confluent. The feeder layer 
was removed and the single cell suspension of stem cells was then treated with 0.8 % 
formaldehyde for 10 min. The cells were sonicated for 10 cycles of 30 sec on/ 30 sec 
off for 10 min and the sonicated chromatin was used in a ChIP assay using the histone 
H3 positive control antibody and the Goat IgG negative control antibody. Pulled down 
and input DNA was amplified using primers designed for the promoter regions of the 
IC2 domain genes.
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Table 5.1: Comparison o f  X-ChIP methods.
My Protocol ChlP-IT express Orange Kit
Chromatin prep -  2 xlO6 cells 
for 3 IPs. Need 6 IPs per 
chromatin prep = 4x 106 cells 
per cell line per time point (~ 2 
plates @ 2 xlO6 cells/plate) = 
600.000 cells/IP
Chromatin Prep -  5 preps each 
prep can do 16 IPs. One 
chromatin prep from 4.5 xlO7 
cells = 2.8 xlO6 cells/IP (~ 1-3 
xlO6 cells/IP). Total ES cells 
required = at least 6 xlO6 cells ~ 
4 plates/ timepoint/ cell line
Chromatin Prep -  For one
ChIP need 125.000 cells/IP. For 
6 ChlPs need 750,000 cells. One 
plate of ES cells will do at least 
12 ChlPs if get 2 xlO6 cells.
Fixing -  0.8% formaldehyde 10 
mins @ RT. 1/10* 1.25M 
Glycine, wash twice with ice 
cold lxPBS, add 200pl lysis 
buffer.
= 10,000 cells/pl buffer.
Fixing -  1% formaldehyde 10 
mins @ RT. Wash lx ice cold 
PBS, Glycine stop fix RT, 5 
mins, wash ice cold PBS. 2ml 
scraping solution, pellet cells, 
add 1ml lysis buffer 
= 45,000 cells/pl buffer
Fixing -  1% formaldehyde 10 
mins @ RT. 1/10* 1.25M 
Glycine, wash twice ice cold lx 
PBS, add 60pl buffer A for 0.75 
x 106 cells = 12, 500 cells/pl 
buffer
Lysis & Shearing -  On ice 10
mins, sonicate with bioruptor 
30s on/ lmin off 15 mins.
Dilute in 1.8ml dilution buffer = 
1000 cells/pl chromatin. 600pl 
chromatin used per IP. 200pl of 
input chromatin = 200,000 cells.
Lysis & Shearing - Split into 
three aliquots, Sonicated with a 
probe sonicator. Pool chromatin 
and spin at 13K rpm 12 mins, 
4°C, aliquoted into 4 tubes 50pl 
used per IP ~ 2.8 x 106 cells per 
IP.
lOpl Input = 560,000 cells.
Lysis & Shearing -  Sonicate 
with a bioruptor 30s on/ 30s off, 
10 mins up to 300 pi per tube. 
Spin @ 13K rpm, 5 mins. lOpl 
Chromatin used per IP ~ 
100,000 cells/IP 
Diluted 1/10 in IP incubation 
mix. lOpl diluted chromatin is 
input = 10,000 cells.
IP -  Pre-cleared with pre­
blocked agarose A slurry (60pl) 
@ 4°C 2 hours. 15K rpm 1 min, 
divide into 3 tubes, add 1-3 pg 
antibody, o/n @ 4°C, 20pl 
agarose slurry, 4°C 2 hours, 15k 
rpm 1 min
IP -  50pl chromatin, 25pi 
beads, lOpl ChIP buffer, lpl 
protease inhibitors, l-3pg 
antibody, up to lOOpl water, o/n 
@ 4°C. spin briefly, pellet with 
magnet, remove supernatant.
IP -  Pre-clear 20 pi beads, 1 
hour @ 4°C, spin 2500rpm, 
transfer lOOpl to new tube, add 
0.5pg Ab/IP (0.5-2pg) o/n @ 
4°C. Add 20pl beads incubate 
@ 4°C 1 hour. Spin 2500 rpm 2 
mins
Washes -  once low salt, once 
high salt, once LiCl, twice TE
Washes -  once ChIP buffer 1, 
twice ChIP buffer 2
Washes -  once buffer 1, twice 
buffer 2, twice buffer 3
Elution -  200|il elution buffer 
with 8.5 pi NaCl rotation RT for 
15 mins; o/n @ 65°C stored 
input treated for crosslinking. 
Dilute samples in 200pl Tris, 
20pg RNase A @ 37°C, 30 
mins, 30pg PK @ 55°C 1 hour, 
Phenol chloroform extract. ChIP 
= 30pl, Input = 50pl lOmM 
Tris. IP= 20.000 cells/ul
Elution -  lOOpl elution buffer, 
add 88pl ChIP buffer 2 + 2pl 
5M NaCl to input DNA. o/n @ 
65°C, 2pl PK 37°C 1 hour, 2pl 
PK stop solution, Pellet beads 
with magnet. Use in PCR. 
Input must be phenol 
chloroform extracted.
IP= 27.000 cells/ul
Elution -  Add 400pl buffer C, 
16pl 5M NaCl, RT with 
rotation. Spin 2500rpm @RT. 
Transfer to new tube, add 390pl 
buffer C to diluted input. 16pl 
5M NaCl thermoshaker 4 hours 
@ 65 °C to reverse crosslinking, 
cool, phenol-chloroform extract 
resuspend in 50pl.
IP= 2000 cells/ul
Two ChIP kits were examined to determine which would be the most efficient 
(table 5.1). The Orange ChIP by Diagenode came out the best. It was designed 
specifically for histone modifications and used the least amount of cells. The ChlP-IT 
express kit would be more useful for examining bound proteins such as Eed and other
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transfactors. Using the conditions determined in the optimising sonication section, we 
analysed the sonication efficiency of the EG and ES cell lysates using the Orange 
ChIP kit. All the undifferentiated stem cell lysates sonicated efficiently between 100 
and 500 bp (figure 5.6 & 5.7). Actin DNA could be amplified from each sonicated 
lysate indicating that the chromatin was intact.
DNA
ladder
B
m m m
DNA
ladder
Figure 5.6: Undifferentiated EG and AG cell chromatin lysate sonication 
efficiency.
A (1) SNL control (163 ng/pl), (2) Sv6 dO (141 ng/pl), (3) AKR1 dO (195 ng/pl). Two 
confluent plates of undifferentiated ES cells were harvested and treated with 0.8 % 
formaldehyde for 10 min at room temperature. Chromatin was harvested using the 
orange ChIP kit from diagenode and sonicated as described previously in figure 5.5. 
Crosslinking was then reversed and the DNA extracted and runout on a 1 % agarose 
TAE gel at 100 V as described in chapter 2. The concentration of the DNA was 
determined by spectrophotometry. The box highlights the location of the majority of 
the sonicated fragments which are found in a region of less than 500 bp. B (1) SNL 
control, (2) Sv6.1 dO, (3) AKR1 dO. Approximately 100 ng of DNA was used in a 
PCR reaction to amplify p-actin.
The sonicated lysate from the differentiated EG cells was sonicated to the 
correct DNA range. However, the amount of DNA recovered after reversing 
crosslinks was considerably lower than expected (figure 5.7). This was likely a result 
of the trypsinisation process which can cause cell death.
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Figure 5.7: Sonication efficiency of the AKR1, TMAS21G and Sv6.1 day 5
lysates after digesting the embryoid bodies with trypsin.
(A) AKR1, (B) TMAS21G and (C) Sv6.1 ES cell sonication efficiencies. Cells were 
grown and differentiated for 5 days as embryoid bodies. Embryoid bodies were 
harvested and trypsinised to produce a single cell suspension. Cells were treated as 
described in figure 5.5. Crosslinking was then reversed and the DNA extracted and 
runout on a 1 % agarose TAE gel at 100 V as described in chapter 2. DNA 
concentration was checked by spectrophotometry and are as follows: AKR1 d5 (91.8 
ng/pl), TMAS21G dO (96.7 ng/pl), TMAS21G d5 (8.2 ng/pl) and Sv6.1 d5 (8.9ng/pl). 
TMAS21G dO chromatin sonication efficiency is shown as a comparison. A PCR 
reaction was performed on the extracted Sv6.1 d5 chromatin to amplify p-actin. 
Boxes indicate the location of the majority of the sonicated fragments around 100-500 
bp.
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The experiment was repeated for the day 5 lysates but instead of using trypsin 
to disaggregate the embryoid bodies, accutase was used as this was a more gentle 
enzymatic treatment and so should result in less cell death. Analysis of the chromatin 
showed that recovery of DNA was low again (figure 5.8). Sonication efficiency was 
unaffected. We next attempted the ChIP protocol on whole embryoid bodies. As the 
size of the embryoid bodies was small, it should not inhibit fixation by formaldehyde. 
The amount of DNA obtained using this method was comparable to that seen in the 
day 0 samples and did not affect the sonication efficiency (figure 5.9).
Figure 5.8: Sonication efficiency of the AKR1, Sv6.1 and TMAS21G day 5
lysates after digesting the embryoid bodies with accutase.
Stem cells were grown and differentiated for 5 days as embryoid bodies. Embryoid 
bodies were harvested and treated with accutase to produce a single cell suspension. 
Chromatin was harvested as described in figure 5.5. Crosslinking was then reversed 
and the DNA extracted and runout on a 1 % agarose TAE gel at 100 V as described in 
chapter 2. DNA concentration was checked by spectrophotometry and are as follows: 
AKRld5 (18.7 ng/pl), Sv6.1 d5 (7.6 ng/pl) and TMAS d5 (15 ng/pl). The box 
highlights the location of the majority of fragments between 100-500 bp.
AKR1 Sv6.1 TMAS 
d5 d5 d5
500 bp
Sonicated 
chromatin
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AKR1 TMAS
Figure 5.9: Sonication efficiency of the AKR1, Sv6.1 and TMAS21G day 5
lysates when treating embryoid bodies directly with formaldehyde.
Stem cells were grown and differentiated for 5 days as embryoid bodies. Embryoid 
bodies were fixed in formaldehyde and chromatin harvested as described in figure 5.5. 
Crosslinking was then reversed and the DNA extracted and runout on a 1 % agarose 
TAE gel at 100 V as described in chapter 2. DNA concentration was checked by 
spectrophotometry and are as follows: AKRld5 (65 ng/pl), Sv6.1 d5 (68 ng/pl) and 
TMAS21G d5 (126 ng/pl). The box highlights the location of the majority of 
fragments between 100-500 bp.
5.2.3 Primer amplification efficiency in real time qPCR
The amount of enrichment of a target is not just dependent on the amount of 
antigen available. Immunoprecipitation is affected by the surrounding chromatin 
environment, such as the nearby histone modifications and attached proteins so that, 
for each gene and each antibody, there will be a difference in the actual enrichment of 
the target DNA. For this reason, absolute levels of different antigens present at the 
same sequence cannot be directly compared. We can only compare the enrichment of 
one histone modification at the different locations and is always expressed as a ratio 
of bound sequence over input or as percentage enrichment over input (Cuthbert and 
Bannister 2005). The primer amplification efficiencies first need to be determined in
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order to accurately calculate percentage enrichment. This is done by making serial 
dilutions of input chromatin then performing real time qPCR on the DNA using the 
ChIP primers. This also allowed us to confirm that the primers worked in the real time 
PCR. The CT value at which the DNA is amplified above the base line was plotted 
against natural log o f the dilution for each set of primers (figure 5.10). The gradient 
of the resulting graph is the simplification efficiency of the primer set. In an ideal 
setting this would be around 2. However we constantly saw amplification efficiencies 
of around 1.4. This figure is then used in the calculations for percentage amplification 
efficiency as described in chapter 2.
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Figure 5.10: Primer amplification efficiencies using real time PCR 
machine.
Serial dilutions of 0.8 % formaldehyde fixed input TMAS21G chromatin was used to 
test the amplification efficiency o f the ChIP primers. (A) Phlda2, (B) Cdknlc, (C) 
Kcnq lo t i  /Lit 7, (D) Kcnql. Average CT was plotted against the natural log of the 
dilution factor. The gradient o f the trendline is the amplification efficiency of the 
primers and is used as part o f the percentage enrichment calculations. Percentage 
enrichment = AA(Input CT-IP CT)*100 where A is the amplification efficiency.
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The percentage enrichment shown in the results takes into account background 
levels of enrichment due to non-specific binding to the plastic-ware and sepharose 
beads. Each antibody has a different enrichment efficiency so can not be directly 
compared to each other. From the data it would appear that levels of H3K4me2 and 
H3K9me3 are at found at much higher levels at all the promoters as the percentage 
enrichment is often similar to H3 levels of enrichment; whereas the enrichment of all 
other modifications are extremely low. This is likely related to the efficiency of pull 
down by the antibody rather than actual levels of the histone modifications. To 
quantify actual levels we would need to compare our levels of enrichment to genes 
that are known to be depleted for the modifications of interest. For example, our 
analysis looked at the changes in the histone modifications across the entire IC2 
domain and we are comparing the enrichment at the repressed promoters to the active 
promoters within this domain. In domains where the expression status of the genes is 
unknown or there are no other genes in which to compare enrichment, we would have 
to compare the enrichment at our target gene to a repressed gene known to be highly 
enriched for our histone modification. This is usually a tissue specific gene that is 
silent in the cells of interest, such as Myoglobin. Enrichment of active chromatin 
markers are normally compared to constitutively expressed genes such as /3-actin. Our 
expression analysis data (chapter 3) already showed that Kcnqlotl/L itl is expressed at 
levels that appeared biallelic in undifferentiated and differentiated EG cells and it has 
been shown by other studies that this gene is also biallelically expressed in 
androgenetic cells (Lee et al. 1999; Ogawaa et al. 2006; Ruf et al. 2006). The other 
genes are known to be silent so, by comparing the pattern of histone modifications 
across the promoters of the IC2 domain genes, we can look at the association o f gene 
expression to histone modifications.
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5.3 Results
5.3.1 Analysis of the enrichment of active histone modifications in 
undifferentiated and differentiated EG and AG cells
In ES cells, the paternally expressed Kcnqlotl/L itl gene is associated with 
enrichment of active histone modifications whereas the paternally silenced Cdknlc 
and Phlda2 are associated with repressive histone modifications (Umlauf et a l 2004). 
From the previous chapters we observed that Kcnqlotl/Litl was expressed in 
undifferentiated EG cells so was likely to be enriched for active modifications. 
Cdknlc and Phlda2 were not expressed in undifferentiated EG cells so may be 
associated with repressive histone modifications.
Three histone modifications associated with ‘open’ chromatin and two histone 
modifications associated with ‘closed’ chromatin were examined in undifferentiated 
and differentiated EG cells using the chromatin immunoprecipitation protocol. The 
enrichment of these histone modifications was also examined in AKR1 androgenetic 
cells which contain two paternal genomes. As there are no available polymorphisms 
within our ES cell line, the AKR1 cell line was used to examine the final chromatin 
modifications associated with the repressed paternal allele in ES cells. This allowed us 
to compare ‘imprinted’ chromatin to ‘non-imprinted’ chromatin.
Figure 5.11 shows the enrichment of markers of ‘open’ chromatin across the 
IC2 domain in Sv6.1 EG cells. Enrichment of H3K9Ac was highest at the 
K cnqlotl/L itl promoter in undifferentiated cells (figure 5.11 A). Lower levels of 
enrichment were associated with the promoters o f the silent genes within this domain. 
After differentiation o f the cells, there was a similar pattern of enrichment with the
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highest levels of H3K9Ac at the Kcnqlotl/L itl and Phlda2 promoters and the lowest 
levels found at the promoters o f Cdknlc and Kcnql (figure 5.11 B).
A similar pattern was seen for H3K4me3 where the greatest enrichment of this 
histone modification was associated with the promoters of Kcnqlotl/L itl, Phlda2 and 
Kcnql in undifferentiated Sv6.1 EG cells (figure 5.11 E). After differentiation of the 
EG cells, the pattern remained relatively the same with the highest levels at 
Kcnqlotl/L itl and Phlda2 (figure 5.11 f). H3K4me2 levels, in contrast, appeared to 
be enriched only at Phlda2 and Kcnql promoters in undifferentiated cells (figure 5.11 
C). After differentiation, the levels o f H3K4me2 appeared to be relatively constant 
across the entire domain (figure 5.11 D).
In the TMAS21G EG cells we observed similar patterns of enrichment in 
undifferentiated and differentiated cells as we saw with the Sv6.1 EG cells (figure 
5.12). H3K9Ac levels appeared to be specifically enriched at the Kcnqlotl/Litl 
promoter in undifferentiated cells (figure 5.12 A). After differentiation, the pattern of 
enrichment was maintained although levels of H3K9Ac were also enriched at the 
Phlda2 promoter (figure 5.12 B). Contrary to what was seen with the Sv6.1 EG cells, 
the highest enrichment o f H3K4me2 was observed at the promoter of K cnqlotl/L itl 
and Kcnql in undifferentiated cells (figure 5.12 C). The lowest levels were observed 
at the promoters of Cdknlc and Phlda2. After differentiation, there was no specific 
enrichment of H3K4me2 at any of the promoters (figure 5.12 D). The greatest 
enrichment of H3K4me3 was observed at the Kcnqlotl/L itl promoter in 
undifferentiated cells (figure 5.12 E) and this pattern was maintained in differentiated 
cells (figure 5.12 F).
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Figure 5.11: Enrichment of active histone modifications at the promoter
regions of Phlda2, Cdknlc, Kcnqlotl/Litl and Kcnql in the undifferentiated
(day 0) and differentiated (day 5) Sv6.1 EG cell line.
The percentage enrichment of each target over input levels is shown for each 
promoter (calculated as described in figure 5.10). ChIP experiments were carried out 
using the Orange ChIP kit (Diagenode) using the optimised sonication and fixing 
conditions. A and B Enrichment of H3K9Ac, C and D enrichment of H3K4me2, E 
and F enrichment of H3K4me3. A, C and E results from undifferentiated cells; B, D 
and F results from differentiated cells. Kcnqlotl/Litl promoter is also the location of 
the ICR.
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Figure 5.12: Enrichment of active histone modifications at the promoter
regions of Phlda2, Cdknlc, Kcnqlotl/Litl and Kcnql in the undifferentiated
(day 0) and differentiated (day 5) TMAS21G EG cell line.
The percentage enrichment of each target over input levels is shown for each 
promoter (calculated as described in figure 5.10). ChIP experiments were carried out 
using the Orange ChIP kit (Diagenode) using the optimised sonication and fixing 
conditions. A and B Enrichment of H3K9Ac, C and D enrichment of H3K4me2, E 
and F enrichment of H3K4me3. A, C and E results from undifferentiated cells; B, D 
and F results from differentiated cells. Kcnqlotl/Litl promoter is also the location of 
the ICR.
Our analysis indicated that histone modifications associated with actively 
expressed genes were enriched at the Kcnqlotl/Litl promoter yet depleted at the 
Cdknlc promoter in both EG cell lines. This pattern was essentially maintained in the
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differentiated cells. Slight differences were observed between the two cell lines which 
could indicate a difference in their time of derivation, passage number, genetic 
background or experimental error. It was interesting to note that results for 
K cnqlotl/L itl and Cdknlc were consistant for both lines whereas the result for 
Phlda2 and Kcnql varied. This suggested the possibility that the Phlda2 and Kcnql 
results may reflect the low or absence of expression in the cell lines.
The results from the EG cells represented the state of ‘non-imprinted’ 
chromatin. Differentiation might model a transitional state into fully silenced 
chromatin brought about by an active silencing process. The active histone 
modifications associated with the repressed allele were examined in the androgenetic 
cell line, AKR1, which contains two paternal genomes. These modifications should 
correlate with the histone modifications found on the repressed paternal allele in ES 
cells and are an indication o f the state of ‘imprinted’ chromatin on the paternal allele 
at this domain. AG cells contain two paternally derived, and thus silent, IC2 domains 
and as a result should allow us to compare our ‘non-imprinted’ chromatin to 
chromatin that has passed through the paternal germ line and undergone full silencing 
of the domain. Differentiation of the AG cells would also allow us to observe changes 
in chromatin that are related to differentiation of the cells. Figure 5.13 A and B show 
the enrichment o f H3K9Ac before and after differentiation, respectively. H3K9Ac 
levels were highest at the Kcnqlotl/L itl promoter in undifferentiated cells. However, 
after differentiation the highest levels of enrichment were observed at the Phlda2 
promoter. Figure 5.13 C and D showed the enrichment of H3K4me2. As with the 
differentiated EG cells, levels of H3K4me2 were level across the entire domain 
however, after differentiation, the highest level of H3K4me2 enrichment was 
observed at Phlda2. The promoters of Phlda2, Kcnqlotl/L itl and Kcnql were
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enriched for H3K4me3 in undifferentiated AG cells (figure 5.13 E and F). After 
differentiation, this pattern was essentially the same.
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Figure 5.13: Enrichment of active histone modifications at the promoter
regions of Phlda2, Cdknlc, Kcnqlotl/L itl and Kcnql in the undifferentiated
(day 0) and differentiated (day 5) AKR1 AG cell line.
The percentage enrichment of each target over input levels is shown for each 
promoter (calculated as described in figure 5.10). ChIP experiments were carried out 
using the Orange ChIP kit (Diagenode) using the optimised sonication and fixing 
conditions. A and B Enrichment of H3K9Ac, C and D enrichment of H3K4me2, E 
and F enrichment of H3K4me3. A, C and E results from undifferentiated cells; B, D 
and F results from differentiated cells. K cnqlotl/L itl promoter is also the location of 
the ICR.
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These results indicated that, in undifferentiated AG cells, K cn qlo tl/L itl is 
marked with H3K9Ac and H3K4me3. H3K4me3 also marks the Phlda2  and Kcnql 
genes at levels of enrichment similar to that seen at the ICR and is maintained in 
differentiated cells. Phlda2 also appeared to be enriched for H3K4me2 and H3K9Ac 
in differentiated cells.
5.3.2 Analysis of the enrichment of repressive histone 
modifications in undifferentiated and differentiated EG and 
AG cells
As the IC2 domain is silent in the undifferentiated and differentiated EG cells, 
it is likely that both the ‘non-imprinted’ chromatin and ‘imprinted’ chromatin were 
enriched for repressive histone modifications. Two repressive histone modifications 
were examined that have been shown to be enriched on the silent paternal allele 
within the IC2 domain (Umlauf et a l 2004). Figure 5.14 shows the enrichment of 
H3K9me3 and H3K27me3 across the IC2 domain in undifferentiated and 
differentiated Sv6.1 EG cells. In the undifferentiated cells, the highest levels of 
enrichment of H3K9me3 appeared at the Kcnql and Phlda2 promoters (figure 5.14 
A). After differentiation this pattern was maintained (figure 5.14 B). The levels of 
H3K9me3 enrichment were similar between the promoters o f  Cdknlc and 
K cnqlotl/L itl at both time points.
H3K27me3 is known to be associated with the repressed alleles o f Cdknlc and 
Kcnql in somatic cells (Umlauf et al. 2004). In undifferentiated cells, we observed 
enrichment of H3K27me3 at the Phlda2 and Kcnql promoters but an absence of 
enrichment at the Cdknlc and K cnqlotl/L itl promoters (figure 5.14 C). After 
differentiation of the cells there was an increase in enrichment at the C dknlc  promoter 
but levels remained low at the K cnqlotl/L itl promoter, possibly indicating that this
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repressive histone modification was recruited to the Cdknlc promoter. This 
modification also appeared to be lost from the Kcnql promoter in differentiated cells.
The enrichment of the repressive histone modifications was also examined in 
the second EG cell line, TMAS21G. This cell line showed a different pattern of  
H3K9me3 enrichment to that observed in the undifferentiated Sv6.1 cells (figure 5.15 
A). H3K9me3 enrichment was highest at the Kcnqlotl/L itl promoter. After 
differentiation, the levels of H3K9me3 appeared to be constant across the domain 
with the highest levels at the Phlda2 and Kcnql promoters (figure 5.15 B). The levels 
of H3K27me3 across the IC2 domain showed the same pattern as observed in Sv6.1 
EG cells (figure 5.15 C and D). In undifferentiated cells, H3K27me3 was enriched on 
the promoter region of Kcnql and was depleted at all other promoters. After 
differentiation of the EG cells we observed enrichment of H3K27me3 at the Cdknlc 
and Phlda2 promoters to levels similar to that observed at the Kcnql promoter.
The data from the EG cells indicated that there were no differences in the 
levels of H3K9me3 across the IC2 domain in differentiated cells. In undifferentiated 
cells, there were some differences in H3K9me3 enrichment between the cell lines. 
H3K27me3 was unchanged after differentiation at the promoter region of Kcnql, and 
Phlda2 was enriched for H3K27me3 only in differentiated TMAS21G cells. 
However, the Cdknlc promoter became enriched for H3K27me3 in both cell lines, 
suggesting that further silencing of Cdknlc had occurred which did not occur at the 
Phlda2 and Kcnql promoters. One key difference between Cdknlc, Kcnql and 
Phlda2 was their expression level in stem cells as we did not detect Kcnql by qRT- 
PCR and Phlda2 was only expressed at low levels.
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Figure 5.14: Enrichment of repressive histone modifications across the IC2 
domain in undifferentiated (day 0) and differentiated (day 5) Sv6.1 EG 
cells.
Enrichment of repressive histone modifications, H3K9me3 (A and B) and H3K27me3 
(C and D), across the IC2 domain in undifferentiated (A and C) and differentiated EG 
cells (B and D). The percentage enrichment of each target over input levels is shown 
for each promoter (calculated as described in figure 5.10). ChIP experiments were 
carried out using the Orange ChIP kit (Diagenode) using the optimised sonication and 
fixing conditions. K cnqlotl/L itl promoter is also the location of the ICR.
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Figure 5.15: Enrichment of repressive histone modifications across the IC2 
domain in undifferentiated (day 0) and differentiated (day 5) TMAS21G 
EG cells.
Enrichment of repressive histone modifications, H3K9me3 (A and B) and H3K27me3 
(C and D), across the IC2 domain in undifferentiated (A and C) and differentiated EG 
cells (B and D). The percentage enrichment of each target over input levels is shown 
for each promoter (calculated as described in figure 5.10). ChIP experiments were 
carried out using the Orange ChIP kit (Diagenode) using the optimised sonication and 
fixing conditions. K cnqlotl/L itl promoter is also the location of the ICR.
The repressive histone modifications were also examined in the AKR1 AG 
cells. In this cell line we observed constant levels of H3K9me3 across the domain in 
undifferentiated cells (figure 5.16 A). This is similar to what was observed in the 
differentiated EG cells, hinting that this histone modification was absent in both forms 
o f ‘silent’ chromatin. However, after differentiation this modification was depleted at 
Kcnqlotl/Litl which could indicate that this modification is responsible for silencing 
in differentiated ES cells (figure 5.16 B).
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Levels of H3K27me3 were lowest at the Kcnqlotl/Litl and Phlda2 promoters 
in undifferentiated and differentiated cells (figure 5.16 C and D). The pattern of 
enrichment of H3K27me3 between Cdknlc and Kcnqlotl/Litl was similar to that 
observed in differentiated EG cells indicating that H3K27me3 may be responsible for 
silencing expression of Cdknlc and Kcnql within the IC2 domain. These results 
indicated that there was very little alteration to the H3K27me3 repressive histone 
modifications in differentiating AG cells and that the acquirement of H3K27me3 
enrichment at the promoter of Cdknlc was an active silencing step in EG cells.
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Figure 5.16: Enrichment of repressive histone modifications across the IC2 
domain in undifferentiated (day 0) and differentiated (day 5) AKR1 AG 
cells
Enrichment of repressive histone modifications, H3K9me3 (A and B) and H3K27me3 
(C and D), across the IC2 domain in undifferentiated (A and C) and differentiated EG 
cells (B and D). The percentage enrichment of each target over input levels is shown 
for each promoter (calculated as described in figure 5.10). ChIP experiments were 
carried out using the Orange ChIP kit (Diagenode) using the optimised sonication and 
fixing conditions. Kcnqlotl/Litl promoter is also the location of the ICR.
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In summary, we found that the active histone marks H3K9Ac and H3K4me3 
were consistently enriched at the Kcnqlotl/L itl promoter compared to Cdknlc in all 
three cell lines (figure 5.17). No change in the status of these marks was observed 
after differentiation. H3K4me2 enrichment varied between EG cell lines in 
undifferentiated cells. However, after differentiation there was no significant 
difference in enrichment at the Cdknlc and Kcnqlotl/L itl promoters in either of the 
EG cell lines. The same result was observed for the H3K9me3 levels where there 
were differences between cell lines in undifferentiated cells but no differences were 
observed after differentiation (figure 5.18). In AG cells, no significant difference was 
observed between Cdknlc and Kcnqlotl/L itl in the undifferentiated cells for either 
H3K4me2 or H3K9me3 enrichment. However, after differentiation both of these 
modifications were depleted at the K cnqlotl/L itl promoter.
H3K27me3 was consistently depleted at the Cdknlc promoter in 
undifferentiated EG cells but was enriched compared to Kcnqlotl/L itl in 
differentiated EG cells. This was consistent for both cell lines. In AG cells enrichment 
of H3K27me3 was highest at the Cdknlc promoter at both time points, compared with 
K cnqlotl/L itl, although this difference was not significant in undifferentiated cells 
(figure 5.18).
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Figure 5.17: Summary of the enrichment of the active histone modifications
associated with Cdknlc and K cnqlotl/L itl promoters in all three cell lines.
Summary o f the data from figures 5.11 to 5.16 showing only the enrichment o f the 
active modifications at the Cdknlc and Kcnqlotl promoters. Each cell line is shown 
going down the page in the order of Sv6.1 (top), TMAS21G (middle), AKR1 
(bottom). The histone modifications are shown across the page in the order of 
H3K9Ac (first), H3K4me2 (second) and H3K4me3 (third). The percentage 
enrichment of each target over input levels is shown for each promoter +/- SE 
(calculated as described in figure 5.10). A Mann-Whitney U test was performed to 
compare the levels of enrichment between the promoters. The significance levels are 
shown. *** p<0.001, ** p<0.01, * p<0.05, NS = no significant difference.
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Figure 5.18: Summary of the enrichment of the repressive histone 
modifications associated with Cdknlc and Kcnqlotl/Litl promoters in all 
three cell lines.
Summary of the data from figures 5.11 to 5.16 showing only the enrichment of the 
repressive modifications at the Cdknlc and Kcnqlotl promoters. Each cell line is 
shown going down the page in the order of Sv6.1 (top), TMAS21G (middle), AKR1 
(bottom). The histone modifications are shown across the page in the order of 
H3K9me3 (first) and H3K27me3 (second). The percentage enrichment of each target 
over input levels is shown for each promoter +/- SE (calculated as described in figure 
5.10). A Mann-Whitney U test was performed to compare the levels of enrichment 
between the promoters. The significance levels are shown. *** p<0.001, ** p<0.01, * 
p<0.05, NS = no significant difference.
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5.4 Discussion
The maternally expressed genes within the IC2 domain appeared to be silent in 
undifferentiated EG cells and suppressed in the differentiated cells. As this 
suppression of Cdknlc expression does not appear to correlate with DNA methylation 
at the Cdknlc promoter, it was likely that enrichment of repressive histone 
modifications and the depletion of active histone modifications were responsible for 
silencing of this gene. Differential histone modifications have been well characterised 
along the IC2 domain in ES and somatic cells but this was the first incidence of  
characterisation of the histone modifications associated with this domain in ‘non­
imprinted’ chromatin. We analysed five of the most commonly studied histone 
modifications that have also been shown to be differentially enriched at the IC2 
domain promoter regions.
5.4.1 Histone modifications of the IC2 domain in ‘non-imprinted’ 
versus 'imprinted’ chromatin
Our analysis of the IC2 domain indicated that there was an enrichment of 
active modifications on the K cnqlotl/L itl promoter, compared with the other 
promoters in both EG cell lines. The enrichment of these active modifications 
correlated with the expression status of this gene in the EG cells. In the AG cells, the 
Kcnqlotl/L itl promoter also showed enrichment of the active histone modifications 
indicating that in ‘non-imprinted’ chromatin, histone modifications associated with 
gene transcription are established at the KvDMRl and are maintained through the 
male germ line.
Cdknlc appears to be depleted for all active histone modifications in the 
undifferentiated EG and AG cells which correlated with the silencing o f this gene.
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These modifications were also absent in the differentiated cells. Surprisingly, in 
undifferentiated cells, the Cdknlc promoter also appeared to be depleted for 
H3K27me3. This was in contrast to the levels observed at the promoter regions of 
Phlda2 and Kcnql. However, after differentiation there was an enrichment of 
H3K27me3 at this promoter in both EG cell lines that then matched the pattern of 
enrichment observed in both the undifferentiated and differentiated AG cells. This 
data indicated that H3K27me3 was actively acquired at the Cdknlc promoter during 
differentiation of the EG cells. This is potentially interesting as H3K27me3 is a target 
of the histone methyltransferase complex PRC2. This complex contains the protein 
Eed which is required for the stability of the complex. Knock out studies of Eed have 
shown that the PRC2 complex is required to methylate H3K27me3 specifically at a 
selection of imprinted genes including Cdknlc, Gtl2 and GrblO (Mager et a l 2003). 
In the Mager et a l  study, loss of Eed resulted in biallelic expression of these genes 
with no loss of methylation at the DMRs, however the expression o f Cdknlc was not 
quantified and does, in fact, appear to be a partial loss of silencing (Mager et a l
2003). Several other imprinted genes examined in the Mager et a l study maintained 
monoallelic expression, including Phlda2, indicating that the PRC2 complex acts to 
silence expression of specific imprinted genes. Other studies have also shown that in 
the placenta, Eed is enriched at the paternally derived Kcnql and Cdknlc promoters 
indicating that it may be required to maintain silencing of these genes in somatic cells 
(Umlauf et a l 2004). There is also evidence to suggest that the methylation of 
H3K27me3 by the PRC2 complex facilitates binding of polycomb (pc), a component 
of the PRC1 complex, acting to further condense the chromatin and inhibit gene 
expression (Cao et a l  2002).
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Phlda2 and Kcnql seemed to be regulated in slightly different ways. The 
Phlda2 gene appeared to acquire enrichment of some active histone modifications 
without any increase in gene expression whereas the Kcnql gene lost enrichment of 
active histone modifications upon differentiation although this gene was not expressed 
in our undifferentiated EG cells. In both cases, levels of H3K27me3 appeared to 
remain enriched in both undifferentiated and differentiated cells indicating that this 
modification is most likely responsible for suppressing transcription. The enrichment 
of both active and repressive histone modifications has been noted at the promoter 
regions of developmentally important genes in stem cells where H3K4me3 and 
H3K27me3 have been shown to be co-ordinately associated with the silent promoters 
of genes in undifferentiated stem cells (Bernstein et a l 2006). After differentiating the 
cells, one or another of the histone marks is lost and leads to either increased gene 
expression or the maintenance of silencing. This occurred for the Kcnql gene in our 
ES and AG cells with the loss of active histone modifications in the differentiated 
cells and maintenance o f silencing, probably due to the presence of H3K27me3. For 
Phlda2, however, we actually see these ‘bivalent’ modifications only in the 
differentiated cells. Expression of Kcnql, although ubiquitously imprinted, is 
restricted to certain tissues in the embryo including the heart and kidney. The bivalent 
chromatin modifications may reflect its status as a tissue-specific gene. Even after 
differentiation, the promoter of this gene still retained high levels of both repressive 
and active histone modifications. A switch to silencing or active marks may not 
necessarily occur until later on in development.
Although we did not observe any significant changes in H3K9me3 patterns at 
any of the promoters in our EG cell lines, paternal silencing of Kcnql has been shown 
to correlate with H3K9 methylation in the placenta. The SET-domain protein G9a is a
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histone methyltransferase involved in H3K9 and K27 methylation at euchromatic 
regions (Ikegami et a l  2007; Wagschal et a l 2008). G9a deficiency results in partial 
CpG hypomethylation at several loci in ES cells, however G9a deficient mice show 
normal DNA methylation at DMRs and imprinted gene expression is unchanged 
(Ikegami et a l 2007; Wagschal et a l 2008). There is some evidence to suggest that 
placental-specific imprinting is impaired in the absence of G9a, correlating with 
reduced levels o f H3K9 di- and tri-methylation. There seems to be a moderate effect 
on trophoblastic differentiation which could be as a result of the relaxation of 
imprinting o f some placental-specfic genes within the IC2 domain such as Osbpl5, 
Ascl2 and CdHl (Wagschal et a l 2008). Consequently, G9a has also been shown to be 
enriched on Ascl2. This data implies that H3K9 methylation is part of a multi-layered 
silencing mechanism. Loss o f one o f the components could result in partial 
derepression o f the placental-specific genes (Wagschal et a l 2008). It has also been 
shown that G9a specifically binds Dnmtl so may be involved in maintenance of 
silencing at tissue specific methylated regions (Esteve et a l  2006). We did not 
observe any differences in H3K9me3 enrichment between Cdknlc and Kcnqlotl/L itl 
in any o f the EG cell lines indicating that this modification is probably not 
contributing to the differences in expression between these two genes. We do see 
enrichment at Cdknlc in the differentiated AG cells which may indicate that this 
modification is an extra silencing step in differentiated ES cells.
5.4.2 Comparison of the histone modifications associated with the 
IC2 domain in ES, EG and AG cells
Our analysis o f the gene expression levels showed that Cdknlc was repressed 
in undifferentiated ES cells. This data correlates with the histone modifications 
associated with the promoter in ES cells observed by Umlauf et a l  (Umlauf et a l
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2004). Umlauf et a l did not see any alleleic differences in Cdknlc histone 
methylation patterns yet, after differentiation, the Cdknlc promoter became enriched 
for H3K4me2 on the maternal allele and enriched for H3K27me3 on the paternal 
allele (Umlauf et a l 2004). Our results for the AG cells indicated that the H3K27me3 
mark is present in undifferentiated cells and is then maintained upon differentiation. It 
could be that the maternal allele is also marked with H3K27me3 in undifferentiated 
ES cells and that the allelic specific differences observed after differentiation is due to 
loss o f H3K27me3 from the maternal allele and not due to enrichment on the paternal 
allele. Although we also observed an increase in H3K4me2 after differentiation of the 
AG cells so, rather than the different parental alleles gaining enrichment of either 
H3K27me3 or H3K4me2, it could be that the allelic specific differences observed in 
the ES cells is due to loss of these modifications. This is consistent with the 
observation that, in ES cells, ‘bivalent’ chromatin marks are associated with 
developmentally important genes (Bernstein et a l 2006). If Cdknlc is marked by both 
H3K4me2 and H3K27me3 then this gene would be repressed and would also account 
for the lack o f allele specific differences observed by Umlauf et a l in undifferentiated 
ES cells. After differentiation, H3K4me2 would then be lost from the paternal allele 
and H3K27me3 lost from the maternal allele to give the differential histone 
modifications seen in the differentiated cells. This would be consistant with our 
results. Umlauf et a l also showed that Cdknlc is expressed in both undifferentiated 
and differentiated ES cells although this was not done quantitively (Umlauf et a l
2004). In our analysis we have showed that, although Cdknlc expression could be 
detected in undifferentiated ES cells at very low levels, this gene was only strongly 
expressed after differentiating the stem cells.
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Phlda2 and Kcnql are also not expressed in undifferentiated ES cells. Umlauf 
et a l did not analyse the enrichment of histone modifications at the Phlda2 or Kcnql 
promoters in ES cells. They did examine the enrichment in the placenta where there 
appeared to be enrichment of H3K9me2 and H3K27me3 on the repressed paternal 
alleles of both genes. The maternal allele appeared to be enriched for H3K4me2 and 
H3K9Ac. In the AG cells, the Phlda2 promoter appeared enriched for the active 
histone modifications which did not correlate with expression of this gene. There was 
also no enrichment o f H3K27me3 in the differentiated cells indicating that other 
modifications may be involved in silencing Phlda2 in these cells.
Our data showed that K cnqlotl/L itl was expressed at levels two-fold higher in 
EG cells than in ES cells. This gene is expressed from a promoter found within the 
KvDMRl and depends on the methylation status of the DMR. In ES cells, the 
KvDMRl is enriched for H3K9Ac and H3K4me2 on the paternal allele and for 
H3K9me2 and H3K27me3 on the maternal allele (Umlauf et a l 2004). Enrichment of 
H3K9Ac, H3K4me2 and H3K4me3 has been observed in somatic cells at actively 
expressed genes and are also found on the unmethylated paternal KvDMRl (Delaval 
et a l 2007). This data is consistant with our results as we also observed enrichment of  
H3K9Ac and H3K4me3 and a depletion of H3K27me3. Our results are consistant 
with that observed on the paternal allele in ES cells indicating that the paternal 
repressive histone modifications are the default pattern at the IC2 domain genes.
5.4.3 Conclusion
The histone modifications associated with the IC2 domain genes are consistant 
with their transcriptional status in EG cells. Active histone modifications are 
associated with the actively transcribed Kcnqlotl/L itl gene whereas the silenced
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Kcnql and Phlda2 are marked with the repressive histone modification H3K27me3. 
Kcnql appears to display bivalent histone modifications consistant with its role as a 
tissue specific imprinted gene. Cdknlc appeared to acquire an additional repressive 
modification, H3K27me3, in differentiated EG cells. It is possible that this is 
mediated by the polycomb repressive complex PRC2 as knockout studies have shown 
that Cdknlc is a target o f this complex.
5.4.4 Summary of findings
• The active K cnqlotl/L itl promoter in EG and AG cells is enriched with active 
histone modifications.
• The repressed genes Phlda2 and Kcnql are associated with both repressive 
and active histone modifications.
• Cdknlc shows enrichment of H3K27me3 only in differentiated EG cells 
mimicking the enrichment seen at this locus in both undifferentiated and 
differentiated AG cells.
•  Active acquirement o f H3K27me3 suggests the suppression o f Cdknlc 
expression involves additional modifications which could be mediated by the 
Eed containing complex PRC2.
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Chapter 6:
General Discussion and Summary of Findings
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6 General discussion and summary of findings
The work in this thesis initially follows on from the finding by Tada et al., that 
the Cdknlc locus was silent in in vivo differentiated EG cells and acquired de novo 
DNA methylation (Tada et al. 1998). Our aim was to replicate these results in vitro 
and examine the epigenetic events that led to the silencing and methylation of 
Cdknlc.
6.1.1 Cdknlc expression in undifferentiated and differentiated EG 
cells
In our study, we found that the levels o f Cdknlc expression in undifferentiated 
EG cells and ES cells were very low (late CT). When we differentiated ES cells in 
vitro, we detected high levels o f Cdknlc expression from day 7 onwards. This was 
consistent with previous data demonstrating that this gene is only expressed after cells 
start to differentiate. In our differentiated EG cells, Cdknlc expression remained at a 
very low level even after several days o f differentiation. This suggested that, as in in 
vivo differentiated EG cells, the Cdknlc locus was suppressed in the absence of a 
germ line imprint. The K cnqlotl/L itl transcript was detectable in both ES and EG 
cells. In EG cells the levels o f expression was approximately two-fold greater than in 
ES cells which suggested that the transcript was expressed from both alleles. 
However, we were not able to demonstrate this directly as no polymorphisms were 
present in the EG cell lines.
At earlier timepoints, the expression o f K cnqlotl/L itl was dynamic in both ES 
and EG cells which could indicate a role in the silencing process. Silencing must have 
occurred at a very early time point as we were not able to detect Cdknlc or Phlda2
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expression even at day one o f differentiation when we observed a modest increase in 
expression in ES cells.
6.1.2 Methylation of the Cdknlc promoter DMR
One of our aims was to determine if  de novo DNA methylation of the Cdknlc 
promoter occurred when the EG cells were differentiated in vitro. Methylation of the 
Cdknlc promoter could be involved in the suppression of Cdknlc expression that we 
observed in the differentiated EG cells. Methylation o f the paternal Cdknlc is present 
in somatic cells (Bhogal et al. 2004; John et al. 1999) and it may function as an extra 
layer of silencing to prevent leaky expression from the paternal allele. However, we 
did not detect any significant DNA methylation o f the Cdknlc promoter in either 
undifferentiated or differentiated EG cells. Unexpectedly, we also did not observe 
Cdknlc methylation in the undifferentiated and differentiated ES or AG cells. Since 
Cdknlc does appear to be suppressed in differentiated EG cells, this suggests that 
silencing of Cdknlc does not require DNA methylation. This is interesting because in 
humans there is no methylation o f Cdknlc yet the gene is still imprinted (Chung et al. 
1996; John et al. 1999; Onyango et al. 2000). There is also imprinted expression in 
the early embryo prior to the acquisition o f DNA methylation (Bhogal et al. 2004).
6.1.3 H3K27me3 enrichment at the Cdknlc promoter in 
differentiated EG cells
Our expression data suggested that silencing of Cdknlc was established in 
differentiated EG cells from a very early time point. We wanted to determine if this 
silencing of Cdknlc occurred in a stepwise fashion. For example, silencing could have 
occurred by the acquisition o f repressive histone modifications during differentiation 
of the EG cells or it could have been that the silent epigenetic state of the locus was
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present in undifferentiated cells. We compared ‘non-imprinted’ chromatin to 
‘imprinted’ chromatin in undifferentiated and differentiated cells to determine if there 
were differences in histone modifications associated with Cdknlc at the two time 
points. Our data showed that K cn qlo tl/L itl promoter was associated with active 
histone marks whereas these marks were depleted at the Cdknlc promoter in both EG 
and AG cells. No changes in these ‘active’ histone modifications were observed upon 
differentiation. In undifferentiated AG cells and differentiated AG and EG cells, the 
Cdknlc promoter was shown to be enriched for the repressive H3K27me3 
modification yet this mark was absent in undifferentiated EG cells indicating that 
H3K27me3 at the Cdknlc promoter was specifically acquired during differentiation of 
the EG cells in vitro. This might involve the action o f the PRC2 complex which has 
been shown to specifically methylate H3K27 at the Cdknlc locus and several other 
imprinted loci (Mager et al. 2003). This was not observed in the AG cells where this 
mark was present in both undifferentiated and differentiated cells. Therefore, despite 
the similarities between the paternal allele and the imprint erased allele (i.e. no 
methylation at KvDMRl, expression o f K cn qlo tl/L itl and no expression of Cdknlc, 
Phlda2, Slc22al8, and Kcnql) the epigenetic status of the chromatin in the 
undifferentiated cells was not the same.
H3K27me3 has been shown to be enriched on the paternal allele of GrblO. 
Yamasaki-Ishisaki et al. showed that H3K27me3 enrichment was localised to the 
promoter of the major-type transcript on the paternal allele (Yamasaki-Ishizaki et a l 
2007). As with Cdknlc, H3K27me3 is involved in silencing o f GrblO  as loss of the 
PRC2 complex component Eed results in biallelic expression o f GrblO  (Mager et al. 
2003). However, unlike the Cdknlc situation, the CpG island overlapping the GrblO 
major-type promoter remains unmethylated in somatic cells (Amaud et al. 2003;
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Hikichi et a l 2003; Yamasaki-Ishizaki et a l  2007). It may be that methylation of this 
CpG island is not needed to suppress paternal GrblO, as seen with Cdknlc, because 
the germ line DMR, in this case, functions as an insulator element. The CTCF protein 
binds the unmethylated DMR and insulates GrblO from its downstream enhancers and 
is analogous to the IC1 domain model o f imprinting. The fact that loss of Eed results 
in biallelic expression o f GrblO indicates that H3K27me3 is important for silencing 
GrblO expression. It would be interesting to determine the sequence o f epigenetic 
events that lead to GrblO silencing in the germ line particularly if, like Cdknlc, 
H3K27me3 is specifically enriched on the GrblO promoter in differentiated EG cells. 
However, it could be that CTCF binding is the main factor responsible for the 
suppression of GrblO expression in differentiated EG cells. As CTCF binding sites 
have also been found in Cdknlc and KvDMRl it may be that this protein also has 
some role in establishing silencing at Cdknlc (Du et a l  2003; Fitzpatrick et a l 2007).
6.1.4 Factors establishing silencing of Cdknlc in differentiated EG 
cells
We did not see any DNA methylation o f the Cdknlc promoter in the 
undifferentiated ES cells, which is consistent with this being a late event in 
embryogenesis i.e. the ES cells are derived from embryos (4.5 dpc) before DNA 
methylation has taken place (Bhogal et a l  2004). However, it might be expected that 
DNA methylation o f the promoter would occur in the differentiated ES and AG cells 
as differentiating the cells as embryoid bodies mimics the events that occur in the pre- 
and post-implantation embryo (Doetschman et a l  1985). It was possible that a key de 
novo methyltransferase or some other factor required for establishing methylation of 
the Cdknlc promoter was not expressed in the differentiated stem cells or that the 
cells did not reach the appropriate differentiated state in which these factors would be
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expressed. DNA methylation of the Cdknlc DMR is acquired during post­
implantation development from 7.5 dpc onwards and likely involves transfactors such 
as Lyphoid specific helicase (Lsh) as well as the de novo DNA methyltransferases 
(Bhogal et al. 2004; Fan et al. 2005; Zhu et al. 2006). It has been shown that 
acquisition of DNA methylation in the mouse depends on the presence of Lsh and has 
been shown to be important for the formation o f normal heterochromatin in the mouse 
(Dennis et al. 2001; Geiman et al. 1998; Yan et al. 2003). Targeted deletion of Lsh 
results in a substantial loss o f DNA methylation in the mouse, particularly at 
repetitive elements and single copy sequences (Dennis et al. 2001). Cdknlc 
expression is specifically affected by the loss o f Lsh and there is hypomethylation of 
the paternal somatic DMR (Fan et al. 2005). This suggests that DNA methylation is 
required for silencing Cdknlc but perhaps at a later stage o f development. No other 
imprinted genes have been shown to be affected. Lsh is known to associate with the 
de novo DNA methyltransferases Dnmt3a and Dnmt3b but not Dnmtl indicating that 
Lsh has a role in establishing methylation patterns but not in their maintenance (De La 
Fuente et al. 2006). In addition to Eed, other factors may be required to establish 
silencing before DNA methylation occurs, such as the deposition of the histone 
variant macroH2A or the binding o f non-histone proteins, such as HP1, which are 
known to be deposited at silent imprinting domains and DMRs (Choo et al. 2006; 
Nesterova et al. 2002; Smallwood et al. 2007).
Many of the epigenetic processes that are thought to be involved in allele- 
specific silencing are also involved in imprinted X inactivation in female mammals 
(Okamoto et al. 2004). This includes transcription of the non-coding RNAs Xist and 
Tsix and the recruitment o f DNA methylation. Repressive histone modifications are 
also recruited to the silent X chromosome by chromatin remodelling complexes such
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as PRC2 (Rougeulle et al. 2004). This remodelling o f chromatin may be a stepwise 
process with certain modifications occurring first providing a base for extra layers of 
silencing, such as ubiquitination o f H2A which occurs on the silent X chromosome 
and correlates with recruitment o f the PRC1 complex (de Napoles et a l  2004; 
Nesterova et al. 2002). Future work could involve examining the expression of 
proteins that are potentially involved in establishing silencing o f Cdknlc in 
differentiating EG and ES cells to determine if  a key element is absent. ChIP could 
also be performed to determine if  these trans-factors localise to the IC2 domain during 
differentiation o f the EG cells, such as Eed and Lsh. Sequential ChIP (SeqChIP) could 
then be used to address whether two proteins occupy the same genomic region and 
could also determine whether this co-occupency is dependent on a particular protein 
binding (Geisberg and Struhl 2004). This would allow us to determine if there is a 
particular sequence o f binding o f transfactors to Cdknlc during differentiation that 
leads to the formation of heterochromatin and methylation of Cdknlc. It would also 
be interesting to identify other somatic DMRs that are absent in ES cells and only 
become de novo methylated in the developing embryo, such as at Nesp55.
6.1.5 Other histone modifications involved in silencing of Cdknlc
We only examined six o f the most common histone modifications associated 
with the IC2 domain genes and, in fact, there are numerous others that have been 
shown to be involved in establishing allele specific differences in chromatin between 
the two parental alleles - such as H3K20 methylation and H3K9 mono- and di- 
methylation. In some cases o f BWS there is down regulation o f CDKN1C expression 
yet there is normal methylation at KvDMRl and the CDKN1C promoter remains 
unmethylated. In these cases the loss o f CDKN1C expression has been shown to be
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associated with the loss o f the active histone mark H3K4me2 and enrichment of 
markers of heterochromatin, H3K9me2 and HPly (Diaz-Meyer et a l 2005). To get a 
full understanding of the histone modifications that are responsible for silencing the 
IC2 domain genes it may be necessary to perform ChIP on the EG cells for a wider 
range of histone modifications. A distinct advantage would be to use ‘ChIP on chip’ 
where ChIP is combined with microarray analysis and could be used to analyse the 
changes in histone modifications across multiple sites within the IC2 domain, 
increasing the resolution of our data (Ren et al. 2000) [‘ChIP on chip’ reviewed in 
(Buck and Lieb 2004)]. We could also use our system to examine earlier time points 
to determine at what time point H3K27me3 appears at the Cdknlc promoter. Our 
expression data indicated that Cdknlc was already silenced by day one of 
differentiation so it is possible that acquisition o f H3K27me3 occurred very early on 
during differentiation. There could also be other repressive histone marks that we 
haven’t yet examined that could be acquired at this time point before H3K27me3. Our 
analysis looked at the relative levels o f the histone modifications within the IC2 
domain comparing the enrichment o f modifications at an actively expressed gene 
(.K cnqlotl/L itl) and a suppressed gene {Cdknlc). It would be interesting to compare 
this enrichment to control genes that are known to be silent in both undifferentiated 
and differentiated EG cells and genes that are expressed at both time points. We could 
then determine whether the enrichment that we observe at our imprinted genes is 
comparable to that of a fully silenced gene. There are several other imprinted genes 
within this cluster, although the majority are tissue specific. With ChIP microarray 
analysis it might be possible to look at the promoter regions o f all the imprinted genes 
within this cluster to determine if  the entire domain is silent from the very beginning
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or if there is a spread of repressive chromatin occurring in the absence o f methylation 
of KvDMRl.
6.1.6 Role of the non-coding RNA in Cdknlc silencing
K cnqlotl/L itl appeared to be expressed throughout the differentiation o f the 
EG and ES cells, although dynamic changes in expression were observed at early time 
points. Recent evidence suggests that transcription of the full length non-coding RNA 
is required for silencing o f the paternal allele in somatic cells indicating that, in our 
EG cells, K cnqlotl/L itl may somehow be responsible for the active silencing of 
Cdknlc (Mancini-DiNardo et al. 2006; Shin et al. 2008). As the different length 
truncations of Kcnqlotl/L itl appeared to have different effects on the silencing of 
Cdknlc, it may be that the transcription of this non-coding RNA is required to recruit 
the PRC2 complex to establish H3K27me3 at distant loci. This then may be the 
initiation mark for the recruitment of other silencing mechanisms such as the PRC1 
complex, HPly, Lsh and ultimately DNA methylation to the silent promoter (figure 
6.1). Shin et al. showed that a 2.6 kb truncation of K cnqlotl/L itl resulted in loss of 
methylation at Cdknlc but imprinting was still maintained in some tissues. It would 
be interesting to see if  we still get methylation o f H3K27 in the absence of 
Kcnqlotl/L itl in the differentiated EG cells or if  this repressive histone mark is lost in 
AG cells when Kcnqlotl/L itl is no longer expressed. This would allow us to 
determine if this non-coding transcript and H3K27me3 were required for establishing 
silencing or maintaining it. It would also be interesting to see what the effect of the 
different truncation lengths had on the chromatin structure around Cdknlc. How the 
non-coding RNA mediates silencing o f the IC2 domain genes is still unclear. It may 
involve altering the local chromatin environment by recruiting complexes such as the
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PRC2 complex. Future work could include using RNA interference (RNAi) 
technology to knock down components o f the PRC2 complex in EG cells to confirm 
that this complex is involved in establishing H3K27me3 at Cdknlc. Preliminary 
experiments, not described in this thesis, were performed with this intention. This 
included cloning Eed oligos to create short hairpin RNA (shRNA) constructs within 
pSUPER-RED in order to knock down Eed expression in EG and ES cells. This 
technology could also be used to identify other transfactors that may be involved in 
silencing and heterochromatin formation. Knockdown of macroH2Al by RNAi has 
already been shown to reduce expression o f some o f the Peg3 domain genes without 
altering DNA methylation at the DMR so is likely involved in establishing 
heterochromatin at some imprinted domains (Choo et a l  2007). Alternatively, 
expressing factors such as Lsh or the DNA methyltransferases (if they are found not 
to be expressed in the ES or EG cells) could allow us to determine if  it is the absence 
of expression of these proteins that is responsible for the hypomethylation of the 
Cdknlc DMR or if  it is because the chromatin structure is not permissive for de novo 
methylation until later in development.
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Figure 6.1: Model of the epigenetic events leading to silencing of Cdknlc.
EG cells differentiated in vitro showed enrichment of the repressive histone 
modification H3K27me3 which was absent in undifferentiated EG cells. Recruitment 
was likely mediated by the action of the PRC2 complex. The Cdknlc promoter was 
hypo-methylated in differentiated EG cells so DNA methylation is probably a late 
epigenetic event required for full long term silencing of paternal Cdknlc in the 
embryo.
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6.1.7 Conclusion
In somatic cells the maternal and paternal alleles of Cdknlc are marked with 
different epigenetic modifications that result in monoallelic expression from the 
maternal allele only. These epigenetic marks are established in the germ line. Our 
results indicated that paternal silencing of Cdknlc is a default silencing process that 
occurs in the male germ line and involves the recruitment of the repressive histone 
mark H3K27me3. In the maternal germ line this default pathway appears to be 
inhibited by methylation of the germ line DMR, KvDMRl, preventing transcription of 
Kcnqlotl/L itl. In BWS, loss of imprinting of KCNQlOTl/LITl is one of the most 
common epigenetic mutations and can be caused by hypomethylation of KvDMRl, 
the maternal methylation mark established in the developing oocyte (Bliek et a l 2001; 
Lee et al. 1999). If this methylation mark is not established in the maternal germ line 
then the IC2 domain undergoes a default pathway resulting in silencing of CDKN1C. 
Loss o f CDKN1C expression and biallelic expression of IGF2 are both causes of 
BWS in humans, either through the action of genetic or epigenetic mutations. 
Studying the epigenetic marks that lead to alterations in expression of these genes in 
the germ line could lead to a better understanding of the causes of the disease and to 
possible therapeutic interventions.
In addition to our study of the IC2 domain genes, we identified several other 
imprinted genes that also appeared to be suppressed in the absence of imprint. The 
majority o f the germ line DMRs are maternally methylated with only a subset that are 
methylated in the male germ line. It is likely that methylation of the germ line DMR is 
the primary imprinting mark that, as in the case of the IC2 domain, switches the 
domain from the default pathway to a maternal specific pathway. In fact recently a
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study has shown that, in the absence of paternal methylation at the IG-DMR, both 
alleles o f the Gtl2-DlkJ imprinted domain establish a maternal histone acetylation 
pattern at the Gtl2 DMR (Carr et al. 2007). Our EG cell model could be used to study 
other imprinting domains, particularly those that, like Cdknlc, are suppressed in 
differentiated EG cells, in order to identify the key epigenetic marks required to 
establish default silencing o f these genes.
6.1.8 Summary
Our EG system provides a unique model for studying the early epigenetic 
events that lead to heritable silencing o f imprinted genes. We were able to show that, 
despite a lack of DNA methylation at the somatic and germ line DMRs, Cdknlc was 
still suppressed in differentiated EG cells and that this was likely due to the active 
acquirement of repressive histone modification marks such as H3K27me3. This 
analysis could be applied to other imprinted domains in order to ascertain the key 
epigenetic modifications that contribute to monoallelic expression in the embryo.
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